Novonix Limited (NVX) 20-F 31 Aug 22 2022 FY Annual report (foreign) Financial data

Document and Entity Information

Document and Entity Information	12 Months Ended
	Jun. 30, 2022 shares
Document Information [Line Items]
Document Type	20-F
Amendment Flag	false
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Registrant Name	NOVONIX LIMITED
Entity Central Index Key	0001859795
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	485,951,369
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Title of 12(b) Security	American Depositary Shares, each representing four ordinary shares, no par value
Trading Symbol	NVX
Security Exchange Name	NASDAQ
Entity File Number	001-41208
Entity Incorporation, State or Country Code	C3
Entity Address, Address Line One	Level 8
Entity Address, Address Line Two	46 Edward Street
Entity Address, City or Town	Brisbane
Entity Address, Country	AU
Entity Address, Postal Zip Code	QLD 4000
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Document Registration Statement	false
Document Accounting Standard	International Financial Reporting Standards
Entity Bankruptcy Proceedings, Reporting Current	false
Auditor Name	PricewaterhouseCoopers
Auditor Firm ID	1379
Auditor Location	Brisbane, Australia
Business Contact
Document Information [Line Items]
Entity Address, Address Line One	Level 8
Entity Address, Address Line Two	46 Edward Street
Entity Address, City or Town	Brisbane
Entity Address, Country	AU
Entity Address, Postal Zip Code	QLD 4000
Contact Personnel Email Address	suzie@novonixgroup.com
Contact Personnel Name	Suzanne Yeates

Consolidated statement of profi

Consolidated statement of profit or loss and other comprehensive income - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenue from contracts with customers	$ 8,417,763	$ 5,227,347	$ 4,253,435
Cost of goods and services (exclusive of depreciation presented separately)	(3,005,977)	(969,774)	(1,245,187)
Administrative and other expenses	(16,736,023)	(3,945,829)	(2,739,398)
Impairment losses		(2,764,940)
Depreciation and amortisation expenses	(5,814,905)	(1,697,754)	(1,380,303)
Loss on equity investment securities at fair value through profit or loss	(10,951,552)
Research and development costs	(7,040,367)	(2,809,984)	(2,423,546)
Nasdaq listing related expenses	(5,830,698)
Share based compensation	(20,190,538)	(5,948,532)	(7,558,953)
Employee benefits expense	(17,572,673)	(5,837,926)	(4,072,223)
Borrowing costs	(2,086,863)	(229,394)	(5,330,961)
Foreign currency gain (loss)	7,168,642	(83,943)	(376,267)
Other income, net	2,202,167	984,652	844,877
Loss before income tax (expense) benefit	(71,441,024)	(18,076,077)	(20,028,526)
Income tax (expense) benefit	0	0	383,655
Loss for the year	(71,441,024)	(18,076,077)	(20,028,526)
Other comprehensive loss for the year, net of tax
Foreign currency translation of foreign operations	9,167,212	(2,101,097)	550,243
Total comprehensive loss	$ (62,273,812)	$ (20,177,174)	$ (19,478,283)
Loss per share attributable to the ordinary equity holders - basic	$ 0.15	$ 0.05	$ 0.15
Loss per share attributable to the ordinary equity holders - diluted	$ 0.15	$ 0.05	$ 0.15
Weighted average shares outstanding - basic	464,437,628	366,289,024	135,918,095
Weighted average shares outstanding - diluted	464,437,628	366,289,024	135,918,095

Consolidated Balance Sheets

Consolidated Balance Sheets - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Current assets
Cash and cash equivalents	$ 207,083,935	$ 136,663,976
Trade and other receivables	3,558,016	2,042,963
Inventory	2,716,143	2,780,373
Prepayments	7,356,917	2,538,207
Escrow reserves	14,639,419
Total current assets	235,354,430	144,025,519
Non-current assets
Property, plant and equipment	151,184,196	31,578,445
Financial assets at fair value through profit or loss	24,179,998
Right-of-use assets	7,443,048	7,406,943
Exploration and evaluation assets	3,218,228	3,108,073
Intangible assets and goodwill	17,938,868	16,581,709
Other assets	242,634	156,584
Total non-current assets	204,206,972	58,831,754
Total assets	439,561,402	202,857,273
Current liabilities
Trade and other payables	9,479,659	4,356,556
Other liabilities	3,938	310,102
Lease liabilities	489,846	410,792
Borrowings	1,474,090	277,060
Total current liabilities	11,447,533	5,354,510
Non-current liabilities
Other labilities	4,352,412
Lease liabilities	7,265,686	7,120,396
Borrowings	52,152,452	5,986,565
Total non-current liabilities	63,770,550	13,106,961
Total liabilities	75,218,083	18,461,471
Net assets	364,343,319	184,395,802
EQUITY
Contributed equity	458,677,068	233,196,507
Reserves	59,040,536	33,132,556
Accumulated losses	(153,374,285)	(81,933,261)
Total equity	$ 364,343,319	$ 184,395,802

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - AUD ($)	Total	Contributed equity	Accumulated losses	Share Based Payments Reserve	Foreign Currency Translation Reserve	Convertible Loan Note Reserve
Balance at the beginning of the year at Jun. 30, 2019	$ 15,772,778	$ 38,163,405	$ (43,828,658)	$ 15,258,956	$ 950,004	$ 5,229,071
Loss for the year	(20,028,526)		(20,028,526)
Other comprehensive income	550,243				550,243
Total comprehensive loss	(19,478,283)		(20,028,526)		550,243
Transactions with owners in their capacity as owners:
Contributions of equity, net of transaction costs	61,688,105	61,688,105
Settlement of limited recourse loan	1,189,081
Equity component of convertible notes, net of transaction costs	990,741					990,741
Share-based payments	7,558,952			7,558,952
Balance at the end of the year at Jun. 30, 2020	66,532,293	99,851,510	(63,857,184)	22,817,908	1,500,247	6,219,812
Loss for the year	(18,076,077)		(18,076,077)
Other comprehensive income	(2,101,097)				(2,101,097)
Total comprehensive loss	(20,177,174)		(18,076,077)		(2,101,097)
Transactions with owners in their capacity as owners:
Contributions of equity, net of transaction costs	131,844,997	131,844,997
Settlement of limited recourse loan	247,154	1,500,000		(1,252,846)
Share-based payments	5,948,532			5,948,532
Balance at the end of the year at Jun. 30, 2021	184,395,802	233,196,507	(81,933,261)	27,513,594	(600,850)	6,219,812
Loss for the year	(71,441,024)		(71,441,024)
Other comprehensive income	9,167,212				9,167,212
Total comprehensive loss	(62,273,812)		(71,441,024)		9,167,212
Transactions with owners in their capacity as owners:
Contributions of equity, net of transaction costs	225,480,561	225,480,561
Share-based payments	16,740,768			16,740,768
Balance at the end of the year at Jun. 30, 2022	$ 364,343,319	$ 458,677,068	$ (153,374,285)	$ 44,254,362	$ 8,566,362	$ 6,219,812

Consolidated statement of cash

Consolidated statement of cash flows	12 Months Ended
	Jun. 30, 2022 AUD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2020 AUD ($)
Cash flows from operating activities
Receipts from customers (inclusive of consumption tax)	$ 9,033,341	$ 5,724,549	$ 3,542,286
Payments to suppliers and employees (inclusive of consumption tax)	(52,830,063)	(14,555,132)	(9,748,626)
Interest received	11,471	35,066	723
Payment of borrowing costs	(2,022,565)	(227,789)	(232,055)
Government grants received	5,454,524	851,242	844,155
Net cash outflow from operating activities	(40,353,292)	(8,172,064)	(5,593,517)
Cash flows from investing activities
Payments for exploration assets	(102,155)	(117,635)	(146,196)
Payment of escrow funds	(20,033,245)
Proceeds from release of escrow funds	6,111,305
Payments for investments	(17,615,757)
Payments for intangibles	(38,198)
Payments for security deposits	(209,455)	(134,250)	(16,369)
Payments for property, plant and equipment	(115,462,952)	(26,164,470)	(5,339,448)
Net cash outflow from investing activities	(147,350,457)	(26,416,355)	(5,502,012)
Cash flows from financing activities
Proceeds on issue of shares	208,290,142	136,818,667	45,845,239
Payment of share issue expenses	(190,374)	(7,908,866)	(1,308,596)
Payment of withholding tax - Performance rights	(3,426,420)
Proceeds from borrowings	45,863,821	4,059,714	6,603,722
Principal elements of lease repayments	(425,506)	(190,426)	(141,968)
Repayment of borrowings	(791,181)	(86,543)	(6,996,422)
Net cash inflow from financing activities	249,320,482	132,692,546	44,001,975
Net increase in cash and cash equivalents	61,616,733	98,104,127	32,906,446
Effects of foreign currency	8,803,226	(247,813)	(153,448)
Cash and cash equivalents at the beginning of the year	136,663,976	38,807,662	6,054,664
Cash and cash equivalents at the end of the year	$ 207,083,935	$ 136,663,976	$ 38,807,662

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2022
Disclosure Of Initial Application Of Standards Or Interpretations [Abstract]
Summary of Significant Accounting Policies	Note 1 Summary of significant accounting policies Corporate information NOVONIX Limited (“NOVONIX,” the “Company,” or the “Group”) is a battery technology and materials business that provides advanced products and mission critical services to leading battery manufacturers, materials companies, automotive original equipment manufacturers (“OEMs”) as well as consumer electronics manufacturers at the forefront of the global electrification economy. NOVONIX was incorporated under the laws of Australia in 2012 under the name Graphitecorp Pty Limited. In 2015, the Company completed an initial public offering of its ordinary shares and the listing of its ordinary shares on the Australian Securities Exchange, or the ASX, and changed the Company’s name to GRAPHITECORP Limited. In 2017, the Company changed its name to NOVONIX Limited. The Company’s headquarters is located at Level 8, 46 Edward Street, Brisbane, Queensland 4000, Australia, and the Company’s registered office is located at Level 11, 66 Eagle Street, Brisbane Queensland, Australia. The financial statements were authorized for issue by the Directors on August 31, 2022. The Directors have the power to amend and reissue the financial statements . Basis of preparation These general-purpose financial statements have been prepared in accordance with International Financial Reporting Standards (”IFRS”) as issued by the International Accounting Standards Board (“IASB”). Material accounting policies adopted in the preparation of these consolidated financial statements are presented below and have been consistently applied unless stated otherwise. Except for cash flow information, the consolidated financial statements have been prepared on an accruals basis and are based on historical costs, modified, where applicable, by the measurement at fair value of selected non-current assets, financial assets and financial liabilities. Going concern These consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of normal business activities and the realization of assets and settlement of liabilities in the normal course of business. As disclosed in these consolidated financial statements , the Group incurred a net loss of $ 71,441,024 (June 30, 2021: $ 18,076,077 ) and net operating cash outflows of $ 40,353,292 (June 30, 2021: $ 8,172,064 ) for the year ended June 30, 2022. As at June 30, 2022 the Group has a cash balance of $ 207,083,935 (30 June 2021: $ 136,663,976 ) and net current assets of $ 223,906,897 (30 June 2021: $ 138,671,009 ). The Group is continuing to execute on its expansion plans of reaching production capacity of 40,000 tonnes per year by 2025 and in order to fund these expansionary activities, which will primarily involve significant capital expenditure, additional funding beyond the existing cash balance at 30 June 2022 will be required. The ability of the Group to continue as a going concern is principally dependent upon one or more of the following: • the successful and profitable growth of the battery materials, battery consulting and battery technology businesses; • the ability of the Group to meet its cash flow forecasts; and • the ability of the Group to raise funds as and when necessary from either customers, governments and/or investors in the form of debt, equity and/or grant funding. These conditions give rise to a material uncertainty which may cast significant doubt (or substantial doubt as contemplated by Public Company Accounting Oversight Board (“PCAOB”) standards) over the Group’s ability to continue as a going concern. The directors believe that the going concern basis of preparation is appropriate as the Group has a strong history of being able to raise capital from debt and equity sources, raising $ 208 million in September 2021 following the investment made by Phillips 66, as well as $ 131 million in March and May 2021. The Directors have considered the impact of COVID 19 and found that the pandemic has not had a significant effect on the Group’s ability to continue as a going concern. Should the Group be unable to continue as a going concern, it may be required to realise its assets and extinguish its liabilities other than in the ordinary course of business, and at amounts that differ from those stated in these consolidated financial statements. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts or classification of liabilities and appropriate disclosures that may be necessary should the Group be unable to continue as a going concern. These consolidated financial statements were authorized for issue by the Directors on August 31, 2022. The Directors have the power to amend and reissue these consolidated financial statements. Principles of consolidation These consolidated financial statements incorporate the assets and liabilities of all subsidiaries of NOVONIX Limited (‘Company’ or ‘Parent Entity’) as at June 30, 2021 and the results of all subsidiaries for the year then ended. NOVONIX Limited and its subsidiaries together are referred to in these financial statements as the ‘Group’. Subsidiaries are all those entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are de-consolidated from the date that control ceases. Intercompany transactions, balances and unrealized gains on transactions between entities in the Group are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group. Where equity instruments are issued in a business combination, the fair value of the instruments is their published market price as at the date of exchange. Transaction costs arising on the issue of equity instruments are recognized directly in equity. The consideration transferred also includes the fair value of any asset or liability resulting from a contingent consideration arrangement. With limited exceptions, all identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. The excess of the consideration transferred, amount of any non-controlling interest in the acquired entity, over the net fair value of the Group's share of the identifiable net assets acquired is recognized as goodwill. If the consideration transferred of the acquisition is less than the Group's share of the net fair value of the identifiable net assets of the subsidiary, the difference is recognized as a gain in the profit and loss in the Consolidated Statement of Profit or Loss and Other Comprehensive Income, but only after a reassessment of the identification and measurement of the net assets acquired. Where settlement of any part of the cash consideration is deferred, the amounts payable in the future are discounted to their present value, as at the date of exchange. The discount rate used is the entity's incremental borrowing rate, being the rate at which a similar borrowing could be obtained from an independent financier under comparable terms and conditions. Fair value measurements Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. For some assets and liabilities, observable market transactions or market information is available. For other assets and liabilities, observable market transactions or market information might not be available. When a price for an identical asset or liability is not observable, another valuation technique is used. To increase consistency and comparability in fair value measurements, there are three levels of the fair value hierarchy based on the inputs used: • Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities • Level 2 – Inputs are inputs other than quoted prices included within Level 1, which are observable for the asset or liability either directly or indirectly • Level 3 – Inputs are unobservable inputs for the asset or liability The Group recognizes transfers between levels of the fair value hierarchy at the end of the reporting period during which the change has occurred. Income tax The income tax expense or benefit for the period is the tax payable on that period’s taxable income based on the applicable income tax rate for each jurisdiction, adjusted by the changes in deferred tax assets and liabilities attributable to temporary differences, unused tax losses and the adjustment recognized for prior periods, where applicable. Deferred tax assets and liabilities are recognized for temporary differences at the tax rates expected to be applied when the assets are recovered or liabilities are settled, based on those tax rates that are enacted or substantively enacted, except for: • When the deferred income tax asset or liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business combination and that, at the time of the transaction, affects neither the accounting nor taxable profits; or (i) • When the taxable temporary difference is associated with interests in subsidiaries, associates or joint ventures, and the timing of the reversal can be controlled and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax assets are recognized for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts will be available to utilize those temporary differences and losses. The carrying amount of recognized and unrecognized deferred tax assets are reviewed at each reporting date. Deferred tax assets recognized are reduced to the extent that it is no longer probable that future taxable profits will be available for the carrying amount to be recovered. Previously unrecognized deferred tax assets are recognized to the extent that it is probable that there are future taxable profits available to recover the asset. Deferred tax assets and liabilities are offset only where there is a legally enforceable right to offset current tax assets against current tax liabilities and deferred tax assets against deferred tax liabilities; and they relate to the same taxable authority on either the same taxable entity or different taxable entities which intend to settle simultaneously. Revenue recognition Revenue from contracts with customers is recognized when control of the goods or services is transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those goods or services . Sales of Goods Revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware. Consulting services The consulting division provides battery cell design, implementation and support services under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided because the customer receives and uses the benefits simultaneously. This is determined based on the actual labor hours spent relative to the total expected labor hours. Where the contracts include multiple performance obligations, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expected cost-plus margin. Contract balances Trade and other receivables A receivable is recognized when the Group’s right to consideration is unconditional, which is generally when goods are delivered or services are performed, as only the passage of time is required before payment is due. Contract liabilities A contract liability is the obligation to transfer goods or services to a customer for which the Group has received consideration (or an amount of consideration is due) from the customer. If a customer pays consideration before the Group transfers goods or services to the customer, a contract liability is recognized when the payment is made or the payment is due (whichever is earlier). Contract liabilities are recognized as revenue when the Group performs under the contract. Other income Interest Interest income is recognized as interest accrues using the effective interest method. This is a method of calculating the amortized cost of a financial asset and allocating the interest income over the relevant period using the effective interest rate, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to the net carrying amount of the financial asset. Grant revenue Grants from government bodies are recognized at their fair value where there is a reasonable assurance that the grant will be received and the group will comply with all attached conditions. Operating segments Operating segments are presented using the ‘management approach’, where the information presented is on the same basis as the internal reports provided to the Chief Operating Decision Makers (‘CODMs’). The CODMs are responsible for the allocation of resources to operating segments and assessing their performance. Current and non-current classification Assets and liabilities are presented in the balance sheet based on current and non-current classification. An asset is classified as current when: it is either expected to be realized or intended to be sold or consumed in normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realized within 12 months after the reporting period; or the asset is cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12 months after the reporting period. All other assets are classified as non-current. A liability is classified as current when: it is either expected to be settled in normal operating cycle; it is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no unconditional right to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities are classified as non-current. Deferred tax assets and liabilities are always classified as non-current. Cash and cash equivalents Cash and cash equivalents includes cash on hand, deposits held at call with financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. For the statement of cash flows presentation purposes, cash and cash equivalents also includes bank overdrafts, which are shown within borrowings in current liabilities on the balance sheet. Other receivables Other receivables are recognized at amortized cost, less any provision for impairment. Inventories Inventories are measured at the lower of cost and net realizable value. The cost of manufactured products includes direct materials, direct labor and an appropriate proportion of variable and fixed overheads. Costs are assigned to individual items of inventory on the basis of weighted average costs. Exploration and evaluation assets Exploration and evaluation expenditure incurred is accumulated in respect of each identifiable area of interest. Such expenditures comprise net direct costs and an appropriate portion of related overhead expenditure but do not include overheads or administration expenditure not having a specific nexus with a particular area of interest. These costs are only carried forward to the extent that they are expected to be recouped through the successful development of the area or where activities in the area have not yet reached a stage which permits reasonable assessment of the existence of economically recoverable reserves and active or significant operations in relation to the area are continuing. A regular review has been undertaken on each area of interest to determine the appropriateness of continuing to carry forward costs in relation to that area of interest. An impairment charge is recognized when the Directors are of the opinion that the carried forward net cost may not be recoverable or the right of tenure in the area lapses. When production commences, the accumulated costs for the relevant area of interest are amortized over the life of the area according to the rate of depletion of the economically recoverable reserves. Loan notes Loan notes are initially measured at fair value less transaction costs. Amortized cost is calculated as the amount at which the loan note is measured at initial recognition less principal repayments, and adjusted for any cumulative amortization of the difference between that initial amount and the maturity amount calculated using the effective interest method. The effective interest method is used to allocate interest expense over the relevant period and is equivalent to the rate that discounts estimated future cash payments over the expected life of the financial instrument to the net carrying amount of the financial liability. Non-derivative financial liabilities, other than financial guarantees, are subsequently measured at amortized cost. Gains or losses are recognized in profit or loss through the amortization process and when then financial liability is derecognized. Property, plant and equipment Property, plant and equipment is stated at historical cost less accumulated depreciation and impairment. Historical cost includes expenditure that is directly attributable to the acquisition of the items. Depreciation is calculated on a straight-line basis to write off the net cost of each item of property, plant and equipment (excluding land) over their expected useful lives as follows: Buildings ​ 25 years Plant and equipment ​ 2 - 20 years The residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date. An item of plant and equipment is derecognized upon disposal or when there is no future economic benefit to the Group. Gains and losses between the carrying amount and the disposal proceeds are taken to profit or loss. Trade and other payables These amounts represent liabilities for goods and services provided to the Group prior to the end of the financial year and which are unpaid. Due to their short-term nature they are measured at amortized cost and are not discounted. The amounts are unsecured and are usually paid within 30 days of recognition. Leases The group leases a warehouse in Tennessee from which the NOVONIX Anode Materials business operates. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes. Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments: • fixed payments (including in-substance fixed payments), less any lease incentives receivable • variable lease payments that are based on an index or a rate, initially measured using the index or rate as at the commencement date • amounts expected to be payable by the group under residual value guarantees • the exercise price of a purchase option if the group is reasonably certain to exercise that option, and • payments of penalties for terminating the lease, if the lease term reflects the group exercising that option. Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for leases in the group, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and conditions. To determine the incremental borrowing rate, the group: • where possible, uses recent third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing conditions since third party financing was received • uses a build-up approach that starts with a risk-free interest rate adjusted for credit risk for leases held by NOVONIX Limited, which does not have recent third party financing, and • makes adjustments specific to the lease, e.g. term, country, currency and security. The group is exposed to potential future increases in variable lease payments based on an index or rate, which are not included in the lease liability until they take effect. When adjustments to lease payments based on an index or rate take effect, the lease liability is reassessed and adjusted against the right-of-use asset. Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. Right-of-use assets are measured at cost comprising the following: • the amount of the initial measurement of lease liability • any lease payments made at or before the commencement date less any lease incentives received • any initial direct costs, and • restoration costs. Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis. If the group is reasonably certain to exercise a purchase option, the right-of-use asset is depreciated over the underlying asset’s useful life. The group does not revalue the right-of-use buildings held by the group. Payments associated with short-term leases of equipment and vehicles and all leases of low-value assets are recognized on a straight-line basis as an expense in profit or loss. Short-term leases are leases with a lease term of 12 months or less. Low-value assets comprise IT equipment and small items of office furniture. Extension options are included in property and equipment leases across the group. These are used to maximize operational flexibility in terms of managing the assets used in the group’s operations. The extension options held are exercisable only by the group and not by the lessor. When the group revises its estimate of the term of any lease (because, for example, it re-assesses the probability of a lessee extension or termination option being exercised), it adjusts the carrying amount of the lease liability to reflect the payments to make over the revised term, which are discounted using a revised discount rate. The carrying value of lease liabilities is similarly revised when the variable element of future lease payments dependent on a rate or index is revised, except the discount rate remains unchanged. In both cases an equivalent adjustment is made to the carrying value of the right-of-use asset, with the revised carrying amount being amortized over the remaining (revised) lease term. If the carrying amount of the right-of-use asset is adjusted to zero, any further reduction is recognized in profit or loss. When the group renegotiates the contractual terms of a lease with the lessor, the accounting depends on the nature of the modification: • if the renegotiation results in one or more additional assets being leased for an amount commensurate with the standalone price for the additional rights-of-use obtained, the modification is accounted for as a separate lease in accordance with the above policy • in all other cases where the renegotiated increases the scope of the lease (whether that is an extension to the lease term, or one or more additional assets being leased), the lease liability is remeasured using the discount rate applicable on the modification date, with the right-of-use asset being adjusted by the same amount • if the renegotiation results in a decrease in the scope of the lease, both the carrying amount of the lease liability and right-of-use asset are reduced by the same proportion to reflect the partial of full termination of the lease with any difference recognized in profit or loss. The lease liability is then further adjusted to ensure its carrying amount reflects the amount of the renegotiated payments over the renegotiated term, with the modified lease payments discounted at the rate applicable on the modification date. The right-of-use asset is adjusted by the same amount. Investments and other financial assets Classification The group classifies its financial assets in the following measurement categories: • those to be measured subsequently at fair value (either through OCI or through profit or loss), and • those to be measured at amortized cost. The classification depends on the entity’s business model for managing the financial assets and the contractual terms of the cash flows. For assets measured at fair value, gains and losses will either be recorded in profit or loss or OCI. For investments in equity instruments that are not held for trading, this will depend on whether the group has made an irrevocable election at the time of initial recognition to account for the equity investment at fair value through other comprehensive income (FVOCI). Recognition and derecognition Regular way purchases and sales of financial assets are recognized on trade date, being the date on which the group commits to purchase or sell the asset. Financial assets are derecognized when the rights to receive cash flows from the financial assets have expired or have been transferred and the group has transferred substantially all the risks and rewards or ownership. Measurement At initial recognition, the group measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss (FVPL), transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at FVPL are expensed in profit or loss. The group subsequently measures all equity investments at fair value. Where the group’s management has elected to present fair value gains and losses on equity investments in OCI, there is no subsequent reclassification or fair value gains and losses to profit or loss following the derecognition of the investment. Dividends from such investments continue to be recognized in Profit or Loss as other income when the group’s right to receive payments is established. Changes in fair value of financial assets at FVPL are recognized in other gains/(losses) in the Consolidated Statement of Profit or Loss and Other Comprehensive Income as applicable. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other changes in fair value. Employee benefits Short-term employee benefits Liabilities for wages and salaries, including non-monetary benefits, annual leave and long service leave expected to be settled within 12 months of the reporting date are measured at the amounts expected to be paid when the liabilities are settled. Other long-term employee benefits The liability for long service leave not expected to be settled within 12 months of the reporting date are measured as the present value of expected future payments to be made in respect of services provided by employees up to the reporting date using the projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and periods of service. Expected future payments are discounted using market yields at the reporting date on corporate bonds with terms to maturity and currency that match, as closely as possible, the estimated future cash outflows. Share-based payments Equity-settled share-based compensation benefits are provided to employees. Equity-settled transactions are awards of shares, options or performance rights over shares, that are provided to employees in exchange for the rendering of services. The cost of equity-settled transactions are measured at fair value on grant date. Fair value is determined using various valuation methods including Black Scholes, Binomial and the Monte Carlo Simulation method that takes into account the exercise price, the term of the performance right, the impact of dilution, the share price at grant date and expect price volatility of the underlying share, the expected dividend yield and the risk-free interest rate for the term of the performance right. The cost of equity-settled transactions are recognized as an expense with a corresponding increase in equity over the vesting period. The cumulative charge to profit or loss is calculated based on the grant date fair value of the award, the best estimate of the number of awards that are likely to vest and the expired portion of the vesting period. The amount recognized in profit or loss for the period is the cumulative amount calculated at each reporting date less amounts already recognized in previous periods. Market conditions are taken into consideration in determining fair value. Therefore, any awards subject to market conditions are considered to vest irrespective of whether or not that market condition has been met, provided all other conditions are satisfied. If equity-settled awards are modified, as a minimum an expense is recognized as if the modification has not been made. An additional expense is recognized, over the remaining vesting period, for any modification that increases the total fair value of the share-based compensation benefit as at the date of modification. Share-based payment expenses are recognized over the period during which the employee provides the relevant services. This period may commence prior to the grant date. In this situation, the entity estimates the grant date fair value of the equity instruments for the purposes of recognizing the services received during the period between service commencement date and grant date. Once the grant date has been established, the earlier estimate is revised so that the amount recognized for services received is ultimately based on the grant date fair value of the equity instruments. If the non-vesting condition is within the control of the Group or employee, the failure to satisfy the condition is treated as a cancellation. If the condition is not within the control of the Group or employee and is not satisfied during the vesting period, any remaining expense for the award is recognized over the remaining vesting period, unless the award is forfeited. If equity-settled awards are cancelled, it is treated as if it has vested on the date of cancellation, and any remaining expense is recognized immediately. If a new replacement award is substituted for the cancelled award, the cancelled and new award is treated as if they were a modification. Issued capital Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds. Impairment of Non-Financial Assets At the end of each reporting period, the Group assesses whether there is any indication that an asset may be impaired. The assessment will include the consideration of external and internal sources of information, including dividends received from subsidiaries, associates or joint ventures deemed to be out of pre-acquisition profits. If such an indication exists, an impairment test is carried out on the asset by comparing the recoverable amount of the asset, being the higher of the asset’s fair value less costs of disposa

Parent Entity Financial Informa

Parent Entity Financial Information	12 Months Ended
	Jun. 30, 2022
Statement Of Financial Position [Abstract]
Parent Entity Financial Information	Note 2 Parent entity financial information The following information has been extracted from the books and records of the parent and has been prepared in accordance with International Financial Reporting Standards. At June 30, 2022 2021 Balance sheet ASSETS Current assets Cash and cash equivalents $ 181,411,905 $ 135,403,115 Trade and other receivables 31,966 132,838 Prepayments 5,291,126 2,462,643 Total current assets 186,734,997 137,998,596 Non-current assets Amounts due from related parties 152,865,669 27,897,817 Exploration and evaluation assets 3,440,105 3,329,950 Imvestments at fair value through profit and loss 24,179,998 — Investments — 17,748,704 Other assets 10,950 8,450 Total non-current assets 180,496,722 48,984,921 Total assets $ 367,231,719 $ 186,983,517 LIABILITIES Payables 2,888,400 2,587,715 Total current liabilities 2,888,400 2,587,715 Total liabilities 2,888,400 2,587,715 Net assets 364,343,319 184,395,802 EQUITY Contributed equity 458,677,068 233,196,507 Reserves 53,900,595 33,733,407 Accumulated losses ( 148,234,344 ) ( 82,534,112 ) Total equity $ 364,343,319 $ 184,395,802 Year Ended June 30, 2022 2021 Statement of Profit or Loss and Other Comprehensive Income Total loss and total comprehensive loss $ ( 65,700,232 ) $ ( 20,177,174 ) Guarantees NOVONIX Limited has not entered into any guarantees, in the current or previous reporting period, in relation to the debts of its subsidiaries. Contingent liabilities At June 30, 2022, NOVONIX Limited did no t have any contingent liabilities (2021: Nil ). Contractual commitments At June 30, 2022, NOVONIX Limited did no t have any contractual commitments (2021: Nil ).

Revenue

Revenue	12 Months Ended
	Jun. 30, 2022
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Abstract]
Revenue	Note 3 Revenue (a) Revenue from contracts with customers The group derives revenue from the transfer of goods and services over time and at a point in time in the following major product lines and segments : Segments Year Ended June 30, 2022 Graphite Battery Battery Total Hardware sales $ — $ 3,517,271 $ — $ 3,517,271 Consulting sales — 4,900,492 — 4,900,492 Revenue from external customers $ — $ 8,417,763 $ — $ 8,417,763 Timing of revenue recognition — At a point in time — 3,517,271 — 3,517,271 Over time — 4,900,492 — 4,900,492 $ — $ 8,417,763 $ — $ 8,417,763 Year Ended June 30, 2021 Segments Graphite Battery Battery Total Hardware sales $ — $ 1,405,086 $ — $ 1,405,086 Consulting sales — 3,822,261 — 3,822,261 Revenue from external customers $ — $ — $ 5,227,347 $ — $ 5,227,347 Timing of revenue recognition — At a point in time — 1,405,086 — 1,405,086 Over time — 3,822,261 — 3,822,261 $ — $ 5,227,347 $ — $ 5,227,347 Year Ended June 30, 2020 Segments Graphite Battery Battery Total Hardware sales $ — $ 2,113,416 $ — $ 2,113,416 Consulting sales — 2,140,019 — 2,140,019 Revenue from external customers $ — $ — $ 4,253,435 $ — $ 4,253,435 Timing of revenue recognition — At a point in time — 2,113,416 — 2,113,416 Over time — 2,140,019 — 2,140,019 $ — $ 4,253,435 $ — $ 4,253,435 Revenues from external customers come from the sale of battery testing hardware equipment and the provision of battery testing and development consulting services. (i) Assets and liabilities related to contracts with customers The Group has recognized the following assets and liabilities related to contracts with customers: At June 30, 2022 2021 Contract liabilities – Hardward sales $ 3,938 $ 310,102 Total other current liabilities $ 3,938 $ 310,102 Revenue recognized in relation to contract liabilities The following table shows how much of the revenue recognized in the current reporting period relates to brought-forward contract liabilities. Year Ended June 30, 2022 2021 2020 Revenue recognized that was included in the contract Hardware sales $ 310,102 $ 98,783 $ 580,845 The Group had no contract assets as of June 30, 2022 and June 30, 2021. See Note 11, Trade and other receivables , for trade receivables. The Group had no remaining performance obligations which have an original expected term of more than one year .

Other Income, Net

Other Income, Net	12 Months Ended
	Jun. 30, 2022
Analysis Of Income And Expense [Abstract]
Other income, net	Note 4 Other income, net Year Ended June 30, 2022 2021 2020 Interest received from unrelated parties 11,471 35,066 723 COVID-19 Government stimulus — 115,501 59,000 Grant funding 1,355,924 818,410 785,154 Fair value gain on borrowings (refer note 22) 302,922 — — Other 531,850 15,675 — Total 2,202,167 984,652 844,877

Loss for the year

Loss for the year	12 Months Ended
	Jun. 30, 2022
Loss For Year [Abstract]
Loss for the year	Note 5 Loss for the year Loss before income tax includes the following specific expenses: Year Ended June 30, 2022 2021 2020 Share-based payments expense^ Performance rights granted $ 15,299,627 $ 2,952,676 $ 78,362 Share rights granted 3,615,341 — 6,291,510 Options granted 1,275,570 2,995,856 1,189,081 Total share-based compensation expense $ 20,190,538 $ 5,948,532 $ 7,558,953 ^ Refer to note 28 for further information regarding share-based payments. Borrowing costs Interest accrued on loan notes — — 3,062,598 Loss on redemption of loan notes — — 1,765,353 Unwinding of fair value gain 55,728 40,547 48,377 Interest accrued on borrowings 2,031,135 188,847 454,633 Total borrowing costs $ 2,086,863 $ 229,394 $ 5,330,961 Impairment losses Fixed assets written off 1 — 2,764,940 — Total impairment losses $ — $ 2,764,940 $ — 1 Impairments recognized during the prior period relate to the redundant furnace technology which has been replaced with new proprietary furnace technology under the Group’s strategic alliance with US-based Harper International Corporation. This amount represents the net book value of fixed assets written off. Year ended June 30, Administrative and other expenses 2022 2021 2020 Insurance $ 5,300,985 $ 383,941 $ 234,544 Legal fees 1,967,564 263,532 558,745 Occupancy expenses 2,385,890 23,038 79,948 Consulting fees 2,280,680 683,856 259,992 Other 4,800,904 2,591,462 1,606,169 Total administrative and other expenses $ 16,736,023 $ 3,945,829 $ 2,739,398

Income Tax Expense

Income Tax Expense	12 Months Ended
	Jun. 30, 2022
Major components of tax expense (income) [abstract]
Income Tax Expense	Note 6 Income tax expense This note provides an analysis of the Group’s income tax expense, shows what amounts are recognised directly in equity and how the tax expense is affected by non-assessable and non-deductible items. It also explains significant estimates made in relation to the Group’s tax position. Year Ended June 30, 2022 2021 2020 (a) Numerical reconciliation of income tax expense to prima facie tax payable Loss before income tax expense $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 26,505,567 ) Tax at the Australian tax rate of 25 % (2021: 26 %) ( 17,860,256 ) ( 4,699,780 ) ( 7,289,031 ) Tax effect of amounts which are not tax deductible (taxable) in calculating taxable income: Share based payments 4,233,641 1,546,618 1,835,215 Income inclusion – Scientific Research and Experimental Development (“SRED”) 66,397 — Unrealized foreign exchange gain 51,246 — Borrowing costs 17,596 10,845 377,735 Other non-deductible amounts 976,484 56,291 — Other non-assessable amounts 4,161 ( 39,005 ) ( 24,234 ) Difference in overseas tax rate ( 739,293 ) ( 139,141 ) ( 90,888 ) Adjustments for current tax of prior periods — — ( 93,052 ) Adjustment to deferred tax assets and liabilities for tax losses and temporary differences not recognized 13,250,024 3,264,172 3,911,457 Income tax expense / (benefit) $ - $ - $ ( 383,655 ) (b) Tax losses Unused tax losses for which no deferred tax asset has been recognized $ 113,552,217 $ 39,772,597 $ 15,128,752 Potential tax benefit $ 28,388,054 $ 9,943,149 $ 4,122,864 (c) Tax expense (income) recognised directly in equity Aggregate current and deferred tax arising in the reporting period and not recognized in net profit or loss or other comprehensive income but directly debited or credited to equity: Deferred tax: Share issue costs — — — At June 30, 2022 2021 (d) Deferred tax assets The balance comprises temporary differences attributable to: Tax losses $ 28,388,054 $ 9,943,149 Exploration and evaluation assets 726,221 930,009 Business capital costs 2,309,219 1,543,399 Intangible assets & property, plant and equipment 2,737,888 — Right of use asset 78,121 31,061 Unrealized exchange loss on borrowings 284,770 261,449 Accrued expenses 624,234 317,498 Other 440,239 402,368 Total deferred tax assets 35,588,746 13,428,933 Set-off of deferred tax liabilities pursuant to set-off provisions ( 1,992,320 ) ( 1,357,943 ) Deferred tax assets not recognized ( 33,596,426 ) ( 12,070,990 ) Net deferred tax assets $ - $ - (e) Deferred tax liabilities The balance comprises temporary differences attributable to: Intangible assets $ - $ 164,713 Property, plant and equipment 1,524,592 1,193,230 Unrealized exchange loss on borrowings 467,728 — Total deferred tax liabilities 1,992,320 1,357,943 Set-off of deferred tax liabilities pursuant to set-off provisions ( 1,992,320 ) ( 1,357,943 ) Net deferred tax liabilities $ - $ - Unused losses which have not been recognized as an asset, will only be obtained if: (i) the group derives future assessable income of a nature and of an amount sufficient to enable the losses to be realized; (ii) the group continues to comply with the conditions for deductibility imposed by the law; and (iii) no changes in tax legislation adversely affect the group in realizing the losses. Offsetting within tax consolidated entity NOVONIX Limited and its wholly-owned Australian subsidiaries have applied the tax consolidation legislation which means that these entities are taxed as a single entity. As a consequence, the deferred tax assets and deferred tax liabilities of these entities have been offset in the consolidated financial statements.

Key Management Personnel Compen

Key Management Personnel Compensation	12 Months Ended
	Jun. 30, 2022
Key Management Personnel Compensation [Abstract]
Key Management Personnel Compensation	Note 7 Key Management Personnel Compensation Refer to Item 6.B., Compensation , of this Annual Report on Form 20-F for details of the remuneration paid or payable to each member of the Group’s key management personnel (KMP) for the year ended June 30, 2022. The totals of remuneration paid to KMP of the Group during the year are as follows: Year Ended June 30, 2022 2021 2020 Short-term employee benefits $ 4,392,815 $ 1,934,648 $ 1,868,521 Post-employment benefits 199,497 29,297 46,218 Termination benefits — 75,000 — Share-based compensation 16,857,548 4,575,735 6,878,627 Total KMP compensation $ 21,449,860 $ 6,614,680 $ 8,793,366 Short-term employee benefits These amounts include fees and benefits paid to the non-executive Chairman as well as all salary, paid leave benefits and fringe benefits paid to Executive Directors. Post-employment benefits These amounts are the superannuation contributions made during the year. Share-based compensation These amounts represent the expense related to the participation of KMP in equity-settled benefit schemes as measured by the fair value of the options and performance rights on grant date.

Auditor_s Remuneration

Auditor’s Remuneration	12 Months Ended
	Jun. 30, 2022
Auditors Remuneration [Abstract]
Auditor’s Remuneration	Note 8 Auditor’s Remuneration The following fees were paid or payable for services provided by PricewaterhouseCoopers Australia (PwC) as the auditor of the Group: Year Ended June 30, 2022 2021 2020 Audit fees $ 367,000 $ 190,329 $ 175,855 Audit-related fees1 381,484 646,300 — Tax fees — — — All other fees — — — Total $ 748,484 $ 836,629 $ 175,855 1 Audit-related fees related to services performed in respect of the US IPO and US filing processes during the years ended June 30, 2022 and 2021.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Note 9 Earnings per share 2022 2021 2020 (a) Basic loss per share Total basic loss per share attributable to the ordinary equity holders of the Company ( 0.15 ) ( 0.05 ) ( 0.15 ) (b) Diluted loss per share Total diluted loss per share attributable to the ordinary equity holders of the Company ( 0.15 ) ( 0.05 ) ( 0.15 ) (c) Reconciliations of loss used in calculating loss per share 2022 2021 2020 Basic loss per share loss attributable to the ordinary equity holders of the Company used in calculating basic loss per share $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 20,028,526 ) Diluted loss per share loss attributable to the ordinary equity holders of the Company used in calculating diluted loss per share $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 20,028,526 ) (d) Weighted average number of shares used as the denominator 2022 2021 2020 Weighted average number of ordinary shares used as the denominator in calculating basic and diluted loss per share 464,437,628 366,289,024 135,918,095 (e) Information concerning the classification of securities Options and rights Options and rights on issue during the year are not included in the calculation of diluted earnings per share because they are antidilutive for the years ended June 30, 2022, 2021 and 2020. These options and rights could potentially dilute basic earnings per share in the future. Details relating to options and rights are set out in Note 28, Share-based Payments .

Cash and Cash Equivalents

Cash and Cash Equivalents	12 Months Ended
	Jun. 30, 2022
Cash And Cash Equivalents [Abstract]
Cash And Cash Equivalents	Note 10 Cash and cash equivalents June 30, 2022 2021 Cash at bank $ 207,083,935 $ 136,663,976 $ 207,083,935 $ 136,663,976 Reconciliation to cash flow statement The above figures reconcile to the amount of cash shown in the statement of cash flows at the end of the financial year as follows: June 30, 2022 2021 Balances as above $ 207,083,935 $ 136,663,976 Bank overdrafts — — Balance per statement of cash flows $ 207,083,935 $ 136,663,976

Trade and Other Receivables

Trade and Other Receivables	12 Months Ended
	Jun. 30, 2022
Trade And Other Current Receivables [Abstract]
Trade and Other Receivables	Note 11 Trade and other receivables June 30, 2022 2021 Trade debtors $ 3,019,580 $ 1,533,963 Other receivables 538,436 509,000 Total trade and other receivables $ 3,558,016 $ 2,042,963 Credit risk The Group has no significant concentration of credit risk with respect to any counterparties or on a geographical basis. Amounts are considered as “past due” when the debt has not been settled, in line with the terms and conditions agreed between the Group and the customer to the transaction. The Group assess impairment on trade and other receivables using the simplified approach of the expected credit loss (ECL) model under IFRS 9, Financial Instruments . Due to the minimal history of bad debt write-offs and strong credit approval processes, the Group have determined that the incorporation of the ECL model will not have a material effect on impairment as at June 30, 2022. The balance of receivables that remain within initial trade terms are considered to be of high credit quality

Prepayments

Prepayments	12 Months Ended
	Jun. 30, 2022
Current Prepayments And Current Accrued Income Including Current Contract Assets [Abstract]
Prepayments	Note 12 Prepayments June 30, 2022 2021 Deferred share issuance costs $ — $ 2,175,347 Prepayments of inventory components 1,619,629 — Prepaid general and administrative expenses 5,737,288 362,860 Total $ 7,356,917 $ 2,538,207 Prepaid general and administrative expenses consisted primarily of prepaid Director and Officer insurance premiums ($ 5.2 million at June 30, 2022). Deferred share issuance costs, which consisted primarily of direct and incremental legal and advisory fees related to the Company’s proposed NASDAQ listing, were capitalized in prepayments on the consolidated balance sheet as at June 30, 2021 . These have been expensed in the current year following a change in the Company’s plans with respect to its contemplated activities in the US capital markets.

Escrow Reserves

Escrow Reserves	12 Months Ended
	Jun. 30, 2022
Escrow Reserves [abstract]
Escrow Reserves	Note 13 Escrow reserves June 30, 2022 2021 Escrow reserves $ 14,639,419 $ — The reserves are funds deposited with the Lender for capital expenditures, insurance, tax and production as additional collateral for the loan obtained in relation to the purchase of the new facility in Chattanooga, Tennessee. Reserves are released as conditions of the loan are satisfied. All conditions are expected to be satisfied within 12 months from the balance sheet date.

Inventory

Inventory	12 Months Ended
	Jun. 30, 2022
Classes Of Inventories [Abstract]
Inventory	Note 14 Inventory June 30, 2022 2021 Raw materials $ 832,538 $ 1,162,142 Components and assemblies 1,838,228 1,618,231 Finished goods – at cost 45,377 — Total Inventory $ 2,716,143 $ 2,780,373 Amounts recognized in profit or loss Inventories recognized as an expense during the year ended June 30, 2022 amounts to $ 3,005,977 (2021: $ 969,774 ). These were included in cost of goods and services (exclusive of depreciation presented separately) in the consolidated statements of profit or loss and other comprehensive income.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Jun. 30, 2022
Disclosure Of Property Plant And Equipment [Abstract]
Property, Plant and Equipment	Note 15 Property, plant and equipment (in Australian dollars) Land Buildings Leasehold Plant and Construction Total At June 30, 2021 $ 372,995 $ 1,821,526 $ 195,082 $ 8,579,868 — $ 10,969,471 Cost — ( 154,725 ) ( 30,524 ) ( 1,163,425 ) — ( 1,348,674 ) Accumulated depreciation Net book amount $ 372,995 $ 1,666,801 $ 164,558 $ 7,416,443 $ - $ 9,620,797 Opening net book amount at June 30, 2020 $ 372,995 $ 1,666,801 $ 164,558 $ 7,416,443 $ — $ 9,620,797 Additions 666,920 4,358,515 482,637 2,982,443 17,754,185 26,244,700 Disposals — — — ( 39,285 ) — ( 39,285 ) Assets written off — — — ( 2,764,940 ) — ( 2,764,940 ) Depreciation charge — ( 67,897 ) ( 110,681 ) ( 996,462 ) — ( 1,175,040 ) Exchange differences 13,960 100,126 ( 9,103 ) ( 411,876 ) ( 894 ) ( 307,787 ) Closing net book amount at June 30, 2021 $ 1,053,875 $ 6,057,545 $ 527,411 $ 6,186,323 $ 17,753,291 $ 31,578,445 Additions 2,177,802 59,330,097 689,185 11,770,912 42,266,050 116,234,046 Disposals — — — ( 39,495 ) — ( 39,495 ) Transfers — — 145,109 12,628,351 ( 12,773,460 ) — Depreciation charge — ( 2,294,080 ) ( 360,141 ) ( 2,313,665 ) — ( 4,967,886 ) Exchange differences 179,664 3,644,794 69,337 1,241,781 3,243,510 8,379,086 Closing net book amount at June 30, 2022 $ 3,411,341 $ - $ 66,738,356 $ - $ 1,070,901 $ - $ 29,474,207 $ - $ 50,489,391 $ - $ 151,184,196 At June 30, 2022 Cost $ 3,411,341 $ 69,383,589 $ 1,600,051 $ 33,780,687 $ 50,489,391 158,665,059 Accumulated depreciation — ( 2,645,233 ) ( 529,150 ) ( 4,306,480 ) — ( 7,480,863 ) Net book amount $ 3,411,341 $ 66,738,356 $ 1,070,901 $ 29,474,207 $ 50,489,391 $ 151,184,196

Financial Assets at Fair Value

Financial Assets at Fair Value Through Profit or Loss	12 Months Ended
	Jun. 30, 2022
Financial assets at fair value through profit or loss [abstract]
Financial Assets at Fair Value Through Profit or Loss	Note 16 Financial assets at fair value through profit or loss Classification of financial assets at fair value through profit or loss The group classifies equity investments for which it has not elected to recognize fair value gains and losses through OCI as financial assets at fair value through profit or loss (FVPL). Financial assets measured at FVPL include the following: June 30, 2022 2021 US unlisted equity securities $ 24,179,998 $ — On January 31, 2022, NOVONIX Limited entered into a Securities Purchase Agreement with KORE Power, Inc. (“KORE Power”) a US based developer of battery cell technology for the clean energy industry, under which NOVONIX Limited acquired 3,333,333 shares of KORE Power Common Stock at an issue price of USD$ 7.50 per share, representing approximately 5 % of the common equity of KORE Power. The consideration for the shares in KORE Power totaled USD$ 25 million (AUD $ 35,131,550 ) and was settled through a combination of 50 % cash and 50 % through the issue of 1,974,723 ordinary shares in NOVONIX Limited. Amounts recognized in profit or loss During the year, a loss of $ 10,951,552 was recognized in the consolidated statement of profit or loss and other comprehensive income related to equity investments held at FVPL. Fair value hierarchy US unlisted equity securities are classified as a Level 3 fair value in the fair value hierarchy as one or more of the significant inputs is not based on observable market data. The following table presents the changes in level 3 instruments during the financial year: Unlisted equity securities Balance at the beginning of the year $ — Purchases during the year: Consideration settled in shares 17,515,793 Consideration settled in cash 17,615,757 Loss on change in fair value recognized in the consolidated statement of profit or loss and other comprehensive income ( 10,951,552 ) Balance at the end of the year $ 24,179,998 There were no transfers between levels 1, 2 or 3 for recurring fair value measurements during the year. The Group’s policy is to recognize transfers into and out of fair value hierarchy levels as at the end of the reporting period. Valuation techniques using significant unobservable inputs – Level 3 This category includes assets where the valuation incorporates significant inputs that are not based on observable market data (unobservable inputs). Unobservable inputs are those not readily available in an active market due to market illiquidity or complexity of the product. These inputs are generally derived and extrapolated from observable inputs to match the risk profile of the financial instrument, and are calibrated against current market assumptions, historic transactions and economic models, where available. The key assumptions used in the fair valuation of KORE Power at June 30, 2022 include (but were not limited to) the share price at which Novonix subscribed for equity in KORE Power, indicators of value derived from actual and proposed share transactions that the Group is aware of, foreign exchange rates, and market observable inputs based on an analysis of share price movements of listed peer companies in the battery technology sector between the date of the initial investment and reporting date.

Exploration and Evaluation Asse

Exploration and Evaluation Assets	12 Months Ended
	Jun. 30, 2022
Disclosure Of Exploration And Evaluation Assets [Abstract]
Exploration and evaluation assets	Note 17 Exploration and evaluation assets June 30, 2022 2021 Exploration and evaluation assets – at cost $ 3,218,228 $ 3,108,073 The capitalized exploration and evaluation assets carried forward above have been determined as follows: Balance at the beginning of the year $ 3,108,073 $ 2,988,921 Expenditure incurred during the year 110,155 119,152 Balance at the end of the year $ 3,218,228 $ 3,108,073 The future development of the Mt Dromedary mine will not occur within the next twelve months given the tonnages of natural graphite required by the NOVONIX Anode Materials business are unlikely to be sufficient to warrant the development of the mine in that timeframe. As well, a significant portion of graphite used by NOVONIX Anode Materials will be synthetic graphite, and the natural graphite required at this time can be more cost effectively sourced from other natural graphite producers. The Mt Dromedary asset however remains a strategic asset for the Group. All tenement rights remain current, with renewal/extension applications lodged for those expiring later in 2022, exploration activity is continuing to the extent required under the tenement rights, and a resource, principally high grade graphite, has been identified. It therefore remains appropriate for the asset to be recognized as an exploration and evaluation asset under IFRS 6 Exploration for and Evaluation of Mineral Resources . The recoverability of the carrying amount of the exploration and evaluation asset is dependent upon the successful development and commercial exploitation or, alternatively, sale of the respective areas of interest. The Directors have assessed that for the exploration and evaluation assets recognized at 30 June 2022, the facts and circumstances do not suggest that the carrying amount may exceed its recoverable amount.

Intangible Assets

Intangible Assets	12 Months Ended
	Jun. 30, 2022
Disclosure of detailed information about intangible assets [abstract]
Intangible Assets	Note 18 Intangible assets Year Ended June 30, 2022 2021 2020 Goodwill $ 17,373,413 $ 15,950,624 $ 17,411,685 Technology 421,296 631,085 955,560 Software 144,159 — — Total $ 17,938,868 $ 16,581,709 $ 18,367,245 Goodwill Technology Software Total Balance at June 30, 2019 $ 17,037,297 $ 1,195,948 $ — $ 18,233,245 Additions 374,388 — — 374,388 Amortization — ( 273,619 ) — ( 273,619 ) Exchange differences — 33,231 — 33,231 Balance at June 30, 2020 $ 17,411,685 $ 955,560 $ — $ 18,367,245 Additions — — — — Amortization — ( 246,217 ) — ( 246,217 ) Exchange differences ( 1,461,061 ) ( 78,258 ) — ( 1,539,319 ) Balance at June 30, 2021 $ 15,950,624 $ 631,085 $ — $ 16,581,709 Additions — — 144,159 144,159 Amortization — ( 253,040 ) — ( 253,040 ) Exchange differences 1,422,789 43,251 — 1,466,040 Balance at June 30, 2022 $ 17,373,413 $ 421,296 $ 144,159 $ 17,938,868 Intangible assets, other than goodwill, have finite useful lives. Technology has a useful life of 5 years and Software has a useful life of 3 years . The current amortization charges for intangible assets are included under depreciation and amortization expense in the statement of profit or loss and other comprehensive income. Goodwill has an indefinite useful life. For the purposes of impairment testing, the cash generating unit has been defined as the business to which the goodwill relates where individual cash flows can be ascertained for the purposes of discounting future cash flows. The total carrying value of goodwill was $ 17,373,413 at June 30, 2022 and $ 15,950,624 at June 30, 2021 and relates solely to NOVONIX Anode Materials LLC, or the Battery Materials segment. The recoverable amount of the NOVONIX Anode Materials LLC cash generating unit (“NOVONIX Anode Materials CGU”) has been determined on a ‘Fair Value Less Costs to Sell’ (“FVLCS”) basis. To determine the recoverable amount, FVLCS was calculated with reference to the capital raising outlined in Note 24 (d) given that the capital raising was directly associated with the planned future expansion of the NOVONIX Anode Materials CGU. Events occurring between the date of the capital raising and June 30, 2022 have also been considered, and the directors do not believe that there have been any material events that would adversely impact the NOVONIX Anode Materials CGU such that the recoverable amount may not exceed the carrying value. The recoverable amount of the NOVONIX Anode Materials CGU was deemed to be in excess of the carrying value of the CGU, and therefore no impairment has been recognized at June 30, 2022.

Trade and Other Payables

Trade and Other Payables	12 Months Ended
	Jun. 30, 2022
Trade And Other Payables [Abstract]
Trade and Other Payables	Note 19 Trade and other payables June 30, 2022 2021 Trade payables $ 3,847,509 $ 1,823,898 Sundry payables and accrued expenses 5,632,150 2,532,658 Total $ 9,479,659 $ 4,356,556

Contract Liabilities

Contract Liabilities	12 Months Ended
	Jun. 30, 2022
Contract Liabilities [Abstract]
Contract Liabilities	Note 20 Contract Liabilities June 30, 2022 2021 Current - contract liabilities - hardware sales contracts $ 3,938 $ 310,102 Non-current - Other liabilities 4,352,412 - $ 4,356,350 $ 310,102 During the financial year the Group received grant funds of USD$ 3,000,000 from the Department of Economic and Community Development in the State of Tennessee, USA. The grant funds are conditional upon the Group creating, filling and maintaining 290 jobs in the State of Tennessee. The grant becomes fully earned once 90% of the performance target is achieved, and is repayable in full if a minimum of 50% of the jobs are not filled. The grant is proportionately repayable between 50% and 90%. Accordingly, as at June 30, 2022 the full amount of the grant has been deferred and classified as contract liabilities and will be recognized in income on a proportionate basis once the minimum 50% target is reached.

Leases

Leases	12 Months Ended
	Jun. 30, 2022
Presentation Of Leases For Lessee [Abstract]
Leases	Note 21 Leases This note provides information for leases where the group is the lessee. Amounts recognized in the balance sheet The balance sheet shows the following amounts relating to leases: June 30, 2022 2021 Right-of-use assets - Buildings $ 7,443,048 $ 7,406,943 Lease liabilities Current $ 489,846 $ 410,792 Non-current 7,265,686 7,120,396 Total $ 7,755,532 $ 7,531,188 There were no additions to the right-of-use assets during the 2022 financial year (2021: $ 5,084,858 ). The movement of $ 36,105 consists of depreciation expense of $ 593,980 and a foreign currency gain of $ 630,085 . Refer to Note 31, Financial risk management , for a maturity analysis of lease liabilities. Amounts recognized in the statement of profit or loss and other comprehensive income The statement of profit or loss and other comprehensive income shows the following amounts relating to leases: Year Ended June 30, 2022 2021 2020 Depreciation of right-of-use assets - Buildings $ 593,980 $ 197,680 $ 210,381 Interest expense $ 312,786 $ 123,763 $ 112,303 The total cash outflow for leases in the year ended June 30, 2022 was $ 425,506 ( 2021 : $ 190,426 ). The Group had no short-term leases at June 30, 2022 and 2021.

Borrowings

Borrowings	12 Months Ended
	Jun. 30, 2022
Disclosure of detailed information about borrowings [abstract]
Borrowings	Note 22 Borrowings 2022 2021 (in Australian dollars) Current Non-Current Total Current Non-Current Total Secured Bank loans (i) $ 1,300,037 $ 50,563,095 $ 51,863,132 $ 110,752 $ 5,297,180 $ 5,407,932 Total secured borrowings 1,300,037 50,563,095 51,863,132 110,752 5,297,180 5,407,932 Unsecured Other loans (ii) 174,053 1,589,357 1,763,410 166,308 689,385 855,693 Total unsecured borrowings 174,053 1,589,357 1,763,410 166,308 689,385 855,693 Total borrowings $ 1,474,090 $ 52,152,452 $ 53,626,542 $ 277,060 $ 5,986,565 $ 6,263,625 (i) Secured liabilities and assets pledged as security (a) In December 2017, the group entered into a loan facility to purchase commercial land and buildings in Nova Scotia from which the Battery Technology Solutions business operates. The initial amount loaned under the facility was CAD $ 1,330,000 . On February 5, 2021, the group extended the loan facility and the total available amount now available under the facility was CAD $ 2,680,000 . At June 30, 2022 the facility had been fully drawn down. The total liability at June 30, 2022 is CAD $ 2,597,512 . The facility is bearing interest at the bank’s base rate minus 1 % payable monthly and principal of the loan repayable in 265 monthly principal instalments of CAD $ 9,760 followed by 1 monthly principal instalment of CAD $ 1,352 , maturing September 2044 . The Group's freehold land and buildings at 177 Bluewater Road, Bedford, Canada are pledged as collateral against the bank loan. The carrying amount of this asset is $ 4,890,976 (June 2021: $ 3,104,819 ). For the year ended June 30, 2022, the Group incurred interest expense of CAD $ 94,210 (2021 – CAD $ 48,168 ; 2020 – CAD $ 64,470 ). (b) On May 28, 2021, the Group purchased commercial land and buildings in Nova Scotia, Canada for CAD$ 3,550,000 from which the Cathode business will operate. The Group entered into a loan facility to purchase the land and buildings. The initial amount loaned under the facility was CAD $ 4,375,000 . On January 24, 2022, the group extended the loan facility and the total available amount now available under the facility was CAD $ 4,985,000 . At June 30, 2022 the facility had been drawn down to CAD $ 4,923,170 and CAD $ 61,830 remains to be disbursed. The total liability at June 30, 2022 is CAD $ 4,923,170 . The facility is bearing interest at the bank’s base rate minus 1 % payable monthly and principal of the loan repayable in 1 monthly principal instalment of CAD $ 18,610 in December 2022, followed by 299 monthly principal instalments of CAD $ 16,610 commencing January 2023, maturing November 2047 . The Group’s freehold land and buildings at 110 Simmonds Drive, Dartmouth, Canada are pledged as collateral against the bank loan. The carrying amount of this asset is $ 5,665,963 (June 2021: $ 4,006,926 ). For the year ended June 30, 2022, the Group incurred interest expense of CAD $ 156,522 (2021 – CAD $ 9,975 ; 2020 – CAD $ Nil ). (c) On January 24, 2022, the group entered into a loan facility to purchase equipment. The total amount available under the facility was CAD $ 2,300,000 . At June 30, 2022 the facility had been drawn down to CAD $ 500,000 and CAD $ 1,800,000 remains to be disbursed. The total liability at June 30, 2022 is CAD $ 500,000 . The facility is bearing interest at the bank’s base rate minus 1.5 % payable monthly and principal of the loan repayable in 1 monthly principal instalment of CAD $ 19,960 in December 2023, followed by 119 monthly principal instalments of CAD $ 19,160 commencing January 2024, maturing November 2033 . Equipment being purchased are pledged as collateral against the bank loan. For the year ended June 30, 2022, the Group incurred interest expense of CAD $ 7,617 (2021 – CAD $ Nil ; 2020 – CAD $ Nil ). (d) On July 28, 2021, the Group purchased commercial land and buildings in Chattanooga, USA for USD $ 42,600,000 to expand the NAM business. The Group entered into a loan facility with PNC Real Estate for USD$ 30,100,000 and an interest rate of 4.09 % to purchase the land and buildings. The loan has been fully drawn down as at June 30, 2022. The total liability at June 30, 2022 is USD $ 29,467,266 . The facility is repayable in monthly instalments, which commenced in September 2021 and end in August 2031 . The land and buildings at 1029 West 19th Street, Chattanooga, USA have been pledged as security for the loan, the carrying amount of which is $ 40,913,359 . For the year ended June 30, 2022, the Group incurred interest expense of USD$ 223,229 (2021 -USD$ 92,189 ; 2020- USD $ 80,445 ). This loan imposes certain loan covenants to ensure that the following financial ratios are met: • net assets of USD$ 30.1 million to be maintained (exclusive of the land and building secured by this loan and minimum liquidity of USD$ 3.1 million); and • a debt service coverage ratio of 1.2 to 1 is to be maintained. NOVONIX Limited has complied with the financial covenants of its borrowing facilities during both the 2022 and 2021 financial years. (ii) Other loans ACOA Loans In December 2017, the group entered into a contribution agreement with Atlantic Canada Opportunities Agency (ACOA), for CAD$ 500,000 . As at June 30, 2022, CAD$ 500,000 of the facility has been drawn down. The funding was to assist with expanding the market to reach new customers through marketing and product improvements. The facility is repayable in monthly instalments which commenced in September 2019 and end in May 2027. In October 2018, the group entered into another contribution agreement with Atlantic Canada Opportunities Agency (ACOA), for CAD$ 500,000 . As at June 30, 2022, CAD$ 500,000 of the facility has been drawn down. The funding was to assist in establishing a battery cell manufacturing facility. The facility is repayable in monthly instalments which commenced in April 2020 and end in March 2026. During the year ended June 30, 2022, the group entered into a further contribution agreement with Atlantic Canada Opportunities Agency (ACOA), for CAD$ 250,000 . As at June 30, 2022, the facility has been fully drawn down. The funding was to assist in expanding the BTS operations. The facility is repayable in monthly instalments commencing in January 2024 and ending December 2026. During the year ended June 30, 2022, the group entered into a further contribution agreement with Atlantic Canada Opportunities Agency (ACOA), for CAD$ 1,000,000 . As at June 30, 2022 it has been drawn down to CAD $ 900,000 . The funding will be used to will assist with purchasing equipment for the cathode pilot line and expansion of cell making capabilities. The facility is repayable in monthly instalments commencing in January 2025 and ending December 2036. Fair value For all borrowings, other than the ACOA loan noted at (ii) above, the fair values are not materially different to their carrying amounts, since the interest payable on those borrowings is either close to current market rates or the borrowings are of a short-term nature. The ACOA loans are interest free. The initial fair value of the ACOA loans were determined using a market interest rate for equivalent borrowings at the issue date. This resulted in a day one gain of $ 100,152 in FY2018 (December 2017 loan), a day one gain of $ 114,106 in FY2019 (October 2018 loan) and a day one gain of $ 302,922 in the year ended June 30, 2022.

Contributed Equity

Contributed Equity	12 Months Ended
	Jun. 30, 2022
Disclosure Of Classes Of Share Capital [Abstract]
Contributed equity	Note 23 Contributed equity (a) Share capital Year Ended 30 June 2022 2021 2022 2021 Number of shares Number of shares Amount Amount Ordinary shares Fully paid 485,951,369 404,601,384 $ 458,677,068 $ 233,196,507 (b) Ordinary share capital Date Details Note Number of Issue Amount July 1, 2020 Balance 348,206,772 $ 99,851,510 July 10, 2020 Exercise of options (e) 250,000 $ 0.80 $ 200,000 Sept 23, 2020 Settlement of limited recourse loan (j) — $ 1,500,000 Sept 24, 2020 Exercise of options (e) 500,000 $ 0.90 $ 450,000 Sept 24, 2020 Exercise of options (e) 2,500,000 $ 0.66 $ 1,650,000 Sept 28, 2020 Exercise of performance rights (g) 158,865 — $ — Mar 3, 2021 Placement to institutional investors (h) 39,700,000 $ 2.90 $ 115,130,000 Mar 16, 2021 Exercise of performance rights (g) 3,400,000 — $ — Mar 16, 2021 Exercise of options (e) 1,500,000 $ 0.74 $ 1,110,000 Mar 16, 2021 Exercise of options (e) 30,000 $ 0.90 $ 27,000 Mar 16, 2021 Exercise of options (e) 33,333 $ 0.50 $ 16,667 May 11, 2021 Placement to directors (h) 5,672,414 $ 2.90 $ 16,450,001 May 24, 2021 Exercise of options (e) 2,500,000 $ 0.66 $ 1,650,000 June 3, 2021 Exercise of options (e) 150,000 $ 0.90 $ 135,000 Share issue costs (i) $ ( 4,973,671 ) June 30, 2021 Balance 404,601,384 $ 233,196,507 Sept 30, 2021 Placement shares (d) 77,962,578 $ 2.67 $ 208,138,475 Dec 14, 2021 Exercise of performance rights (c) 1,291,851 — $ — Feb 1, 2022 KORE Power Consideration Shares (f) 1,974,723 $ 8.87 $ 17,515,793 Mar 8, 2022 Exercise of options (e) 33,333 $ 0.50 $ 16,667 May 31, 2022 Exercise of performance rights (c) 87,500 — $ — Share issue costs — $ ( 190,374 ) June 30, 2022 Balance 485,951,369 $ 458,677,068 (c) Exercise of performance rights On September 28, 2020, 158,865 ordinary shares were issued to an entity controlled by Philip St Baker, on the exercise of 158,865 vested performance rights. On March 16, 2021, 3,400,000 ordinary shares were issued to Key Management Personnel and other employees on the exercise of 3,400,000 vested performance rights. On May 31, 2022, 87,500 ordinary shares were issued to Key Management Personnel and other employees on the exercise of 87,500 vested performance rights. On December 14, 2021, 1,291,851 ordinary shares were issued on the exercise of vested performance rights. Of these, 599,851 were issued to Key Management Personnel (Robert Natter 200,000 ; Anthony Bellas 200,000 ; Nick Liveris 107,851 ; Chris Burns 92,000 ) following shareholder approval at the Annual General Meeting held on November 30, 2021. 600,000 were issued to Philip St Baker (a related party of Director Trevor St Baker), and 92,000 were issued to employees of the Group. (d) Placement shares On September 30, 2021, 77,962,578 ordinary shares were issued to Phillips 66 for a purchase price of USD$ 150 million, which converted to AUD$ 2.67 per share. (e) Exercise of options On July 10, 2020, 250,000 options were exercised by a Director, Admiral Robert Natter, at $ 0.80 per share. On September 24, 2020, 500,000 options were exercised by a Director, Admiral Robert Natter, at $ 0.90 per share and 2,500,000 options were exercised by a Director, Andrew Liveris, at $ 0.66 per share. On March 16, 2021 employees of the Group exercised 1,500,000 options at $ 0.74 per share, 30,000 options at $ 0.90 per share and 33,333 options at $ 0.50 per share. On May 24, 2021, 2,500,000 options were exercised by a Director, Andrew Liveris, at $ 0.66 per share. On June 3, 2021 employees of the Group exercised 150,000 options at $ 0.90 per share. On March 8, 2022, 33,333 options were exercised at $ 0.50 per share. (f) KORE Power Consideration Shares On January 31, 2022, NOVONIX Limited entered into a Securities Purchase Agreement with KORE Power, Inc. (“KORE Power”) a US based developer of battery cell technology for the clean energy industry, under which NOVONIX Limited acquired 3,333,333 shares of KORE Power Common Stock, representing approximately 5 % of the common equity of KORE Power. The consideration for the shares in KORE Power totaled USD$ 25 M and was settled through a combination of 50 % cash and 50 % through the issue of 1,974,723 ordinary shares in NOVONIX Limited (refer to note 16). (g) Institutional placement On March 3, 2021 the Company issued 39,700,000 ordinary fully paid shares to institutional investors at $ 2.90 per share. (h) Director placement On May 11, 2021 5,672,414 ordinary shares were issued to directors or their nominees raising $ 16.45 million. 4,137,931 of these ordinary shares were issued to Trevor St Baker’s nominees at $ 2.90 per share, 1,034,483 of these ordinary shares were issued to Andrew Liveris’ nominees at $ 2.90 per share, 431,034 of these ordinary shares were issued to Robert Natter at $ 2.90 per share and 68,966 of these ordinary shares were issued to Robert Cooper at $ 2.90 per share. (i) Share issue expenses During the year ended June 30, 2021 the Company had cash outflows for share issue expenses of $ 7,908,866 , of which $ 4,973,671 related to the year ended June 30, 2021, $ 1,458,798 related to the capital raising completed in June 2020 and the balance related to deferred share issuance costs. (j) Settlement of limited recourse loan On September 23, 2020, Philip St Baker, as part of his separation arrangements with the Company, settled the $ 1,500,000 limited recourse loan entered into in 2019 for the purpose of funding the exercise of 5,000,000 options. The loan was settled through: • the relinquishing of 736,968 vested performance rights, which were convertible on a 1 :1 basis to ordinary shares, with a market value of $ 1,252,846 ; and • outstanding net employee entitlements amounting to $ 247,154 . The relinquishment of the vested performance rights has been recognized within the share-based payment reserve. (k) Capital Management The Group’s objectives when managing capital are to safeguard its ability to continue as a going concern, so that it can continue to provide returns for shareholders, benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital. The capital structure of the Group includes equity attributable to equity holders, comprising of issued capital, reserves and accumulated losses. In order to maintain or adjust the capital structure, the Company may issue new shares, sell assets to reduce debt or adjust the level of activities undertaken by the company. The Group monitors capital on the basis of cash flow requirements for operational, and exploration and evaluation expenditure. The Group will continue to use capital market issues to satisfy anticipated funding requirements. The Group has no externally imposed capital requirements. The Group’s strategy for capital risk management is unchanged from prior years.

Reserves

Reserves	12 Months Ended
	Jun. 30, 2022
Disclosure of reserves within equity [abstract]
Reserves	a) Note 24 Reserves Year Ended June 30, 2022 2021 Share-based payment reserve $ 44,254,362 $ 27,513,594 Foreign currency translation reserve 8,566,362 ( 600,850 ) Convertible loan note reserve 6,219,812 6,219,812 $ 59,040,536 $ 33,132,556 (a) Share-based payment reserve Year Ended June 30, 2022 2021 2020 Share-based payment reserve $ 44,254,362 $ 27,513,594 $ 22,817,908 Movements: Opening balance 27,513,594 22,817,908 15,258,956 Equity settled options cancelled — — — Settlement of limited recourse loan — ( 1,252,846 ) 1,189,081 Performance rights net-settled in current period (refer note 28) ( 3,426,420 ) — — Equity settled share-based payments 20,190,538 5,948,532 6,369,871 Exchange differences ( 23,350 ) — — Closing balance $ 44,254,362 $ 27,513,594 $ 22,817,908 The share-based payment reserve includes items recognized as expenses on valuation of director, employee and contractor share rights, options, and performance rights. (b) Foreign currency translation reserve Year Ended June 30, 2022 2021 2020 Foreign currency translation reserve $ 8,566,362 $ ( 600,850 ) $ 1,500,247 Movements: Opening balance ( 600,850 ) 1,500,247 950,004 Exchange differences on translation of foreign operations 9,167,212 ( 2,101,097 ) 550,243 Closing balance $ 8,566,362 $ ( 600,850 ) $ 1,500,247 The foreign currency translation reserve includes exchange differences arising on translation of a foreign controlled subsidiary. (c) Convertible loan note reserve June 30 2022 2021 Convertible loan note reserve $ 6,219,812 $ 6,219,812 Movements: Opening balance 6,219,812 6,219,812 Exchange differences on translation of foreign operations — — Closing balance $ 6,219,812 $ 6,219,812 (d) Convertible loan notes are compound financial instruments The present value of the liability component of the loan notes issued in August 2019, at initial recognition, was $ 3,009,259 . The balance of $ 990,741 was recognized in the convertible note reserve. In discounting the loan notes to present value to determine the equity proportion of the compound financial instrument, NOVONIX adopted an effective interest rate of 24.25 % pa. The present value of the liability component of the loan notes issued in March 2019, at initial recognition, was $ 5,170,660 . The balance of $ 1,702,340 was recognized in the convertible note reserve. In discounting the loan notes to present value to determine the equity proportion of the compound financial instrument, NOVONIX adopted an effective interest rate of 24.5 % pa. The present value of the liability component of the loan notes issued in August 2018, at initial recognition, was $ 4,361,289 . The balance of $ 1,100,611 was recognized in the convertible note reserve. In discounting the loan notes to present value to determine the equity proportion of the compound financial instrument, NOVONIX adopted an effective interest rate of 25.6 % pa.

Operating Segments

Operating Segments	12 Months Ended
	Jun. 30, 2022
Disclosure Of Operating Segments [Abstract]
Operating Segments	Note 25 Operating segments The Group has identified its operating segments based on the internal reports that are reviewed and used by the Board of Directors (Chief Operating Decision Makers) in assessing performance and determining the allocation of resources. The Group is managed primarily on an operational basis. Operating segments are determined on the basis of financial information reported to the Board. The board has identified three operating segments being Battery Materials, Battery Technology and Graphite Exploration and Mining. The Battery Materials segment develops and manufactures battery anode materials, and the Battery Technology segment develops battery cell testing equipment, performs consulting services and carries out research and development in battery development. The Graphite Exploration and Mining segment manages the Mt Dromedary asset. Basis of accounting for purposes of reporting by operating segments a. Accounting policies adopted Unless stated otherwise, all amounts reported to the Board of Directors, being the chief operating decision makers, with respect to operating segments, are determined in accordance with accounting policies that are consistent with those adopted in the annual consolidated financial statements of the Group. b. Segment assets Where an asset is used across multiple segments, the asset is allocated to the segment that receives the majority of the economic value from the asset. In most instances, segment assets are clearly identifiable on the basis of their nature and physical location. c. Segment liabilities Liabilities are allocated to segments where there is a direct nexus between the incurrence of the liability and the operations of the segment. Borrowings and tax liabilities are generally considered to relate to the Group as a whole and are not allocated. Segment liabilities include trade and other payables. d. Unallocated items The following items for revenue, expenses, assets and liabilities are not allocated to operating segments as they are not considered part of the core operations of any segment: – Interest income – Prepayments for deferred issuance costs – Corporate administrative and other expenses – Income tax expense – Corporate share-based payment expenses – Corporate marketing and project development expenses – Corporate cash – Corporate trade and other payables – Corporate trade and other receivables e. Segment information Segment performance Battery Battery Graphite Unallocated Total 2022 Segment revenue 1 $ — $ 8,417,763 $ — $ — $ 8,417,763 Other income 531,850 1,658,846 — — 2,190,696 Interest income — 6,042 — 5,429 11,471 Total income 531,850 10,082,651 — 5,429 10,619,930 Segment net profit / (loss) before tax $ ( 28,538,900 ) $ ( 8,730,995 ) $ — $ ( 34,171,129 ) $ ( 71,441,024 ) Battery Battery Graphite Unallocated Total 2021 Segment revenue 1 $ — $ 5,227,347 $ — $ — $ 5,227,347 Other income 69,204 798,882 — 81,500 949,586 Interest income — — — 35,066 35,066 Total income 69,204 6,026,229 — 116,566 6,211,999 Segment net profit / (loss) before tax $ ( 11,968,654 ) $ ( 63,661 ) $ ( 46,424 ) $ ( 5,997,338 ) $ ( 18,076,077 ) Battery Battery Graphite Unallocated Total 2020 Segment revenue 1 $ — $ 4,253,435 $ — $ — $ 4,253,435 Other income — 785,154 — 59,000 844,154 Interest income — — — 723 723 Total income — 5,038,589 — 59,723 5,098,312 Segment net profit / (loss) before tax $ — $ ( 853,084 ) $ ( 7,426,978 ) $ ( 11,748,464 ) $ ( 20,028,526 ) 1 See Note 3, Revenue , for segment revenue by product line for the years ended June 30, 2022, 2021 and 2020. Segment assets Battery Battery Graphite Unallocated Total 2022 Segment assets $ 197,613,494 $ 27,616,815 $ 3,229,178 $ 211,101,915 $ 439,561,402 Battery Battery Graphite Unallocated Total 2021 Segment assets $ 47,899,929 $ 13,990,451 $ 3,116,523 $ 137,850,370 $ 202,857,273 Segment liabilities Battery Battery Graphite Unallocated Total 2022 Segment liabilities $ 59,326,240 $ 13,003,443 $ — $ 2,888,400 $ 75,218,083 Battery Battery Graphite Unallocated Total 2021 Segment liabilities $ 9,277,070 $ 7,440,067 $ - $ 1,744,334 $ 18,461,471 Geographical Segments For the purposes of segment reporting, all segment activities relating to Graphite Exploration and Mining are carried out in Australia and all segment activities relating to Battery Materials and Battery Technology are carried out in North America. In fiscal 2022, North America, Asia and Europe accounted for 79 %, 17 % and 4 % of revenues, respectively. In fiscal 2021, North America, Asia and Europe accounted for 82 %, 8 % and 10 % of revenues, respectively. In fiscal 2020, North America, Asia and Europe accounted for 77 %, 13 % and 10 % of revenues, respectively.

Cash Flow Information

Cash Flow Information	12 Months Ended
	Jun. 30, 2022
Cash Flow Information [Abstract]
Cash Flow Information	Note 26 Cash flow information Reconciliation of profit / (loss) after income tax to net cash outflow from operating activities Year Ended June 30, 2022 2021 2020 Loss for the period $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 20,028,526 ) Adjustments for Share-based compensation 20,190,538 5,948,532 7,558,953 Borrowing costs 64,297 760 5,098,906 Fixed assets written off — 2,764,940 210,773 Loss on sale of fixed assets — 6,777 — Loss on equity investment securities at fair value through profit or loss 10,951,552 — — Foreign exchange (gain) / loss ( 7,194,955 ) 106,787 387,371 Non-cash termination settlement — 294,247 — Depreciation and amortization expense 5,814,905 1,697,754 1,380,303 Government incentives ( 302,922 ) ( 49,278 ) — Change in operating assets and liabilities: (Increase)/decrease in other operating assets ( 6,028,224 ) ( 1,927,128 ) ( 976,969 ) Increase in trade creditors and other operating liabilities 7,592,541 1,060,622 775,672 Net cash outflow from operating activities $ ( 40,353,292 ) $ ( 8,172,064 ) $ ( 5,593,517 ) (a) Net debt reconciliation This section sets out an analysis of net debt and the movements in net debt for each period presented. Net debt 2022 2021 Cash and cash equivalents $ 207,083,935 $ 136,663,976 Lease liability - repayable within one year ( 489,846 ) ( 410,792 ) Borrowings – repayable within one year (including overdraft) ( 1,474,090 ) ( 277,060 ) Lease liability - repayable after one year ( 7,265,686 ) ( 7,120,396 ) Borrowings – repayable after one year ( 52,152,452 ) ( 5,986,565 ) Net cash (debt) $ 145,701,861 $ 122,869,163 Cash and cash equivalents 207,083,935 136,663,976 Gross debt – fixed interest rates ( 9,518,941 ) ( 8,386,881 ) Gross debt – variable interest rates ( 51,863,133 ) ( 5,407,932 ) Net cash (debt) $ 145,701,861 $ 122,869,163 Liabilities from financing activities Cash Borrowings due Borrowings due Total Net debt as of June 30, 2020 $ 38,807,662 $ ( 416,041 ) $ ( 4,716,074 ) $ 33,675,547 Cashflows 97,856,314 329,873 ( 4,029,769 ) 94,156,418 Other non-cash movements — ( 601,684 ) ( 4,361,118 ) ( 4,962,802 ) Net cash as of June 30, 2021 136,663,976 ( 687,852 ) ( 13,106,961 ) 122,869,163 Cashflows 61,654,881 669,246 ( 45,316,323 ) 17,007,804 Other non-cash movements 8,765,078 ( 1,945,330 ) ( 994,854 ) 5,824,894 Net cash as of June 30, 2022 $ 207,083,935 $ ( 1,963,936 ) $ ( 59,418,138 ) $ 145,701,861 (b) Non-cash investing and financing activities Non-cash investing and financing activities disclosed in other notes are: • Right of use assets – note 21 • Options and shares issued to employees – note 28

Interests in Subsidiaries

Interests in Subsidiaries	12 Months Ended
	Jun. 30, 2022
Default Root [Abstract]
Interests in Subsidiaries	Note 27 Interests in subsidiaries Information about Principal Subsidiaries The Group’s material subsidiaries at June 30 are set out in the following table. Unless otherwise stated, each entity has share capital consisting solely of ordinary shares that are held by the Group, and the proportion of ownership interest held equals the voting rights held by the Group. The country of incorporation or registration is also their principal place of business. The functional currency of each of the Group’s entities is the currency of the primary economic environment in which that entity operates. The consolidated financial statements are presented in Australian dollars, which is NOVONIX Limited’s functional currency. Ownership interest Place of business Functional 2022 2021 Principal Name of entity incorporation Currency % % activities MD South Tenements Pty Ltd Australia AUD 100 % 100 % Graphite exploration Novonix Battery Technology Solutions, Inc. Canada CAN 100 % 100 % Battery technology services. Novonix Corp USA USD 100 % 100 % Investment Novonix Anode Materials, LLC USA USD 100 % 100 % Battery materials development

Share-based payments

Share-based payments	12 Months Ended
	Jun. 30, 2022
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Abstract]
Share-based payments	Note 28 Share-based payments Performance Rights and Options Executive key management personnel (“KMP”) participate in the Group’s Long-Term Incentive Program (“LTIP”) comprising grants of performance rights and options with varying vesting conditions. The performance rights and options carry no dividend or voting rights. Performance rights and options may vest immediately or dependent on the recipient remaining in employment, or achievement of performance related vesting conditions, by the vesting date. When exercisable, each performance right and option is convertible into one ordinary share of NOVONIX Limited. If an executive ceases employment before the rights or options vest, the rights or options will be forfeited, except in limited circumstances that they are approved by the board on a case-by-case basis. Share rights Non-executive Directors participate on an annual grant of equity awards using a value-based approach, which the Board has adopted by issuing Share Rights to Non-Executive Directors of the Company each financial year with a fixed US dollar value of USD$ 110,000 . The share rights carry no dividend or voting rights. When exercisable, each share right is convertible into one ordinary share of NOVONIX Limited. If a non-executive director ceases to hold office before the share rights vest, the rights will convert on a prorate basis. ero The following table presents the composition of share-based payments expense for the years ended June 30, 2022, June 30, 2021 and June 30, 2020 (in Australian dollars). Year Ended June 30, 2022 2021 2020 Share rights granted in current year $ 3,615,341 — — Performance rights granted in current year 15,034,334 2,952,676 78,362 Performance rights granted in prior years 265,293 — — Options granted in current year — — 113,199 Options granted in prior years 1,275,570 2,995,856 7,367,392 Share based payment expense 20,190,538 5,948,532 7,558,953 Payments of withholding tax - Performance rights ( 3,426,420 ) — — Exchange differences ( 23,350 ) — — Movement in share-based payments reserve $ 16,740,768 $ 5,948,532 $ 7,558,953 SHARE RIGHTS A summary of movements of all share rights issued is as follows: Year Ended June 30, 2022 Number on issue Share rights outstanding at July 1 — Granted 309,049 Forfeited ( 6,510 ) Exercised — Share rights outstanding at June 30 302,539 Share rights exercisable at June 30 302,539 Share rights were granted to non-executive Directors following shareholder approval at the Annual General Meeting on November 30, 2021. The share rights are convertible to ordinary shares on a 1 :1 basis and vested on June 30, 2022. The value of each share right was determined with reference to the market value of the underlying securities on grant date. An expense of $ 3,615,341 has been recognized in the year ended June 30, 2022. No share rights were granted during the years ended June 30, 2021 and 2020. Further details of the share rights are set out in the table below: Name Grant date Number Vesting date Fair value Expiry Expense recognized Anthony Bellas November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 788,700 Andrew Liveris November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 788,700 Robert Cooper November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 788,700 Zhanna Golodryga November 30, 2021 17,549 June 30, 2022 $ 11.95 June 30, 2023 209,711 Trevor St Baker November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 710,905 2 Greg Baynton November 30, 2021 27,500 June 30, 2022 $ 11.95 June 30, 2023 328,625 1 Total expense recognized 3,615,341 1 Greg Baynton retired as a Director on November 30, 2021 but retained his performance rights. The expense associated with his Share Rights was accelerated and the full value of the share rights was recognized at his retirement date 2 Trevor St Baker resigned as a Director on May 26, 2022, causing 6,510 of share rights previously issued to him to be forfeited. PERFORMANCE RIGHTS A summary of movements of all performance rights issued is as follows: 2022 2021 2020 Performance rights outstanding at July 1 1,600,000 3,395,833 3,395,833 Granted 4,676,946 3,500,000 — Awarded^ 667,831 — — Forfeited ( 200,000 ) ( 1,000,000 ) — Exercised ( 1,687,500 ) ( 3,558,865 ) — Settled — ( 736,968 ) — Performance rights outstanding at June 30 5,057,277 1,600,000 3,395,833 Performance rights exercisable at June 30 — 600,000 2,395,833 ^ Performance rights awarded to Key Management Personnel that are subject to shareholder approval which will be sought at the 2022 Annual General Meeting of Shareholders scheduled for October 26, 2022. Performance rights granted in the current period During the year ended June 30, 2022, performance rights (convertible to ordinary shares on a 1 :1 basis) were granted to Key Management Personnel, other employees and contractors as set out in the table below. The value of each performance right was determined with reference to the market value of the underlying securities on grant date. 200,000 performance rights were forfeited during the year as not all vesting conditions were met. Further details of the performance rights are set out in the table below: Name Grant date Number Vesting date Fair value Expiry Expense recognized Rashda Buttar October 6, 2021 150,000 ¼ April 22, 2022 $ 4.92 Cessation of employment $ 363,094 ¼ April 22, 2023 ¼ April 22, 2024 ¼ April 22, 2025 January 28, 2022 255,238 June 30, 2024 $ 7.21 Cessation of employment 318,508 Anthony Bellas November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 Robert Natter November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 Nick Liveris November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 January 28, 2022 667,831 June 30, 2024 $ 2.28 ^ Cessation of employment 263,536 Chris Burns November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 January 28, 2022 1,412,000 June 30, 2024 $ 7.21 Cessation of employment 1,762,013 Non-KMP employees July 1, 2021 1,000,000 ¼ June 30, 2022 $ 2.32 Cessation of employment 1,208,731 ¼ June 30, 2023 ¼ June 30, 2024 ¼ June 30, 2025 Non-KMP employees October 6, 2021 220,000 $ 4.92 Cessation of employment 327,301 Non-KMP employees December 2, 2021 100,000 $ 12.15 Cessation of employment 540,801 Non-KMP employees December 20, 2021 15,589 $ 8.88 Cessation of employment 37,916 Non-KMP employees October 6, 2021 500,000 $ 4.92 Cessation of employment 614,522 Non-KMP employees February 14, 2022 20,000 4 equal annual $ 5.81 Cessation of employment 20,226 Non-KMP employees February 24, 2022 6,009 tranches $ 4.82 Cessation of employment 5,095 Non-KMP employees April 12, 2022 42,317 commencing on the $ 5.90 Cessation of employment 5,408 Non-KMP employees April 20, 2022 11,359 anniversary of $ 6.01 Cessation of employment 876 Non-KMP employees May 2, 2022 17,430 employment $ 5.01 Cessation of employment 1,245 Non-KMP employees May 23, 2022 53,200 $ 3.93 Cessation of employment 3,046 Non-KMP employees May 28, 2022 10,853 $ 3.73 Cessation of employment 577 Non-KMP employees June 6, 2022 11,400 $ 3.51 Cessation of employment 114 Non-KMP employees June 15, 2022 40,698 $ 2.47 Cessation of employment 1,290 Non-KMP employees June 22, 2022 10,853 $ 2.27 Cessation of employment 35 Total number issued 5,344,777 Total expense recognized $ 15,034,334 ^ On January 28, 2022 667,831 performance rights were awarded to Nick Liveris. These performance rights are subject to shareholder approval which will be sought at the 2022 Annual General Meeting of shareholders and have not been formerly granted at June 30, 2022. The fair value per performance right represents an estimate at June 30, 2022 of the grant date fair value of the performance rights. Performance rights net-settled in the current period The Group has an obligation to withhold tax on the vesting of performance rights for employee’s resident in the USA and Canada. As consideration for the withholding tax, the Group reduces the number of shares to be issued to the employees (net settled). During the year the Group net settled the following share based share-based payments: Name Vesting date Performance rights Net settled shares Withholding obligation Chris Burns November 30, 2021 200,000 92,000 $ 1,290,600 Nick Liveris November 30, 2021 200,000 107,851 1,101,180 Non-KMP employees December 11, 2021 200,000 92,000 1,034,640 Total $ 3,426,420 OPTIONS A summary of movements of all options issued is as follows: 2022 Weighted Average Exercise Price Options outstanding as of July 1 32,103,334 $ 0.51 Granted to employees — — Granted to loan note holders — — Cancelled — — Forfeited ( 2,740,000 ) $ 0.53 Exercised ( 33,333 ) $ 0.50 Options outstanding as of June 30 29,330,001 $ 0.51 Options exercisable at June 30 13,796,667 $ 0.52 The weighted average remaining contractual life of options outstanding at June 30, 2022 was 4.8 years (2021: 5.8 years). The range of exercise prices for options outstanding at June 30, 2022 was $ 0.50 to $ 1.40 (2021: $ 0.50 to $ 1.40 ; and 2020: $ 0.50 to $ 1.40 ). There were no options granted during the year ended June 30, 2022. The model inputs for the valuations of options granted during the years ended June 30, 2021 and 2020 were as follows: a. On March 14, 2021, 100,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The fair value of these options totaled $ 247,297 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Number of options 33,333 33,333 33,334 Exercise price $ 0.50 $ 0.50 $ 0.50 Award date March 14, 2021 March 14, 2021 March 14, 2021 Expiry date March 14, 2021 March 14, 2031 March 14, 2031 Vesting date February 24, 2022 February 24, 2023 February 24, 2024 Volatility 96.28 % 96.28 % 96.28 % Dividend yield 0 % 0 % 0 % Risk-free interest rate 1.72 % 1.72 % 1.72 % Fair value at grant date $ 2.4101 $ 2.4811 $ 2.5277 b. On December 14, 2020, 100,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The fair value of these options totaled $ 83,444 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Number of options 33,333 33,333 33,334 Exercise price $ 0.50 $ 0.50 $ 0.50 Award date December 14, 2020 December 14, 2020 December 14, 2020 Expiry date December 14, 2030 December 14, 2030 December 14, 2030 Vesting date February 24, 2021 February 24, 2022 February 24, 2023 Volatility 94.2 % 94.2 % 94.2 % Dividend yield 0 % 0 % 0 % Risk-free interest rate 0.98 % 0.98 % 0.98 % Fair value at grant date $ 0.7878 $ 0.8394 $ 0.8758 c. On January 16, 2020, 1,000,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The options vest in 10 tranches on achievement of progressive PUREgraphite sales milestones. The vesting dates in the table below represent the current estimate of when the vesting conditions will be met. The fair value of these options totaled $ 377,390 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Tranche 4 Tranche 5 Tranche 6 Tranche 7 Tranche 8 Tranche 9 Tranche 10 Number of options 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 Exercise price $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 Award date January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 Expiry date January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 Vesting date May 31, 2022 March 31, 2023 June 30, 2023 November 30, 2023 December 31, 2023 February 28, 2024 March 31, 2024 April 30, 2024 May 31, 2024 June 30, 2024 Volatility 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % Dividend yield 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % Risk-free interest rate 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % Fair value at grant date $ 0.3541 $ 0.3648 $ 0.3726 $ 0.3753 $ 0.3809 $ 0.3819 $ 0.3832 $ 0.3839 $ 0.3883 $ 0.3889 d. On December 7, 2019, 1,000,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The options vest in 10 tranches on achievement of progressive PUREgraphite sales milestones. The vesting dates in the table below represent the current estimate of when the vesting conditions will be met. The fair value of these options totaled $ 456,580 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Tranche 4 Tranche 5 Tranche 6 Tranche 7 Tranche 8 Tranche 9 Tranche 10 Number of options 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 Exercise price $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 Award date December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 Expiry date December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 Vesting date May 31, 2022 March 31, 2023 June 30, 2023 November 30, 2023 December 31, 2023 February 28, 2024 March 31, 2024 April 30, 2024 May 31, 2024 June 30, 2024 Volatility 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % Dividend yield 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % Risk-free interest rate 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % Fair value at grant date $ 0.4274 $ 0.4415 $ 0.4513 $ 0.4543 $ 0.4611 $ 0.4623 $ 0.4636 $ 0.4644 $ 0.4696 $ 0.4703 e. On July 8, 2019, 2,500,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The options vest in 10 tranches on achievement of progressive PUREgraphite sales milestones. The vesting dates in the table below represent the current estimate of when the vesting conditions will be met. The fair value of these options totaled $ 804,375 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Tranche 4 Tranche 5 Tranche 6 Tranche 7 Tranche 8 Tranche 9 Tranche 10 Number of options 250,000 250,000 250,000 250,000 250,000 250,000 250,000 250,000 250,000 250,000 Exercise price $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 Award date July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 Expiry date July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 Vesting date May 31, 2022 March 31, 2023 June 30, 2023 November 30, 2023 December 31, 2023 February 28, 2024 March 31, 2024 April 30, 2024 May 31, 2024 June 30, 2024 Volatility 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % Dividend yield 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % Risk-free interest rate 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % Fair value at grant date $ 0.3026 $ 0.3115 $ 0.3179 $ 0.3201 $ 0.3248 $ 0.3255 $ 0.3264 $ 0.3270 $ 0.3307 $ 0.3310

Related Party Transactions

Related Party Transactions	12 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related party transactions	Note 29 Related party transactions During the financial year: (a) On November 30, 2021, 800,000 performance rights (convertible to ordinary shares on a 1 :1 basis) were granted to Robert Natter, Chairman ( 200,000 ), Tony Bellas, non-executive Director ( 200,000 ), Chris Burns, CEO ( 200,000 ) and Nick Liveris, CFO ( 200,000 ). The performance rights were formally approved by shareholders at the AGM on November 30,2021. The value of each performance right was determined to be $ 11.95 , with a vesting date of November 30, 2021. These performance rights were converted to shares on December 14, 2021. An expense of $ 9,560,000 has been recognized in the year ended June 30, 2022. (b) On November 30, 2021, the following Share rights were issued to non-executive Directors. The share rights are convertible to ordinary shares on a 1 :1 basis, and vested on June 30, 2022: a. Tony Bellas (Director) – 66,000 share rights b. Andrew Liveris (Director) – 66,000 share rights c. Robert Cooper (Director) – 66,000 share rights d. Trevor St Baker (Director) – 66,000 share rights e. Greg Baynton (former Director) – 27,500 share rights f. Zhanna Golodryga (Director) – 17,549 share rights (c) On January 28, 2022, 1,412,000 performance rights were granted to Chris Burns as an LTI for FY2022. The performance rights (convertible to ordinary shares on a 1 :1 basis) vest on June 30, 2024. 50 % of the performance rights vest subject to continued employment, and 50 % vest subject to the achievement of performance conditions. (d) On January 28, 2022, 255,238 performance rights were granted to Rashda Buttar as an LTI for FY2022. The performance rights (convertible to ordinary shares on a 1 :1 basis) vest on June 30, 2024. 50 % of the performance rights vest subject to continued employment, and 50 % vest subject to the achievement of performance conditions. (e) On January 28, 2022, 667,831 performance rights were awarded to Nick Liveris as an LTI for FY2022. The granting and issue of the performance rights is subject to shareholder approval which will be sought at the 2022 Annual General Meeting of Shareholders and the performance rights have not been issued at June 30, 2022. The performance rights (convertible to ordinary shares on a 1 :1 basis) vest on June 30, 2024 . 50 % of the performance rights vest subject to continued employment, and 50 % vest subject to the achievement of performance conditions. During the prior financial year: (f) On December 14, 2020, 2,250,000 performance rights (convertible to ordinary shares on a 1 :1 basis) were granted to Chris Burns, CEO ( 1,500,000 ) and Nick Liveris, CFO ( 750,000 ). The performance rights were formally approved by shareholders at the AGM on November 17, 2020. The value of each performance right was determined to be $ 1.06 , with a vesting date of January 4, 2021 and an expiry date of June 30, 2022. An expense of $ 2,044,286 has been recognised in the year ended June 30, 2021. (g) The Group entered into a separation agreement with Philip St Baker following his resignation on September 23,2020, which included the settlement of a $ 1,500,000 limited resource loan. Refer note 24(j). (h) On March 16 ,2021 the following performance rights were exercised and converted into fully paid ordinary shares: a. Greg Baynton (Director) – 300,000 performance rights b. Chris Burns (CEO) – 1,800,000 performance rights c. Nicholas Liveris (CFO) – 900,000 performance rights During the 2020 financial year: (i) Philip St Baker was paid rent totaling $ 77,579 (USD$ 52,000 ), for the use of property owned by Mr St Baker in Colorado, USA. Mr St Baker’s salary has been adjusted to reflect the additional benefit Mr St Baker is receiving. (j) 10,000,000 unsecured loan notes with a face value of $ 0.40 were issued to the St Baker Energy Innovation Fund, a related party of Mr St Baker. Prior to the issue of the loan notes, the St Baker Energy Innovation Fund provided the Company with a $ 4,000,000 short-term unsecured loan bearing interest at a rate of 10 %. Following shareholder approval on 31 July 2019 for the loan notes, the short-term loan was converted to loan notes. (k) In March 2020 the Company entered into a short-term loan agreement with the St Baker Energy Innovation Fund for $ 3,400,000 . The loan is unsecured, interest bearing at a rate of 12.5 % pa from the date of drawdown calculated on a daily basis and is repayable upon the earlier of the Company raising sufficient funds and 6 months. This loan was settled as part of the June 2020 Capital Raising. (l) At a General Meeting of Shareholders held on 30 June 2020, Shareholders approved the issue of 67,085,100 fully paid ordinary shares to the St Baker Energy Innovation Fund at an issue price of $ 0.29 per share raising $ 19,454,679 . The consideration for the shares received consisted of cash and the retirement of both convertible loan notes and short-term loans owing. Details of the Strategic Placement are set out in the table below: Face value of loan notes and balance of short-term loan Interest accrued Placement proceeds Total Shares issued (Number) Loan notes redeemed $ 10,000,000 $ 1,187,397 - $ 11,187,397 38,577,232 Short-term loan repaid 3,400,000 131,575 - 3,531,575 12,177,845 Placement proceeds - - 4,735,707 4,735,707 16,330,023 Total $ 13,400,000 $ 1,318,972 $ 4,735,707 $ 19,454,679 67,085,100 (m) The Group entered into short-term loan agreements with directors totaling $ 3,148,960 . These loans were unsecured, interest bearing at a rate of 8 % pa from the date of drawdown calculated on a daily basis, and were repayable upon the earlier of the Company raising sufficient funds and 6 months. These loans were settled as part of the Capital Raising. There were no other related party transactions during the current or prior financial years. For details of disclosures relating to key management personnel, refer to Note 7.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jun. 30, 2022
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 30 Commitments and Contingencies (a) Exploration commitments Year Ended June 30, 2022 2021 Commitments for payments under exploration permits in existence at the reporting date but not recognized as liabilities payable $ 23,000 $ 13,000 So as to maintain current rights to tenure of various exploration tenements, the Group will be required to outlay amounts in respect of tenement exploration expenditure commitments. These outlays, which arise in relation to granted tenements are noted above. The outlays may be varied from time to time, subject to approval of the relevant government departments, and may be relieved if a tenement is relinquished. Exploration commitments are calculated on the assumption that each of these tenements will be held for its full term. But, in fact, commitments will decrease materially as exploration advances and ground that is shown to be unprospective is progressively surrendered. Expenditure commitments on prospective ground will be met out of existing funds, farm-outs, and new capital raisings. (b) Capital commitments Significant capital expenditure contracted for at the end of the reporting period but not recognized as liabilities is as follows: Year Ended June 30, 2022 2021 Property, plant and equipment $ 14,893,026 $ 10,182,218 The capital commitments relate to purchases of property, plant and equipment in connection with the expansion of our business and development of our technologies in the NAM and BTS business segments and are expected to be recognized within the next twelve months. (c) Legal Proceedings The Group is currently not a party to any material legal proceedings. From time to time, the Group may become involved in legal proceedings arising in the ordinary course of business. Such claims or legal actions, even if without merit, could result in the expenditure of significant financial and management resources and potentially result in civil liability for damages.

Financial Risk Management

Financial Risk Management	12 Months Ended
	Jun. 30, 2022
Disclosure Of Financial Instruments [Abstract]
Financial Risk Management	Note 31 Financial risk management This note explains the group’s exposure to financial risks and how these risks could affect the group’s future financial performance. Current year profit and loss information has been included where relevant to add further context. The totals for each category of financial instruments, measured in accordance with IAS 39: Financial Instruments: Recognition and Measurement, as detailed in the accounting policies to these consolidated financial statements, are as follows: June 30 2022 2021 Notes Financial assets Cash and cash equivalents 10 $ 207,083,935 $ 136,663,976 Trade and other receivables 11 3,558,016 2,042,963 Financial assets at fair value through profit or loss 16 24,179,998 — Total financial assets 234,821,949 138,706,939 Financial liabilities Trade payables 19 3,847,509 1,823,898 Lease liabilities 21 7,755,532 7,531,188 Borrowings 22 53,626,542 6,263,625 Total financial liabilities $ 65,229,583 $ 15,618,711 The Board has overall responsibility for the determination of the Group’s risk management objectives and policies. The overall objective of the Board is to set policies that seek to reduce risk as far as possible without unduly affecting the Group’s competitiveness and flexibility. Market risk Market risk is the risk that the change in market prices, such as foreign exchange rates, interest rates and equity prices will affect the Group’s income or the value of its holdings of financial instruments. Foreign currency risk Foreign exchange risk arises from future transactions and recognized assets and liabilities denominated in a currency that is not the functional currency of the relevant Group entity. Exposure to foreign currency risk may result in the fair value or future cash flows of a financial instrument fluctuating due to movement in foreign exchange rates of currencies in which the Group holds financial instruments which are other than the AUD functional currency of the Group. With instruments being held by overseas operations, fluctuations in the US dollar and the Canadian dollar may impact on the Group’s financial results. The following table shows the foreign currency risk as on the financial assets and liabilities of the Group’s operations denominated in currencies other than the functional currency of the operations. The group’s exposure to foreign currency risk at the end of the reporting period, expressed in Australian dollars, was as follows: 2022 2021 2022 2021 Cash at bank $ - $ - $ 128,936,395 $ 69,950,408 Trade receivables — — 2,587,528 1,305,421 Trade payables — — 804,376 460,536 Borrowings $ 13,376 $ 1,919 $ - $ - Cash flow and fair value interest rate risk The group’s main interest rate risk arises from long-term borrowings with variable rates, which expose the group to cash flow interest rate risk. During 2022, the group’s borrowings at variable rates were denominated in Canadian and US dollars. As the Group has interest-bearing cash assets, the Company’s income and operating cash flows are exposed to changes in market interest rates. The Company manages its exposure to changes in interest rates by using fixed term deposits. At June 30, 2022 , if interest rates had changed by -/+ 100 basis points from the year-end rates with all other variables held constant, post-tax profit / (loss) for the year would have been $ 1,552,208 ( June 30, 2021 : $ 1,237,193 ) lower/higher, as a result of higher/lower interest income from cash and cash equivalents. Credit risk Credit risk is managed on a Group basis. Credit risk arises primarily from cash and cash equivalents and deposits with banks and financial institutions, and trade and other receivables. For bank and financial institutions, only independently rated parties with a minimum rating of ‘AAA’ are accepted. For trade and other receivables, amounts are considered as “past due” when the debt has not been settled, in line with the terms and conditions agreed between the Group and the customer to the transaction. Due to a strong credit approval process, the Group has a minimal history of bad debt write-offs. The balance of receivables that remain within initial trade terms are considered to be of high credit quality. The credit quality of financial assets that are neither past due nor impaired can be assessed by reference to external credit ratings (if available). The credit quality of financial assets that are neither past due nor impaired can be assessed by reference to external credit ratings (if available). Liquidity risk Prudent liquidity risk management implies maintaining sufficient cash and marketable securities to meet obligations when due. The Group manages liquidity risk by continuously monitoring forecast and actual cash flows. No finance facilities were available to the Group at the end of the reporting period. All financial assets mature within one year. The maturity of all financial liabilities is set out in the table below. Financing arrangements The group’s undrawn borrowing facilities as at June 30, 2022 totals $ 2,095,015 (CAD $ 1,861,830 ) which relates to the loan facilities secured over commercial land and buildings (refer note 22). Maturities of financial liabilities As of June 30, 2022, the contractual maturities of the group’s non-derivative financial liabilities were as follows: Contractual Less than 6 - 12 Between Between Over 5 Total Carrying At June 30, 2022 Trade payables $ 9,479,659 $ — $ — $ — $ — $ 9,479,659 $ 9,479,659 Lease liabilities 403,904 403,904 832,181 2,496,544 5,779,037 9,915,570 7,755,532 Borrowings 1,588,618 1,661,129 3,472,057 10,648,817 50,294,010 67,664,631 53,626,542 Total non-derivatives $ 11,472,181 $ 2,065,033 $ 4,304,238 $ 13,145,361 $ 56,073,047 $ 87,059,860 $ 70,861,733

Events After the Reporting Date

Events After the Reporting Date	12 Months Ended
	Jun. 30, 2022
Disclosure Of Nonadjusting Events After Reporting Period [Abstract]
Events After the Reporting Date	Note 32 Events after the reporting date Since the end of the financial year: There have been no other matters or circumstances that have arisen since the end of the financial year which significantly affected or could significantly affect the operations of the Company, the results of those operations or the state of affairs of the Company in future financial years.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Initial Application Of Standards Or Interpretations [Abstract]
Basis of Preparation	Basis of preparation These general-purpose financial statements have been prepared in accordance with International Financial Reporting Standards (”IFRS”) as issued by the International Accounting Standards Board (“IASB”). Material accounting policies adopted in the preparation of these consolidated financial statements are presented below and have been consistently applied unless stated otherwise. Except for cash flow information, the consolidated financial statements have been prepared on an accruals basis and are based on historical costs, modified, where applicable, by the measurement at fair value of selected non-current assets, financial assets and financial liabilities.
Going Concern	Going concern These consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of normal business activities and the realization of assets and settlement of liabilities in the normal course of business. As disclosed in these consolidated financial statements , the Group incurred a net loss of $ 71,441,024 (June 30, 2021: $ 18,076,077 ) and net operating cash outflows of $ 40,353,292 (June 30, 2021: $ 8,172,064 ) for the year ended June 30, 2022. As at June 30, 2022 the Group has a cash balance of $ 207,083,935 (30 June 2021: $ 136,663,976 ) and net current assets of $ 223,906,897 (30 June 2021: $ 138,671,009 ). The Group is continuing to execute on its expansion plans of reaching production capacity of 40,000 tonnes per year by 2025 and in order to fund these expansionary activities, which will primarily involve significant capital expenditure, additional funding beyond the existing cash balance at 30 June 2022 will be required. The ability of the Group to continue as a going concern is principally dependent upon one or more of the following: • the successful and profitable growth of the battery materials, battery consulting and battery technology businesses; • the ability of the Group to meet its cash flow forecasts; and • the ability of the Group to raise funds as and when necessary from either customers, governments and/or investors in the form of debt, equity and/or grant funding. These conditions give rise to a material uncertainty which may cast significant doubt (or substantial doubt as contemplated by Public Company Accounting Oversight Board (“PCAOB”) standards) over the Group’s ability to continue as a going concern. The directors believe that the going concern basis of preparation is appropriate as the Group has a strong history of being able to raise capital from debt and equity sources, raising $ 208 million in September 2021 following the investment made by Phillips 66, as well as $ 131 million in March and May 2021. The Directors have considered the impact of COVID 19 and found that the pandemic has not had a significant effect on the Group’s ability to continue as a going concern. Should the Group be unable to continue as a going concern, it may be required to realise its assets and extinguish its liabilities other than in the ordinary course of business, and at amounts that differ from those stated in these consolidated financial statements. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts or classification of liabilities and appropriate disclosures that may be necessary should the Group be unable to continue as a going concern. These consolidated financial statements were authorized for issue by the Directors on August 31, 2022. The Directors have the power to amend and reissue these consolidated financial statements.
Principles of Consolidation	Principles of consolidation These consolidated financial statements incorporate the assets and liabilities of all subsidiaries of NOVONIX Limited (‘Company’ or ‘Parent Entity’) as at June 30, 2021 and the results of all subsidiaries for the year then ended. NOVONIX Limited and its subsidiaries together are referred to in these financial statements as the ‘Group’. Subsidiaries are all those entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are de-consolidated from the date that control ceases. Intercompany transactions, balances and unrealized gains on transactions between entities in the Group are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group. Where equity instruments are issued in a business combination, the fair value of the instruments is their published market price as at the date of exchange. Transaction costs arising on the issue of equity instruments are recognized directly in equity. The consideration transferred also includes the fair value of any asset or liability resulting from a contingent consideration arrangement. With limited exceptions, all identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. The excess of the consideration transferred, amount of any non-controlling interest in the acquired entity, over the net fair value of the Group's share of the identifiable net assets acquired is recognized as goodwill. If the consideration transferred of the acquisition is less than the Group's share of the net fair value of the identifiable net assets of the subsidiary, the difference is recognized as a gain in the profit and loss in the Consolidated Statement of Profit or Loss and Other Comprehensive Income, but only after a reassessment of the identification and measurement of the net assets acquired. Where settlement of any part of the cash consideration is deferred, the amounts payable in the future are discounted to their present value, as at the date of exchange. The discount rate used is the entity's incremental borrowing rate, being the rate at which a similar borrowing could be obtained from an independent financier under comparable terms and conditions.
Fair Value Measurements	Fair value measurements Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. For some assets and liabilities, observable market transactions or market information is available. For other assets and liabilities, observable market transactions or market information might not be available. When a price for an identical asset or liability is not observable, another valuation technique is used. To increase consistency and comparability in fair value measurements, there are three levels of the fair value hierarchy based on the inputs used: • Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities • Level 2 – Inputs are inputs other than quoted prices included within Level 1, which are observable for the asset or liability either directly or indirectly • Level 3 – Inputs are unobservable inputs for the asset or liability The Group recognizes transfers between levels of the fair value hierarchy at the end of the reporting period during which the change has occurred.
Income Tax	Income tax The income tax expense or benefit for the period is the tax payable on that period’s taxable income based on the applicable income tax rate for each jurisdiction, adjusted by the changes in deferred tax assets and liabilities attributable to temporary differences, unused tax losses and the adjustment recognized for prior periods, where applicable. Deferred tax assets and liabilities are recognized for temporary differences at the tax rates expected to be applied when the assets are recovered or liabilities are settled, based on those tax rates that are enacted or substantively enacted, except for: • When the deferred income tax asset or liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business combination and that, at the time of the transaction, affects neither the accounting nor taxable profits; or (i) • When the taxable temporary difference is associated with interests in subsidiaries, associates or joint ventures, and the timing of the reversal can be controlled and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax assets are recognized for deductible temporary differences and unused tax losses only if it is probable that future taxable amounts will be available to utilize those temporary differences and losses. The carrying amount of recognized and unrecognized deferred tax assets are reviewed at each reporting date. Deferred tax assets recognized are reduced to the extent that it is no longer probable that future taxable profits will be available for the carrying amount to be recovered. Previously unrecognized deferred tax assets are recognized to the extent that it is probable that there are future taxable profits available to recover the asset. Deferred tax assets and liabilities are offset only where there is a legally enforceable right to offset current tax assets against current tax liabilities and deferred tax assets against deferred tax liabilities; and they relate to the same taxable authority on either the same taxable entity or different taxable entities which intend to settle simultaneously.
Revenue Recognition	Revenue recognition Revenue from contracts with customers is recognized when control of the goods or services is transferred to the customer at an amount that reflects the consideration to which the Group expects to be entitled in exchange for those goods or services . Sales of Goods Revenue for the hardware is recognized at a point in time when the hardware is delivered, the legal title has passed and the customer has accepted the hardware. Consulting services The consulting division provides battery cell design, implementation and support services under fixed-price and variable price contracts. Revenue from providing services is recognized in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognized based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided because the customer receives and uses the benefits simultaneously. This is determined based on the actual labor hours spent relative to the total expected labor hours. Where the contracts include multiple performance obligations, the transaction price will be allocated to each performance obligation based on the stand-alone selling prices. Where these are not directly observable, they are estimated based on expected cost-plus margin.
Contract Balances	Contract balances Trade and other receivables A receivable is recognized when the Group’s right to consideration is unconditional, which is generally when goods are delivered or services are performed, as only the passage of time is required before payment is due. Contract liabilities A contract liability is the obligation to transfer goods or services to a customer for which the Group has received consideration (or an amount of consideration is due) from the customer. If a customer pays consideration before the Group transfers goods or services to the customer, a contract liability is recognized when the payment is made or the payment is due (whichever is earlier). Contract liabilities are recognized as revenue when the Group performs under the contract.
Other Income	Other income Interest Interest income is recognized as interest accrues using the effective interest method. This is a method of calculating the amortized cost of a financial asset and allocating the interest income over the relevant period using the effective interest rate, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to the net carrying amount of the financial asset. Grant revenue Grants from government bodies are recognized at their fair value where there is a reasonable assurance that the grant will be received and the group will comply with all attached conditions.
Operating Segments	Operating segments Operating segments are presented using the ‘management approach’, where the information presented is on the same basis as the internal reports provided to the Chief Operating Decision Makers (‘CODMs’). The CODMs are responsible for the allocation of resources to operating segments and assessing their performance.
Current and Non-Current Classification	Current and non-current classification Assets and liabilities are presented in the balance sheet based on current and non-current classification. An asset is classified as current when: it is either expected to be realized or intended to be sold or consumed in normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realized within 12 months after the reporting period; or the asset is cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12 months after the reporting period. All other assets are classified as non-current. A liability is classified as current when: it is either expected to be settled in normal operating cycle; it is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no unconditional right to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities are classified as non-current. Deferred tax assets and liabilities are always classified as non-current.
Cash and Cash Equivalents	Cash and cash equivalents Cash and cash equivalents includes cash on hand, deposits held at call with financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. For the statement of cash flows presentation purposes, cash and cash equivalents also includes bank overdrafts, which are shown within borrowings in current liabilities on the balance sheet.
Other Receivables	Other receivables Other receivables are recognized at amortized cost, less any provision for impairment.
Inventories	Inventories Inventories are measured at the lower of cost and net realizable value. The cost of manufactured products includes direct materials, direct labor and an appropriate proportion of variable and fixed overheads. Costs are assigned to individual items of inventory on the basis of weighted average costs.
Exploration and Evaluation Assets	Exploration and evaluation assets Exploration and evaluation expenditure incurred is accumulated in respect of each identifiable area of interest. Such expenditures comprise net direct costs and an appropriate portion of related overhead expenditure but do not include overheads or administration expenditure not having a specific nexus with a particular area of interest. These costs are only carried forward to the extent that they are expected to be recouped through the successful development of the area or where activities in the area have not yet reached a stage which permits reasonable assessment of the existence of economically recoverable reserves and active or significant operations in relation to the area are continuing. A regular review has been undertaken on each area of interest to determine the appropriateness of continuing to carry forward costs in relation to that area of interest. An impairment charge is recognized when the Directors are of the opinion that the carried forward net cost may not be recoverable or the right of tenure in the area lapses. When production commences, the accumulated costs for the relevant area of interest are amortized over the life of the area according to the rate of depletion of the economically recoverable reserves.
Loan Notes	Loan notes Loan notes are initially measured at fair value less transaction costs. Amortized cost is calculated as the amount at which the loan note is measured at initial recognition less principal repayments, and adjusted for any cumulative amortization of the difference between that initial amount and the maturity amount calculated using the effective interest method. The effective interest method is used to allocate interest expense over the relevant period and is equivalent to the rate that discounts estimated future cash payments over the expected life of the financial instrument to the net carrying amount of the financial liability. Non-derivative financial liabilities, other than financial guarantees, are subsequently measured at amortized cost. Gains or losses are recognized in profit or loss through the amortization process and when then financial liability is derecognized.
Property, Plant and Equipment	Property, plant and equipment Property, plant and equipment is stated at historical cost less accumulated depreciation and impairment. Historical cost includes expenditure that is directly attributable to the acquisition of the items. Depreciation is calculated on a straight-line basis to write off the net cost of each item of property, plant and equipment (excluding land) over their expected useful lives as follows: Buildings ​ 25 years Plant and equipment ​ 2 - 20 years The residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date. An item of plant and equipment is derecognized upon disposal or when there is no future economic benefit to the Group. Gains and losses between the carrying amount and the disposal proceeds are taken to profit or loss.
Trade and Other Payables	Trade and other payables These amounts represent liabilities for goods and services provided to the Group prior to the end of the financial year and which are unpaid. Due to their short-term nature they are measured at amortized cost and are not discounted. The amounts are unsecured and are usually paid within 30 days of recognition.
Leases	Leases The group leases a warehouse in Tennessee from which the NOVONIX Anode Materials business operates. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes. Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments: • fixed payments (including in-substance fixed payments), less any lease incentives receivable • variable lease payments that are based on an index or a rate, initially measured using the index or rate as at the commencement date • amounts expected to be payable by the group under residual value guarantees • the exercise price of a purchase option if the group is reasonably certain to exercise that option, and • payments of penalties for terminating the lease, if the lease term reflects the group exercising that option. Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for leases in the group, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and conditions. To determine the incremental borrowing rate, the group: • where possible, uses recent third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing conditions since third party financing was received • uses a build-up approach that starts with a risk-free interest rate adjusted for credit risk for leases held by NOVONIX Limited, which does not have recent third party financing, and • makes adjustments specific to the lease, e.g. term, country, currency and security. The group is exposed to potential future increases in variable lease payments based on an index or rate, which are not included in the lease liability until they take effect. When adjustments to lease payments based on an index or rate take effect, the lease liability is reassessed and adjusted against the right-of-use asset. Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period. Right-of-use assets are measured at cost comprising the following: • the amount of the initial measurement of lease liability • any lease payments made at or before the commencement date less any lease incentives received • any initial direct costs, and • restoration costs. Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis. If the group is reasonably certain to exercise a purchase option, the right-of-use asset is depreciated over the underlying asset’s useful life. The group does not revalue the right-of-use buildings held by the group. Payments associated with short-term leases of equipment and vehicles and all leases of low-value assets are recognized on a straight-line basis as an expense in profit or loss. Short-term leases are leases with a lease term of 12 months or less. Low-value assets comprise IT equipment and small items of office furniture. Extension options are included in property and equipment leases across the group. These are used to maximize operational flexibility in terms of managing the assets used in the group’s operations. The extension options held are exercisable only by the group and not by the lessor. When the group revises its estimate of the term of any lease (because, for example, it re-assesses the probability of a lessee extension or termination option being exercised), it adjusts the carrying amount of the lease liability to reflect the payments to make over the revised term, which are discounted using a revised discount rate. The carrying value of lease liabilities is similarly revised when the variable element of future lease payments dependent on a rate or index is revised, except the discount rate remains unchanged. In both cases an equivalent adjustment is made to the carrying value of the right-of-use asset, with the revised carrying amount being amortized over the remaining (revised) lease term. If the carrying amount of the right-of-use asset is adjusted to zero, any further reduction is recognized in profit or loss. When the group renegotiates the contractual terms of a lease with the lessor, the accounting depends on the nature of the modification: • if the renegotiation results in one or more additional assets being leased for an amount commensurate with the standalone price for the additional rights-of-use obtained, the modification is accounted for as a separate lease in accordance with the above policy • in all other cases where the renegotiated increases the scope of the lease (whether that is an extension to the lease term, or one or more additional assets being leased), the lease liability is remeasured using the discount rate applicable on the modification date, with the right-of-use asset being adjusted by the same amount • if the renegotiation results in a decrease in the scope of the lease, both the carrying amount of the lease liability and right-of-use asset are reduced by the same proportion to reflect the partial of full termination of the lease with any difference recognized in profit or loss. The lease liability is then further adjusted to ensure its carrying amount reflects the amount of the renegotiated payments over the renegotiated term, with the modified lease payments discounted at the rate applicable on the modification date. The right-of-use asset is adjusted by the same amount.
Investments and other financial assets	Investments and other financial assets Classification The group classifies its financial assets in the following measurement categories: • those to be measured subsequently at fair value (either through OCI or through profit or loss), and • those to be measured at amortized cost. The classification depends on the entity’s business model for managing the financial assets and the contractual terms of the cash flows. For assets measured at fair value, gains and losses will either be recorded in profit or loss or OCI. For investments in equity instruments that are not held for trading, this will depend on whether the group has made an irrevocable election at the time of initial recognition to account for the equity investment at fair value through other comprehensive income (FVOCI). Recognition and derecognition Regular way purchases and sales of financial assets are recognized on trade date, being the date on which the group commits to purchase or sell the asset. Financial assets are derecognized when the rights to receive cash flows from the financial assets have expired or have been transferred and the group has transferred substantially all the risks and rewards or ownership. Measurement At initial recognition, the group measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss (FVPL), transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at FVPL are expensed in profit or loss. The group subsequently measures all equity investments at fair value. Where the group’s management has elected to present fair value gains and losses on equity investments in OCI, there is no subsequent reclassification or fair value gains and losses to profit or loss following the derecognition of the investment. Dividends from such investments continue to be recognized in Profit or Loss as other income when the group’s right to receive payments is established. Changes in fair value of financial assets at FVPL are recognized in other gains/(losses) in the Consolidated Statement of Profit or Loss and Other Comprehensive Income as applicable. Impairment losses (and reversal of impairment losses) on equity investments measured at FVOCI are not reported separately from other changes in fair value.
Employee Benefits	Employee benefits Short-term employee benefits Liabilities for wages and salaries, including non-monetary benefits, annual leave and long service leave expected to be settled within 12 months of the reporting date are measured at the amounts expected to be paid when the liabilities are settled. Other long-term employee benefits The liability for long service leave not expected to be settled within 12 months of the reporting date are measured as the present value of expected future payments to be made in respect of services provided by employees up to the reporting date using the projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and periods of service. Expected future payments are discounted using market yields at the reporting date on corporate bonds with terms to maturity and currency that match, as closely as possible, the estimated future cash outflows. Share-based payments Equity-settled share-based compensation benefits are provided to employees. Equity-settled transactions are awards of shares, options or performance rights over shares, that are provided to employees in exchange for the rendering of services. The cost of equity-settled transactions are measured at fair value on grant date. Fair value is determined using various valuation methods including Black Scholes, Binomial and the Monte Carlo Simulation method that takes into account the exercise price, the term of the performance right, the impact of dilution, the share price at grant date and expect price volatility of the underlying share, the expected dividend yield and the risk-free interest rate for the term of the performance right. The cost of equity-settled transactions are recognized as an expense with a corresponding increase in equity over the vesting period. The cumulative charge to profit or loss is calculated based on the grant date fair value of the award, the best estimate of the number of awards that are likely to vest and the expired portion of the vesting period. The amount recognized in profit or loss for the period is the cumulative amount calculated at each reporting date less amounts already recognized in previous periods. Market conditions are taken into consideration in determining fair value. Therefore, any awards subject to market conditions are considered to vest irrespective of whether or not that market condition has been met, provided all other conditions are satisfied. If equity-settled awards are modified, as a minimum an expense is recognized as if the modification has not been made. An additional expense is recognized, over the remaining vesting period, for any modification that increases the total fair value of the share-based compensation benefit as at the date of modification. Share-based payment expenses are recognized over the period during which the employee provides the relevant services. This period may commence prior to the grant date. In this situation, the entity estimates the grant date fair value of the equity instruments for the purposes of recognizing the services received during the period between service commencement date and grant date. Once the grant date has been established, the earlier estimate is revised so that the amount recognized for services received is ultimately based on the grant date fair value of the equity instruments. If the non-vesting condition is within the control of the Group or employee, the failure to satisfy the condition is treated as a cancellation. If the condition is not within the control of the Group or employee and is not satisfied during the vesting period, any remaining expense for the award is recognized over the remaining vesting period, unless the award is forfeited. If equity-settled awards are cancelled, it is treated as if it has vested on the date of cancellation, and any remaining expense is recognized immediately. If a new replacement award is substituted for the cancelled award, the cancelled and new award is treated as if they were a modification.
Issued Capital	Issued capital Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Impairment of Non-Financial Assets	Impairment of Non-Financial Assets At the end of each reporting period, the Group assesses whether there is any indication that an asset may be impaired. The assessment will include the consideration of external and internal sources of information, including dividends received from subsidiaries, associates or joint ventures deemed to be out of pre-acquisition profits. If such an indication exists, an impairment test is carried out on the asset by comparing the recoverable amount of the asset, being the higher of the asset’s fair value less costs of disposal and value in use, to the asset’s carrying amount. Any excess of the assets carrying amount over its recoverable amount is recognized immediately in profit or loss, unless the asset is carried at a revalued amount in accordance with another Standard. Any impairment loss of a revalued asset is treated as a revaluation decrease in accordance with that other Standard. Where it is not possible to estimate the recoverable amount of an individual asset, the Group estimates the recoverable amount of the cash-generating unit to which the asset belongs. Impairment testing is performed annually for goodwill, intangible assets with indefinite lives and intangible assets not yet available for use.
Intangible Assets	Intangible Assets Other than Goodwill Brand Name Brand names are recognized at fair value on the date of acquisition. They have a finite life and are subsequently carried at cost less any accumulated amortization and any impairment losses. Brand names are amortized over their useful life of 10 years. Technology Technology is recognized at fair value on the date of acquisition. It has a finite life and is subsequently carried at cost less any accumulated amortization and any impairment losses. Technology is amortized over its useful life of 5 years. Software Software is recognized at fair value on the date of acquisition. It has a finite life and is subsequently carried at cost less any accumulated amortization and any impairment losses. Software is amortized over its useful life of 3 years.
Goodwill	Goodwill Goodwill acquired on a business combination is initially measured at cost, being the excess of the consideration transferred for the business combination over the Group’s interest in the net fair value of the acquiree’s identifiable assets, liabilities and contingent liabilities. Following initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is reviewed for impairment, annually, or more frequently, if events or changes in circumstances indicate that the carrying value may be impaired (refer note 18). As at the acquisition date, any goodwill acquired is allocated to each of the cash-generating units that are expected to benefit from the combination’s synergies. Impairment is determined by assessing the recoverable amount of the cash-generating unit to which the goodwill relates. Where the recoverable amount of the cash-generating unit is less than the carrying amount, an impairment loss is recognized. Where goodwill forms part of a cash-generating unit and part of the operation within that unit is disposed, the goodwill associated with the disposed operation is included in the carrying amount of the operation when determining the gain or loss on disposal of the operation. Disposed goodwill in this circumstance is measured on the basis of the relative values of the disposed operation and the portion of the cash-generating unit retained.
Borrowing Costs	Borrowing costs Borrowing costs are recognized in profit or loss in the period in which they are incurred.
Foreign Currency Transactions and Balances	Foreign Currency Transactions and Balances Functional and presentation currency The functional currency of each of the Group’s entities is the currency of the primary economic environment in which that entity operates. The consolidated financial statements are presented in Australian dollars, which is the parent entity’s functional currency. Transactions and balances Foreign currency transactions are translated into functional currency using the exchange rates prevailing at the date of the transaction. Foreign currency monetary items are translated at the year-end exchange rate. Non-monetary items measured at historical cost continue to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange rate at the date when fair values were determined. Exchange differences arising on the translation of monetary items are recognized in profit or loss, except where deferred in equity as a qualifying cash flow or net investment hedge. Exchange differences arising on the translation of non-monetary items are recognized directly in other comprehensive income to the extent that the underlying gain or loss is recognized in other comprehensive income; otherwise the exchange difference is recognized in profit or loss. Group companies The financial results and position of foreign operations, whose functional currency is different from the Group’s presentation currency, are translated as follows: ‑ Assets and liabilities are translated at exchange rates prevailing at the end of the reporting period; ‑ Income and expenses are translated at the average exchange rates for the period; and ‑ Accumulated losses are translated at the exchange rates prevailing at the date of the transaction. Exchange differences arising on translation of foreign operations with functional currencies other than Australian dollars are recognized in other comprehensive income and included in the foreign currency translation reserve in the balance sheet. The cumulative amount of these differences is reclassified into profit or loss in the period in which the operation is disposed of.
Earnings Per Share	Earnings per Share Basic earnings per share Basic earnings per share is calculated by dividing the profit attributable to the owners of NOVONIX Limited, excluding any costs of servicing equity other than ordinary shares, by the weighted average number of ordinary shares outstanding during the financial year, adjusted for bonus elements in ordinary shares issued during the financial year. Diluted earnings per share Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after-income tax effect of interest and other financing costs associated with dilutive potential ordinary shares and the weighted average number of shares assumed to have been issued for no consideration in relation to dilutive potential ordinary shares.
Goods and Services Tax (‘GST’) and Other Similar Taxes	Goods and Services Tax (‘GST’) and other similar taxes Revenues, expenses and assets are recognized net of the amount of associated GST, unless the GST incurred is not recoverable from the tax authority. In this case it is recognized as part of the cost of the acquisition of the asset or as part of the expense. Receivables and payables are stated inclusive of the amount of GST receivable or payable. The net amount of GST recoverable from, or payable to, the tax authority is included in other receivables or other payables in the balance sheet. Cash flows are presented on a gross basis. The GST components of cash flows arising from investing or financing activities which are recoverable from, or payable to the tax authority, are presented as operating cash flows. Commitments and contingencies are disclosed net of the amount of GST recoverable from, or payable to, the tax authority.
New and amended standards and interpretations	New and amended standards and interpretations The Group has adopted all of the new, revised or amending accounting standards and interpretations issued by the International Accounting Standards Board that are mandatory for the current reporting period. None of the new and amended standards have had any material impact on the financial statements. Standards issued but not yet effective Amendments to IAS 1 – Classification of Liabilities as Current or Non-current (including Amendment to IAS 1 –Classification of Liabilities as Current or Non-current – Deferral of Effective Date issued in July 2020): In January 2020, the International Accounting Standards Board (“IASB”) issued Classification of Liabilities as Current or Non-current , which amended IAS 1 Presentation of Financial Statements . The amendments clarified how an entity classifies debt and other financial liabilities as current or non-current in particular circumstances. The amendments are effective for annual reporting periods beginning on or after January 1, 2023, with earlier application permitted. The Group is currently evaluating the impact, if any, this standard will have on the consolidated financial statements. Amendments to IAS 37 – Onerous Contracts: Cost of Fulfilling a Contract: In May 2020, the IASB issued Onerous Contracts: Cost of Fulfilling a Contract, which amended IAS 37 Provisions, Contingent Liabilities and Contingent Assets. The amendments specify which costs an entity includes in determining the cost of fulfilling a contract for the purpose of assessing whether the contract is onerous. The amendments are effective for annual periods beginning on or after January 1, 2022. Early application is permitted. Entities apply the amendments to contracts for which the entity has not yet fulfilled all its obligations at the beginning of the annual reporting period in which the entity first applies the amendments. The comparatives are not restated. The Group is currently evaluating the impact, if any, this standard will have on the consolidated financial statements.
Critical Accounting Estimates and Judgements	Critical accounting estimates and judgements The preparation of the financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Group’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements, are disclosed below. Exploration and evaluation costs Exploration and evaluation costs have been capitalized on the basis that the Group intend to commence commercial production in the future, from which time the costs will be amortized in proportion to the depletion of the mineral resources. Key judgements are applied in considering costs to be capitalized which includes determining expenditures directly related to these activities and allocating overheads between those that are expensed and capitalized. In addition, costs are only capitalized that are expected to be recovered either through successful development or sale of the relevant mining interest. Factors that could impact the future commercial production at the mine include the level of reserves and resources, future technology changes, which could impact the cost of mining, future legal changes and changes in commodity prices. To the extent that capitalized costs are determined not to be recoverable in the future, they will be written off in the period in which this determination is made. Value of intangible assets relating to acquisitions The Group has allocated portions of the cost of acquisitions to technology intangibles, valued using the relief from royalty method. These calculations require the use of assumptions including future revenue forecasts and a royalty rate. Technology is amortized over its useful life of 5 years. Impairment of goodwill and identifiable intangible assets The Group determines whether goodwill is impaired on an annual basis. This assessment requires an estimation of the recoverable amount of the cash-generating units to which the goodwill is allocated. Share based payment transactions The Group measures the cost of equity settled transactions with employees by reference to the fair value of the equity instruments at the date at which they are granted. The fair value is determined by using either a binomial or Monte Carlo option pricing model taking into account the terms and conditions upon which the instruments were granted. The accounting estimates and assumptions, including share price volatility, interest rates and vesting periods would have no impact on the carrying amounts of assets and liabilities within the next annual reporting period but may impact the profit or loss and equity. Fair Value of Financial Instruments carried at fair value through profit loss The fair value of financial instruments that are not traded in an active market is determined using valuation techniques. The group uses its judgement to select a variety of methods and make assumptions that are mainly based on market conditions existing at the end of each reporting period. For details of the key assumptions used and the impact of changes to these assumptions see note 16. Other areas of critical accounting estimates and judgements include: • Unused tax losses for which no deferred tax asset has been recognized (Refer to Note 6) • The vesting dates of share options (Refer to Note 28)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Initial Application Of Standards Or Interpretations [Abstract]
Summary of Property, Plant and Equipment Over Their Expected Useful Lives	Depreciation is calculated on a straight-line basis to write off the net cost of each item of property, plant and equipment (excluding land) over their expected useful lives as follows: Buildings ​ 25 years Plant and equipment ​ 2 - 20 years

Parent Entity Financial Infor_2

Parent Entity Financial Information (Tables)	12 Months Ended
	Jun. 30, 2022
Statement Of Financial Position [Abstract]
Summary of Information Extracted From Books and Records of Parent	The following information has been extracted from the books and records of the parent and has been prepared in accordance with International Financial Reporting Standards. At June 30, 2022 2021 Balance sheet ASSETS Current assets Cash and cash equivalents $ 181,411,905 $ 135,403,115 Trade and other receivables 31,966 132,838 Prepayments 5,291,126 2,462,643 Total current assets 186,734,997 137,998,596 Non-current assets Amounts due from related parties 152,865,669 27,897,817 Exploration and evaluation assets 3,440,105 3,329,950 Imvestments at fair value through profit and loss 24,179,998 — Investments — 17,748,704 Other assets 10,950 8,450 Total non-current assets 180,496,722 48,984,921 Total assets $ 367,231,719 $ 186,983,517 LIABILITIES Payables 2,888,400 2,587,715 Total current liabilities 2,888,400 2,587,715 Total liabilities 2,888,400 2,587,715 Net assets 364,343,319 184,395,802 EQUITY Contributed equity 458,677,068 233,196,507 Reserves 53,900,595 33,733,407 Accumulated losses ( 148,234,344 ) ( 82,534,112 ) Total equity $ 364,343,319 $ 184,395,802 Year Ended June 30, 2022 2021 Statement of Profit or Loss and Other Comprehensive Income Total loss and total comprehensive loss $ ( 65,700,232 ) $ ( 20,177,174 )

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Abstract]
Summary of Revenue From Transfer of Goods And Services	The group derives revenue from the transfer of goods and services over time and at a point in time in the following major product lines and segments : Segments Year Ended June 30, 2022 Graphite Battery Battery Total Hardware sales $ — $ 3,517,271 $ — $ 3,517,271 Consulting sales — 4,900,492 — 4,900,492 Revenue from external customers $ — $ 8,417,763 $ — $ 8,417,763 Timing of revenue recognition — At a point in time — 3,517,271 — 3,517,271 Over time — 4,900,492 — 4,900,492 $ — $ 8,417,763 $ — $ 8,417,763 Year Ended June 30, 2021 Segments Graphite Battery Battery Total Hardware sales $ — $ 1,405,086 $ — $ 1,405,086 Consulting sales — 3,822,261 — 3,822,261 Revenue from external customers $ — $ — $ 5,227,347 $ — $ 5,227,347 Timing of revenue recognition — At a point in time — 1,405,086 — 1,405,086 Over time — 3,822,261 — 3,822,261 $ — $ 5,227,347 $ — $ 5,227,347 Year Ended June 30, 2020 Segments Graphite Battery Battery Total Hardware sales $ — $ 2,113,416 $ — $ 2,113,416 Consulting sales — 2,140,019 — 2,140,019 Revenue from external customers $ — $ — $ 4,253,435 $ — $ 4,253,435 Timing of revenue recognition — At a point in time — 2,113,416 — 2,113,416 Over time — 2,140,019 — 2,140,019 $ — $ 4,253,435 $ — $ 4,253,435
Summary of Assets and Liabilities Related to Contracts with Customers Recognised	The Group has recognized the following assets and liabilities related to contracts with customers: At June 30, 2022 2021 Contract liabilities – Hardward sales $ 3,938 $ 310,102 Total other current liabilities $ 3,938 $ 310,102
Summary of Revenue Recognised in Current Reporting Period Relates to Brought-Forward Contract Liabilities	The following table shows how much of the revenue recognized in the current reporting period relates to brought-forward contract liabilities. Year Ended June 30, 2022 2021 2020 Revenue recognized that was included in the contract Hardware sales $ 310,102 $ 98,783 $ 580,845

Other Income, Net (Tables)

Other Income, Net (Tables)	12 Months Ended
	Jun. 30, 2022
Analysis Of Income And Expense [Abstract]
Summary of Other Income, Net	Year Ended June 30, 2022 2021 2020 Interest received from unrelated parties 11,471 35,066 723 COVID-19 Government stimulus — 115,501 59,000 Grant funding 1,355,924 818,410 785,154 Fair value gain on borrowings (refer note 22) 302,922 — — Other 531,850 15,675 — Total 2,202,167 984,652 844,877

Loss for the year (Tables)

Loss for the year (Tables)	12 Months Ended
	Jun. 30, 2022
Loss For Year [Abstract]
Loss Before Income Tax	Loss before income tax includes the following specific expenses: Year Ended June 30, 2022 2021 2020 Share-based payments expense^ Performance rights granted $ 15,299,627 $ 2,952,676 $ 78,362 Share rights granted 3,615,341 — 6,291,510 Options granted 1,275,570 2,995,856 1,189,081 Total share-based compensation expense $ 20,190,538 $ 5,948,532 $ 7,558,953 ^ Refer to note 28 for further information regarding share-based payments. Borrowing costs Interest accrued on loan notes — — 3,062,598 Loss on redemption of loan notes — — 1,765,353 Unwinding of fair value gain 55,728 40,547 48,377 Interest accrued on borrowings 2,031,135 188,847 454,633 Total borrowing costs $ 2,086,863 $ 229,394 $ 5,330,961 Impairment losses Fixed assets written off 1 — 2,764,940 — Total impairment losses $ — $ 2,764,940 $ — 1 Impairments recognized during the prior period relate to the redundant furnace technology which has been replaced with new proprietary furnace technology under the Group’s strategic alliance with US-based Harper International Corporation. This amount represents the net book value of fixed assets written off.
Schedule of Administrative and Other Expenses	Year ended June 30, Administrative and other expenses 2022 2021 2020 Insurance $ 5,300,985 $ 383,941 $ 234,544 Legal fees 1,967,564 263,532 558,745 Occupancy expenses 2,385,890 23,038 79,948 Consulting fees 2,280,680 683,856 259,992 Other 4,800,904 2,591,462 1,606,169 Total administrative and other expenses $ 16,736,023 $ 3,945,829 $ 2,739,398

Income Tax Expense (Tables)

Income Tax Expense (Tables)	12 Months Ended
	Jun. 30, 2022
Major components of tax expense (income) [abstract]
Schedule of Components of Income Tax Expense Benefit and Deferred Tax Assets and Liabilities	This note provides an analysis of the Group’s income tax expense, shows what amounts are recognised directly in equity and how the tax expense is affected by non-assessable and non-deductible items. It also explains significant estimates made in relation to the Group’s tax position. Year Ended June 30, 2022 2021 2020 (a) Numerical reconciliation of income tax expense to prima facie tax payable Loss before income tax expense $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 26,505,567 ) Tax at the Australian tax rate of 25 % (2021: 26 %) ( 17,860,256 ) ( 4,699,780 ) ( 7,289,031 ) Tax effect of amounts which are not tax deductible (taxable) in calculating taxable income: Share based payments 4,233,641 1,546,618 1,835,215 Income inclusion – Scientific Research and Experimental Development (“SRED”) 66,397 — Unrealized foreign exchange gain 51,246 — Borrowing costs 17,596 10,845 377,735 Other non-deductible amounts 976,484 56,291 — Other non-assessable amounts 4,161 ( 39,005 ) ( 24,234 ) Difference in overseas tax rate ( 739,293 ) ( 139,141 ) ( 90,888 ) Adjustments for current tax of prior periods — — ( 93,052 ) Adjustment to deferred tax assets and liabilities for tax losses and temporary differences not recognized 13,250,024 3,264,172 3,911,457 Income tax expense / (benefit) $ - $ - $ ( 383,655 ) (b) Tax losses Unused tax losses for which no deferred tax asset has been recognized $ 113,552,217 $ 39,772,597 $ 15,128,752 Potential tax benefit $ 28,388,054 $ 9,943,149 $ 4,122,864 (c) Tax expense (income) recognised directly in equity Aggregate current and deferred tax arising in the reporting period and not recognized in net profit or loss or other comprehensive income but directly debited or credited to equity: Deferred tax: Share issue costs — — — At June 30, 2022 2021 (d) Deferred tax assets The balance comprises temporary differences attributable to: Tax losses $ 28,388,054 $ 9,943,149 Exploration and evaluation assets 726,221 930,009 Business capital costs 2,309,219 1,543,399 Intangible assets & property, plant and equipment 2,737,888 — Right of use asset 78,121 31,061 Unrealized exchange loss on borrowings 284,770 261,449 Accrued expenses 624,234 317,498 Other 440,239 402,368 Total deferred tax assets 35,588,746 13,428,933 Set-off of deferred tax liabilities pursuant to set-off provisions ( 1,992,320 ) ( 1,357,943 ) Deferred tax assets not recognized ( 33,596,426 ) ( 12,070,990 ) Net deferred tax assets $ - $ - (e) Deferred tax liabilities The balance comprises temporary differences attributable to: Intangible assets $ - $ 164,713 Property, plant and equipment 1,524,592 1,193,230 Unrealized exchange loss on borrowings 467,728 — Total deferred tax liabilities 1,992,320 1,357,943 Set-off of deferred tax liabilities pursuant to set-off provisions ( 1,992,320 ) ( 1,357,943 ) Net deferred tax liabilities $ - $ -

Key Management Personnel Comp_2

Key Management Personnel Compensation (Tables)	12 Months Ended
	Jun. 30, 2022
Key Management Personnel Compensation [Abstract]
Summary of Remuneration Paid to KMP of Group	The totals of remuneration paid to KMP of the Group during the year are as follows: Year Ended June 30, 2022 2021 2020 Short-term employee benefits $ 4,392,815 $ 1,934,648 $ 1,868,521 Post-employment benefits 199,497 29,297 46,218 Termination benefits — 75,000 — Share-based compensation 16,857,548 4,575,735 6,878,627 Total KMP compensation $ 21,449,860 $ 6,614,680 $ 8,793,366

Auditor_s Remuneration (Tables)

Auditor’s Remuneration (Tables)	12 Months Ended
	Jun. 30, 2022
Auditors Remuneration [Abstract]
Summary of Detailed Information About Auditor's Remuneration	The following fees were paid or payable for services provided by PricewaterhouseCoopers Australia (PwC) as the auditor of the Group: Year Ended June 30, 2022 2021 2020 Audit fees $ 367,000 $ 190,329 $ 175,855 Audit-related fees1 381,484 646,300 — Tax fees — — — All other fees — — — Total $ 748,484 $ 836,629 $ 175,855 1 Audit-related fees related to services performed in respect of the US IPO and US filing processes during the years ended June 30, 2022 and 2021.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	2022 2021 2020 (a) Basic loss per share Total basic loss per share attributable to the ordinary equity holders of the Company ( 0.15 ) ( 0.05 ) ( 0.15 ) (b) Diluted loss per share Total diluted loss per share attributable to the ordinary equity holders of the Company ( 0.15 ) ( 0.05 ) ( 0.15 )
Schedule of Reconciliations of Loss Used in Calculating Loss Per Share	(c) Reconciliations of loss used in calculating loss per share 2022 2021 2020 Basic loss per share loss attributable to the ordinary equity holders of the Company used in calculating basic loss per share $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 20,028,526 ) Diluted loss per share loss attributable to the ordinary equity holders of the Company used in calculating diluted loss per share $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 20,028,526 )
Schedule of Weighted Average Number of Shares Used as the Denominator	(d) Weighted average number of shares used as the denominator 2022 2021 2020 Weighted average number of ordinary shares used as the denominator in calculating basic and diluted loss per share 464,437,628 366,289,024 135,918,095

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	12 Months Ended
	Jun. 30, 2022
Cash And Cash Equivalents [Abstract]
Summary of Cash at Bank	June 30, 2022 2021 Cash at bank $ 207,083,935 $ 136,663,976 $ 207,083,935 $ 136,663,976
Summary of Reconciliation to Cash Flow Statement	The above figures reconcile to the amount of cash shown in the statement of cash flows at the end of the financial year as follows: June 30, 2022 2021 Balances as above $ 207,083,935 $ 136,663,976 Bank overdrafts — — Balance per statement of cash flows $ 207,083,935 $ 136,663,976

Trade and Other Receivables (Ta

Trade and Other Receivables (Tables)	12 Months Ended
	Jun. 30, 2022
Trade And Other Current Receivables [Abstract]
Summary of Trade and Other Receivables	June 30, 2022 2021 Trade debtors $ 3,019,580 $ 1,533,963 Other receivables 538,436 509,000 Total trade and other receivables $ 3,558,016 $ 2,042,963

Prepayments (Tables)

Prepayments (Tables)	12 Months Ended
	Jun. 30, 2022
Current Prepayments And Current Accrued Income Including Current Contract Assets [Abstract]
Summary of Prepayments	June 30, 2022 2021 Deferred share issuance costs $ — $ 2,175,347 Prepayments of inventory components 1,619,629 — Prepaid general and administrative expenses 5,737,288 362,860 Total $ 7,356,917 $ 2,538,207

Escrow Reserves (Tables)

Escrow Reserves (Tables)	12 Months Ended
	Jun. 30, 2022
Escrow Reserves [abstract]
Summary of Escrow Reserves	June 30, 2022 2021 Escrow reserves $ 14,639,419 $ —

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Jun. 30, 2022
Classes Of Inventories [Abstract]
Summary of Inventory	June 30, 2022 2021 Raw materials $ 832,538 $ 1,162,142 Components and assemblies 1,838,228 1,618,231 Finished goods – at cost 45,377 — Total Inventory $ 2,716,143 $ 2,780,373

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Property Plant And Equipment [Abstract]
Summary of Property, Plant and Equipment	(in Australian dollars) Land Buildings Leasehold Plant and Construction Total At June 30, 2021 $ 372,995 $ 1,821,526 $ 195,082 $ 8,579,868 — $ 10,969,471 Cost — ( 154,725 ) ( 30,524 ) ( 1,163,425 ) — ( 1,348,674 ) Accumulated depreciation Net book amount $ 372,995 $ 1,666,801 $ 164,558 $ 7,416,443 $ - $ 9,620,797 Opening net book amount at June 30, 2020 $ 372,995 $ 1,666,801 $ 164,558 $ 7,416,443 $ — $ 9,620,797 Additions 666,920 4,358,515 482,637 2,982,443 17,754,185 26,244,700 Disposals — — — ( 39,285 ) — ( 39,285 ) Assets written off — — — ( 2,764,940 ) — ( 2,764,940 ) Depreciation charge — ( 67,897 ) ( 110,681 ) ( 996,462 ) — ( 1,175,040 ) Exchange differences 13,960 100,126 ( 9,103 ) ( 411,876 ) ( 894 ) ( 307,787 ) Closing net book amount at June 30, 2021 $ 1,053,875 $ 6,057,545 $ 527,411 $ 6,186,323 $ 17,753,291 $ 31,578,445 Additions 2,177,802 59,330,097 689,185 11,770,912 42,266,050 116,234,046 Disposals — — — ( 39,495 ) — ( 39,495 ) Transfers — — 145,109 12,628,351 ( 12,773,460 ) — Depreciation charge — ( 2,294,080 ) ( 360,141 ) ( 2,313,665 ) — ( 4,967,886 ) Exchange differences 179,664 3,644,794 69,337 1,241,781 3,243,510 8,379,086 Closing net book amount at June 30, 2022 $ 3,411,341 $ - $ 66,738,356 $ - $ 1,070,901 $ - $ 29,474,207 $ - $ 50,489,391 $ - $ 151,184,196 At June 30, 2022 Cost $ 3,411,341 $ 69,383,589 $ 1,600,051 $ 33,780,687 $ 50,489,391 158,665,059 Accumulated depreciation — ( 2,645,233 ) ( 529,150 ) ( 4,306,480 ) — ( 7,480,863 ) Net book amount $ 3,411,341 $ 66,738,356 $ 1,070,901 $ 29,474,207 $ 50,489,391 $ 151,184,196

Financial Assets at Fair Valu_2

Financial Assets at Fair Value Through Profit or Loss (Tables)	12 Months Ended
	Jun. 30, 2022
Financial assets at fair value through profit or loss [abstract]
Summary of Financial Assets Measured at FVPL	Financial assets measured at FVPL include the following: June 30, 2022 2021 US unlisted equity securities $ 24,179,998 $ —
Summary of Changes in Level 3 Instruments	The following table presents the changes in level 3 instruments during the financial year: Unlisted equity securities Balance at the beginning of the year $ — Purchases during the year: Consideration settled in shares 17,515,793 Consideration settled in cash 17,615,757 Loss on change in fair value recognized in the consolidated statement of profit or loss and other comprehensive income ( 10,951,552 ) Balance at the end of the year $ 24,179,998

Exploration and Evaluation As_2

Exploration and Evaluation Assets (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Exploration And Evaluation Assets [Abstract]
Schedule of Exploration and Evaluation Assets	June 30, 2022 2021 Exploration and evaluation assets – at cost $ 3,218,228 $ 3,108,073 The capitalized exploration and evaluation assets carried forward above have been determined as follows: Balance at the beginning of the year $ 3,108,073 $ 2,988,921 Expenditure incurred during the year 110,155 119,152 Balance at the end of the year $ 3,218,228 $ 3,108,073

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure of detailed information about intangible assets [abstract]
Schedule of Intangible Assets	Year Ended June 30, 2022 2021 2020 Goodwill $ 17,373,413 $ 15,950,624 $ 17,411,685 Technology 421,296 631,085 955,560 Software 144,159 — — Total $ 17,938,868 $ 16,581,709 $ 18,367,245 Goodwill Technology Software Total Balance at June 30, 2019 $ 17,037,297 $ 1,195,948 $ — $ 18,233,245 Additions 374,388 — — 374,388 Amortization — ( 273,619 ) — ( 273,619 ) Exchange differences — 33,231 — 33,231 Balance at June 30, 2020 $ 17,411,685 $ 955,560 $ — $ 18,367,245 Additions — — — — Amortization — ( 246,217 ) — ( 246,217 ) Exchange differences ( 1,461,061 ) ( 78,258 ) — ( 1,539,319 ) Balance at June 30, 2021 $ 15,950,624 $ 631,085 $ — $ 16,581,709 Additions — — 144,159 144,159 Amortization — ( 253,040 ) — ( 253,040 ) Exchange differences 1,422,789 43,251 — 1,466,040 Balance at June 30, 2022 $ 17,373,413 $ 421,296 $ 144,159 $ 17,938,868

Trade and Other Payables (Table

Trade and Other Payables (Tables)	12 Months Ended
	Jun. 30, 2022
Trade And Other Payables [Abstract]
Summary of Unsecured Liabilities	June 30, 2022 2021 Trade payables $ 3,847,509 $ 1,823,898 Sundry payables and accrued expenses 5,632,150 2,532,658 Total $ 9,479,659 $ 4,356,556

Contract Liabilities (Tables)

Contract Liabilities (Tables)	12 Months Ended
	Jun. 30, 2022
Contract Liabilities [Abstract]
Summary of Contract Liabilities	June 30, 2022 2021 Current - contract liabilities - hardware sales contracts $ 3,938 $ 310,102 Non-current - Other liabilities 4,352,412 - $ 4,356,350 $ 310,102

Leases (Tables)

Leases (Tables)	12 Months Ended
	Jun. 30, 2022
Presentation Of Leases For Lessee [Abstract]
Summary of Leases Recognized in Balance Sheet	The balance sheet shows the following amounts relating to leases: June 30, 2022 2021 Right-of-use assets - Buildings $ 7,443,048 $ 7,406,943 Lease liabilities Current $ 489,846 $ 410,792 Non-current 7,265,686 7,120,396 Total $ 7,755,532 $ 7,531,188
Summary of Lease Amounts Recognized in Profit or Loss and Other Comprehensive Income	The statement of profit or loss and other comprehensive income shows the following amounts relating to leases: Year Ended June 30, 2022 2021 2020 Depreciation of right-of-use assets - Buildings $ 593,980 $ 197,680 $ 210,381 Interest expense $ 312,786 $ 123,763 $ 112,303

Borrowings (Tables)

Borrowings (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure of detailed information about borrowings [abstract]
Summary of Borrowings	2022 2021 (in Australian dollars) Current Non-Current Total Current Non-Current Total Secured Bank loans (i) $ 1,300,037 $ 50,563,095 $ 51,863,132 $ 110,752 $ 5,297,180 $ 5,407,932 Total secured borrowings 1,300,037 50,563,095 51,863,132 110,752 5,297,180 5,407,932 Unsecured Other loans (ii) 174,053 1,589,357 1,763,410 166,308 689,385 855,693 Total unsecured borrowings 174,053 1,589,357 1,763,410 166,308 689,385 855,693 Total borrowings $ 1,474,090 $ 52,152,452 $ 53,626,542 $ 277,060 $ 5,986,565 $ 6,263,625 (i) Secured liabilities and assets pledged as security (a) In December 2017, the group entered into a loan facility to purchase commercial land and buildings in Nova Scotia from which the Battery Technology Solutions business operates. The initial amount loaned under the facility was CAD $ 1,330,000 . On February 5, 2021, the group extended the loan facility and the total available amount now available under the facility was CAD $ 2,680,000 . At June 30, 2022 the facility had been fully drawn down. The total liability at June 30, 2022 is CAD $ 2,597,512 . The facility is bearing interest at the bank’s base rate minus 1 % payable monthly and principal of the loan repayable in 265 monthly principal instalments of CAD $ 9,760 followed by 1 monthly principal instalment of CAD $ 1,352 , maturing September 2044 . The Group's freehold land and buildings at 177 Bluewater Road, Bedford, Canada are pledged as collateral against the bank loan. The carrying amount of this asset is $ 4,890,976 (June 2021: $ 3,104,819 ). For the year ended June 30, 2022, the Group incurred interest expense of CAD $ 94,210 (2021 – CAD $ 48,168 ; 2020 – CAD $ 64,470 ). (b) On May 28, 2021, the Group purchased commercial land and buildings in Nova Scotia, Canada for CAD$ 3,550,000 from which the Cathode business will operate. The Group entered into a loan facility to purchase the land and buildings. The initial amount loaned under the facility was CAD $ 4,375,000 . On January 24, 2022, the group extended the loan facility and the total available amount now available under the facility was CAD $ 4,985,000 . At June 30, 2022 the facility had been drawn down to CAD $ 4,923,170 and CAD $ 61,830 remains to be disbursed. The total liability at June 30, 2022 is CAD $ 4,923,170 . The facility is bearing interest at the bank’s base rate minus 1 % payable monthly and principal of the loan repayable in 1 monthly principal instalment of CAD $ 18,610 in December 2022, followed by 299 monthly principal instalments of CAD $ 16,610 commencing January 2023, maturing November 2047 . The Group’s freehold land and buildings at 110 Simmonds Drive, Dartmouth, Canada are pledged as collateral against the bank loan. The carrying amount of this asset is $ 5,665,963 (June 2021: $ 4,006,926 ). For the year ended June 30, 2022, the Group incurred interest expense of CAD $ 156,522 (2021 – CAD $ 9,975 ; 2020 – CAD $ Nil ). (c) On January 24, 2022, the group entered into a loan facility to purchase equipment. The total amount available under the facility was CAD $ 2,300,000 . At June 30, 2022 the facility had been drawn down to CAD $ 500,000 and CAD $ 1,800,000 remains to be disbursed. The total liability at June 30, 2022 is CAD $ 500,000 . The facility is bearing interest at the bank’s base rate minus 1.5 % payable monthly and principal of the loan repayable in 1 monthly principal instalment of CAD $ 19,960 in December 2023, followed by 119 monthly principal instalments of CAD $ 19,160 commencing January 2024, maturing November 2033 . Equipment being purchased are pledged as collateral against the bank loan. For the year ended June 30, 2022, the Group incurred interest expense of CAD $ 7,617 (2021 – CAD $ Nil ; 2020 – CAD $ Nil ). (d) On July 28, 2021, the Group purchased commercial land and buildings in Chattanooga, USA for USD $ 42,600,000 to expand the NAM business. The Group entered into a loan facility with PNC Real Estate for USD$ 30,100,000 and an interest rate of 4.09 % to purchase the land and buildings. The loan has been fully drawn down as at June 30, 2022. The total liability at June 30, 2022 is USD $ 29,467,266 . The facility is repayable in monthly instalments, which commenced in September 2021 and end in August 2031 . The land and buildings at 1029 West 19th Street, Chattanooga, USA have been pledged as security for the loan, the carrying amount of which is $ 40,913,359 . For the year ended June 30, 2022, the Group incurred interest expense of USD$ 223,229 (2021 -USD$ 92,189 ; 2020- USD $ 80,445 ). This loan imposes certain loan covenants to ensure that the following financial ratios are met: • net assets of USD$ 30.1 million to be maintained (exclusive of the land and building secured by this loan and minimum liquidity of USD$ 3.1 million); and • a debt service coverage ratio of 1.2 to 1 is to be maintained. NOVONIX Limited has complied with the financial covenants of its borrowing facilities during both the 2022 and 2021 financial years.

Contributed Equity (Tables)

Contributed Equity (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Classes Of Share Capital [Abstract]
Schedule of Share Capital	(a) Share capital Year Ended 30 June 2022 2021 2022 2021 Number of shares Number of shares Amount Amount Ordinary shares Fully paid 485,951,369 404,601,384 $ 458,677,068 $ 233,196,507 (b) Ordinary share capital Date Details Note Number of Issue Amount July 1, 2020 Balance 348,206,772 $ 99,851,510 July 10, 2020 Exercise of options (e) 250,000 $ 0.80 $ 200,000 Sept 23, 2020 Settlement of limited recourse loan (j) — $ 1,500,000 Sept 24, 2020 Exercise of options (e) 500,000 $ 0.90 $ 450,000 Sept 24, 2020 Exercise of options (e) 2,500,000 $ 0.66 $ 1,650,000 Sept 28, 2020 Exercise of performance rights (g) 158,865 — $ — Mar 3, 2021 Placement to institutional investors (h) 39,700,000 $ 2.90 $ 115,130,000 Mar 16, 2021 Exercise of performance rights (g) 3,400,000 — $ — Mar 16, 2021 Exercise of options (e) 1,500,000 $ 0.74 $ 1,110,000 Mar 16, 2021 Exercise of options (e) 30,000 $ 0.90 $ 27,000 Mar 16, 2021 Exercise of options (e) 33,333 $ 0.50 $ 16,667 May 11, 2021 Placement to directors (h) 5,672,414 $ 2.90 $ 16,450,001 May 24, 2021 Exercise of options (e) 2,500,000 $ 0.66 $ 1,650,000 June 3, 2021 Exercise of options (e) 150,000 $ 0.90 $ 135,000 Share issue costs (i) $ ( 4,973,671 ) June 30, 2021 Balance 404,601,384 $ 233,196,507 Sept 30, 2021 Placement shares (d) 77,962,578 $ 2.67 $ 208,138,475 Dec 14, 2021 Exercise of performance rights (c) 1,291,851 — $ — Feb 1, 2022 KORE Power Consideration Shares (f) 1,974,723 $ 8.87 $ 17,515,793 Mar 8, 2022 Exercise of options (e) 33,333 $ 0.50 $ 16,667 May 31, 2022 Exercise of performance rights (c) 87,500 — $ — Share issue costs — $ ( 190,374 ) June 30, 2022 Balance 485,951,369 $ 458,677,068

Reserves (Tables)

Reserves (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure of reserves within equity [abstract]
Summary of Reserves	Year Ended June 30, 2022 2021 Share-based payment reserve $ 44,254,362 $ 27,513,594 Foreign currency translation reserve 8,566,362 ( 600,850 ) Convertible loan note reserve 6,219,812 6,219,812 $ 59,040,536 $ 33,132,556 (a) Share-based payment reserve Year Ended June 30, 2022 2021 2020 Share-based payment reserve $ 44,254,362 $ 27,513,594 $ 22,817,908 Movements: Opening balance 27,513,594 22,817,908 15,258,956 Equity settled options cancelled — — — Settlement of limited recourse loan — ( 1,252,846 ) 1,189,081 Performance rights net-settled in current period (refer note 28) ( 3,426,420 ) — — Equity settled share-based payments 20,190,538 5,948,532 6,369,871 Exchange differences ( 23,350 ) — — Closing balance $ 44,254,362 $ 27,513,594 $ 22,817,908 The share-based payment reserve includes items recognized as expenses on valuation of director, employee and contractor share rights, options, and performance rights. (b) Foreign currency translation reserve Year Ended June 30, 2022 2021 2020 Foreign currency translation reserve $ 8,566,362 $ ( 600,850 ) $ 1,500,247 Movements: Opening balance ( 600,850 ) 1,500,247 950,004 Exchange differences on translation of foreign operations 9,167,212 ( 2,101,097 ) 550,243 Closing balance $ 8,566,362 $ ( 600,850 ) $ 1,500,247 The foreign currency translation reserve includes exchange differences arising on translation of a foreign controlled subsidiary. (c) Convertible loan note reserve June 30 2022 2021 Convertible loan note reserve $ 6,219,812 $ 6,219,812 Movements: Opening balance 6,219,812 6,219,812 Exchange differences on translation of foreign operations — — Closing balance $ 6,219,812 $ 6,219,812

Operating Segments (Tables)

Operating Segments (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Operating Segments [Abstract]
Schedule of Segment Performance	Segment performance Battery Battery Graphite Unallocated Total 2022 Segment revenue 1 $ — $ 8,417,763 $ — $ — $ 8,417,763 Other income 531,850 1,658,846 — — 2,190,696 Interest income — 6,042 — 5,429 11,471 Total income 531,850 10,082,651 — 5,429 10,619,930 Segment net profit / (loss) before tax $ ( 28,538,900 ) $ ( 8,730,995 ) $ — $ ( 34,171,129 ) $ ( 71,441,024 ) Battery Battery Graphite Unallocated Total 2021 Segment revenue 1 $ — $ 5,227,347 $ — $ — $ 5,227,347 Other income 69,204 798,882 — 81,500 949,586 Interest income — — — 35,066 35,066 Total income 69,204 6,026,229 — 116,566 6,211,999 Segment net profit / (loss) before tax $ ( 11,968,654 ) $ ( 63,661 ) $ ( 46,424 ) $ ( 5,997,338 ) $ ( 18,076,077 ) Battery Battery Graphite Unallocated Total 2020 Segment revenue 1 $ — $ 4,253,435 $ — $ — $ 4,253,435 Other income — 785,154 — 59,000 844,154 Interest income — — — 723 723 Total income — 5,038,589 — 59,723 5,098,312 Segment net profit / (loss) before tax $ — $ ( 853,084 ) $ ( 7,426,978 ) $ ( 11,748,464 ) $ ( 20,028,526 ) 1 See Note 3, Revenue , for segment revenue by product line for the years ended June 30, 2022, 2021 and 2020.
Schedule of Segment Assets	Segment assets Battery Battery Graphite Unallocated Total 2022 Segment assets $ 197,613,494 $ 27,616,815 $ 3,229,178 $ 211,101,915 $ 439,561,402 Battery Battery Graphite Unallocated Total 2021 Segment assets $ 47,899,929 $ 13,990,451 $ 3,116,523 $ 137,850,370 $ 202,857,273
Schedule of Segment Liabilities	Segment liabilities Battery Battery Graphite Unallocated Total 2022 Segment liabilities $ 59,326,240 $ 13,003,443 $ — $ 2,888,400 $ 75,218,083 Battery Battery Graphite Unallocated Total 2021 Segment liabilities $ 9,277,070 $ 7,440,067 $ - $ 1,744,334 $ 18,461,471

Cash Flow Information (Tables)

Cash Flow Information (Tables)	12 Months Ended
	Jun. 30, 2022
Cash Flow Information [Abstract]
Disclosure of Reconciliation of Profit / (Loss) After Income Tax to Net Cash Outflow From Operating Activities	Reconciliation of profit / (loss) after income tax to net cash outflow from operating activities Year Ended June 30, 2022 2021 2020 Loss for the period $ ( 71,441,024 ) $ ( 18,076,077 ) $ ( 20,028,526 ) Adjustments for Share-based compensation 20,190,538 5,948,532 7,558,953 Borrowing costs 64,297 760 5,098,906 Fixed assets written off — 2,764,940 210,773 Loss on sale of fixed assets — 6,777 — Loss on equity investment securities at fair value through profit or loss 10,951,552 — — Foreign exchange (gain) / loss ( 7,194,955 ) 106,787 387,371 Non-cash termination settlement — 294,247 — Depreciation and amortization expense 5,814,905 1,697,754 1,380,303 Government incentives ( 302,922 ) ( 49,278 ) — Change in operating assets and liabilities: (Increase)/decrease in other operating assets ( 6,028,224 ) ( 1,927,128 ) ( 976,969 ) Increase in trade creditors and other operating liabilities 7,592,541 1,060,622 775,672 Net cash outflow from operating activities $ ( 40,353,292 ) $ ( 8,172,064 ) $ ( 5,593,517 )
Summary of Analysis of Net Debt and Movements in Net Debt	This section sets out an analysis of net debt and the movements in net debt for each period presented. Net debt 2022 2021 Cash and cash equivalents $ 207,083,935 $ 136,663,976 Lease liability - repayable within one year ( 489,846 ) ( 410,792 ) Borrowings – repayable within one year (including overdraft) ( 1,474,090 ) ( 277,060 ) Lease liability - repayable after one year ( 7,265,686 ) ( 7,120,396 ) Borrowings – repayable after one year ( 52,152,452 ) ( 5,986,565 ) Net cash (debt) $ 145,701,861 $ 122,869,163 Cash and cash equivalents 207,083,935 136,663,976 Gross debt – fixed interest rates ( 9,518,941 ) ( 8,386,881 ) Gross debt – variable interest rates ( 51,863,133 ) ( 5,407,932 ) Net cash (debt) $ 145,701,861 $ 122,869,163 Liabilities from financing activities Cash Borrowings due Borrowings due Total Net debt as of June 30, 2020 $ 38,807,662 $ ( 416,041 ) $ ( 4,716,074 ) $ 33,675,547 Cashflows 97,856,314 329,873 ( 4,029,769 ) 94,156,418 Other non-cash movements — ( 601,684 ) ( 4,361,118 ) ( 4,962,802 ) Net cash as of June 30, 2021 136,663,976 ( 687,852 ) ( 13,106,961 ) 122,869,163 Cashflows 61,654,881 669,246 ( 45,316,323 ) 17,007,804 Other non-cash movements 8,765,078 ( 1,945,330 ) ( 994,854 ) 5,824,894 Net cash as of June 30, 2022 $ 207,083,935 $ ( 1,963,936 ) $ ( 59,418,138 ) $ 145,701,861

Interests in Subsidiaries (Tabl

Interests in Subsidiaries (Tables)	12 Months Ended
	Jun. 30, 2022
Default Root [Abstract]
Summary of Information About Principal Subsidiaries	The Group’s material subsidiaries at June 30 are set out in the following table. Unless otherwise stated, each entity has share capital consisting solely of ordinary shares that are held by the Group, and the proportion of ownership interest held equals the voting rights held by the Group. The country of incorporation or registration is also their principal place of business. The functional currency of each of the Group’s entities is the currency of the primary economic environment in which that entity operates. The consolidated financial statements are presented in Australian dollars, which is NOVONIX Limited’s functional currency. Ownership interest Place of business Functional 2022 2021 Principal Name of entity incorporation Currency % % activities MD South Tenements Pty Ltd Australia AUD 100 % 100 % Graphite exploration Novonix Battery Technology Solutions, Inc. Canada CAN 100 % 100 % Battery technology services. Novonix Corp USA USD 100 % 100 % Investment Novonix Anode Materials, LLC USA USD 100 % 100 % Battery materials development

Share-based payments (Tables)

Share-based payments (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Abstract]
Composition of Share Based Payments Expense	The following table presents the composition of share-based payments expense for the years ended June 30, 2022, June 30, 2021 and June 30, 2020 (in Australian dollars). Year Ended June 30, 2022 2021 2020 Share rights granted in current year $ 3,615,341 — — Performance rights granted in current year 15,034,334 2,952,676 78,362 Performance rights granted in prior years 265,293 — — Options granted in current year — — 113,199 Options granted in prior years 1,275,570 2,995,856 7,367,392 Share based payment expense 20,190,538 5,948,532 7,558,953 Payments of withholding tax - Performance rights ( 3,426,420 ) — — Exchange differences ( 23,350 ) — — Movement in share-based payments reserve $ 16,740,768 $ 5,948,532 $ 7,558,953
Summary of Movements of All Share Rights Issued	A summary of movements of all share rights issued is as follows: Year Ended June 30, 2022 Number on issue Share rights outstanding at July 1 — Granted 309,049 Forfeited ( 6,510 ) Exercised — Share rights outstanding at June 30 302,539 Share rights exercisable at June 30 302,539
Summary of Share Rights	Further details of the share rights are set out in the table below: Name Grant date Number Vesting date Fair value Expiry Expense recognized Anthony Bellas November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 788,700 Andrew Liveris November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 788,700 Robert Cooper November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 788,700 Zhanna Golodryga November 30, 2021 17,549 June 30, 2022 $ 11.95 June 30, 2023 209,711 Trevor St Baker November 30, 2021 66,000 June 30, 2022 $ 11.95 June 30, 2023 710,905 2 Greg Baynton November 30, 2021 27,500 June 30, 2022 $ 11.95 June 30, 2023 328,625 1 Total expense recognized 3,615,341 1 Greg Baynton retired as a Director on November 30, 2021 but retained his performance rights. The expense associated with his Share Rights was accelerated and the full value of the share rights was recognized at his retirement date 2 Trevor St Baker resigned as a Director on May 26, 2022, causing 6,510 of share rights previously issued to him to be forfeited.
Summary of Movements of All Performance Rights Issued	A summary of movements of all performance rights issued is as follows: 2022 2021 2020 Performance rights outstanding at July 1 1,600,000 3,395,833 3,395,833 Granted 4,676,946 3,500,000 — Awarded^ 667,831 — — Forfeited ( 200,000 ) ( 1,000,000 ) — Exercised ( 1,687,500 ) ( 3,558,865 ) — Settled — ( 736,968 ) — Performance rights outstanding at June 30 5,057,277 1,600,000 3,395,833 Performance rights exercisable at June 30 — 600,000 2,395,833 ^ Performance rights awarded to Key Management Personnel that are subject to shareholder approval which will be sought at the 2022 Annual General Meeting of Shareholders scheduled for October 26, 2022.
Summary of Performance Rights	Further details of the performance rights are set out in the table below: Name Grant date Number Vesting date Fair value Expiry Expense recognized Rashda Buttar October 6, 2021 150,000 ¼ April 22, 2022 $ 4.92 Cessation of employment $ 363,094 ¼ April 22, 2023 ¼ April 22, 2024 ¼ April 22, 2025 January 28, 2022 255,238 June 30, 2024 $ 7.21 Cessation of employment 318,508 Anthony Bellas November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 Robert Natter November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 Nick Liveris November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 January 28, 2022 667,831 June 30, 2024 $ 2.28 ^ Cessation of employment 263,536 Chris Burns November 30, 2021 200,000 November 30, 2021 $ 11.95 June 30, 2022 2,390,000 January 28, 2022 1,412,000 June 30, 2024 $ 7.21 Cessation of employment 1,762,013 Non-KMP employees July 1, 2021 1,000,000 ¼ June 30, 2022 $ 2.32 Cessation of employment 1,208,731 ¼ June 30, 2023 ¼ June 30, 2024 ¼ June 30, 2025 Non-KMP employees October 6, 2021 220,000 $ 4.92 Cessation of employment 327,301 Non-KMP employees December 2, 2021 100,000 $ 12.15 Cessation of employment 540,801 Non-KMP employees December 20, 2021 15,589 $ 8.88 Cessation of employment 37,916 Non-KMP employees October 6, 2021 500,000 $ 4.92 Cessation of employment 614,522 Non-KMP employees February 14, 2022 20,000 4 equal annual $ 5.81 Cessation of employment 20,226 Non-KMP employees February 24, 2022 6,009 tranches $ 4.82 Cessation of employment 5,095 Non-KMP employees April 12, 2022 42,317 commencing on the $ 5.90 Cessation of employment 5,408 Non-KMP employees April 20, 2022 11,359 anniversary of $ 6.01 Cessation of employment 876 Non-KMP employees May 2, 2022 17,430 employment $ 5.01 Cessation of employment 1,245 Non-KMP employees May 23, 2022 53,200 $ 3.93 Cessation of employment 3,046 Non-KMP employees May 28, 2022 10,853 $ 3.73 Cessation of employment 577 Non-KMP employees June 6, 2022 11,400 $ 3.51 Cessation of employment 114 Non-KMP employees June 15, 2022 40,698 $ 2.47 Cessation of employment 1,290 Non-KMP employees June 22, 2022 10,853 $ 2.27 Cessation of employment 35 Total number issued 5,344,777 Total expense recognized $ 15,034,334 ^ On January 28, 2022 667,831 performance rights were awarded to Nick Liveris. These performance rights are subject to shareholder approval which will be sought at the 2022 Annual General Meeting of shareholders and have not been formerly granted at June 30, 2022. The fair value per performance right represents an estimate at June 30, 2022 of the grant date fair value of the performance rights.
Summary of Group Net Settled in Share-Based Payments	During the year the Group net settled the following share based share-based payments: Name Vesting date Performance rights Net settled shares Withholding obligation Chris Burns November 30, 2021 200,000 92,000 $ 1,290,600 Nick Liveris November 30, 2021 200,000 107,851 1,101,180 Non-KMP employees December 11, 2021 200,000 92,000 1,034,640 Total $ 3,426,420
Summary of Movements of Options Issued	A summary of movements of all options issued is as follows: 2022 Weighted Average Exercise Price Options outstanding as of July 1 32,103,334 $ 0.51 Granted to employees — — Granted to loan note holders — — Cancelled — — Forfeited ( 2,740,000 ) $ 0.53 Exercised ( 33,333 ) $ 0.50 Options outstanding as of June 30 29,330,001 $ 0.51 Options exercisable at June 30 13,796,667 $ 0.52
Valuations of Options Granted	The model inputs for the valuations of options granted during the years ended June 30, 2021 and 2020 were as follows: a. On March 14, 2021, 100,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The fair value of these options totaled $ 247,297 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Number of options 33,333 33,333 33,334 Exercise price $ 0.50 $ 0.50 $ 0.50 Award date March 14, 2021 March 14, 2021 March 14, 2021 Expiry date March 14, 2021 March 14, 2031 March 14, 2031 Vesting date February 24, 2022 February 24, 2023 February 24, 2024 Volatility 96.28 % 96.28 % 96.28 % Dividend yield 0 % 0 % 0 % Risk-free interest rate 1.72 % 1.72 % 1.72 % Fair value at grant date $ 2.4101 $ 2.4811 $ 2.5277 b. On December 14, 2020, 100,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The fair value of these options totaled $ 83,444 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Number of options 33,333 33,333 33,334 Exercise price $ 0.50 $ 0.50 $ 0.50 Award date December 14, 2020 December 14, 2020 December 14, 2020 Expiry date December 14, 2030 December 14, 2030 December 14, 2030 Vesting date February 24, 2021 February 24, 2022 February 24, 2023 Volatility 94.2 % 94.2 % 94.2 % Dividend yield 0 % 0 % 0 % Risk-free interest rate 0.98 % 0.98 % 0.98 % Fair value at grant date $ 0.7878 $ 0.8394 $ 0.8758 c. On January 16, 2020, 1,000,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The options vest in 10 tranches on achievement of progressive PUREgraphite sales milestones. The vesting dates in the table below represent the current estimate of when the vesting conditions will be met. The fair value of these options totaled $ 377,390 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Tranche 4 Tranche 5 Tranche 6 Tranche 7 Tranche 8 Tranche 9 Tranche 10 Number of options 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 Exercise price $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 Award date January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 January 16, 2020 Expiry date January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 January 16, 2030 Vesting date May 31, 2022 March 31, 2023 June 30, 2023 November 30, 2023 December 31, 2023 February 28, 2024 March 31, 2024 April 30, 2024 May 31, 2024 June 30, 2024 Volatility 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % 82.80 % Dividend yield 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % Risk-free interest rate 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % 1.18 % Fair value at grant date $ 0.3541 $ 0.3648 $ 0.3726 $ 0.3753 $ 0.3809 $ 0.3819 $ 0.3832 $ 0.3839 $ 0.3883 $ 0.3889 d. On December 7, 2019, 1,000,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The options vest in 10 tranches on achievement of progressive PUREgraphite sales milestones. The vesting dates in the table below represent the current estimate of when the vesting conditions will be met. The fair value of these options totaled $ 456,580 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Tranche 4 Tranche 5 Tranche 6 Tranche 7 Tranche 8 Tranche 9 Tranche 10 Number of options 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 Exercise price $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 Award date December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 December 7, 2019 Expiry date December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 December 7, 2029 Vesting date May 31, 2022 March 31, 2023 June 30, 2023 November 30, 2023 December 31, 2023 February 28, 2024 March 31, 2024 April 30, 2024 May 31, 2024 June 30, 2024 Volatility 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % 84.89 % Dividend yield 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % Risk-free interest rate 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % 1.14 % Fair value at grant date $ 0.4274 $ 0.4415 $ 0.4513 $ 0.4543 $ 0.4611 $ 0.4623 $ 0.4636 $ 0.4644 $ 0.4696 $ 0.4703 e. On July 8, 2019, 2,500,000 share options were awarded to an employee of the group (who is not KMP). The terms of the options are set out in the table below. The options hold no voting or dividend rights and are not transferable. The options vest in 10 tranches on achievement of progressive PUREgraphite sales milestones. The vesting dates in the table below represent the current estimate of when the vesting conditions will be met. The fair value of these options totaled $ 804,375 . This value was calculated using a binomial option pricing model applying the following inputs: Tranche 1 Tranche 2 Tranche 3 Tranche 4 Tranche 5 Tranche 6 Tranche 7 Tranche 8 Tranche 9 Tranche 10 Number of options 250,000 250,000 250,000 250,000 250,000 250,000 250,000 250,000 250,000 250,000 Exercise price $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 $ 0.50 Award date July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 July 8, 2019 Expiry date July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 July 8, 2029 Vesting date May 31, 2022 March 31, 2023 June 30, 2023 November 30, 2023 December 31, 2023 February 28, 2024 March 31, 2024 April 30, 2024 May 31, 2024 June 30, 2024 Volatility 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % 85.08 % Dividend yield 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % 0 % Risk-free interest rate 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % 1.32 % Fair value at grant date $ 0.3026 $ 0.3115 $ 0.3179 $ 0.3201 $ 0.3248 $ 0.3255 $ 0.3264 $ 0.3270 $ 0.3307 $ 0.3310

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Summary of Strategic Placement	Details of the Strategic Placement are set out in the table below: Face value of loan notes and balance of short-term loan Interest accrued Placement proceeds Total Shares issued (Number) Loan notes redeemed $ 10,000,000 $ 1,187,397 - $ 11,187,397 38,577,232 Short-term loan repaid 3,400,000 131,575 - 3,531,575 12,177,845 Placement proceeds - - 4,735,707 4,735,707 16,330,023 Total $ 13,400,000 $ 1,318,972 $ 4,735,707 $ 19,454,679 67,085,100

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Jun. 30, 2022
Commitments and Contingencies [Abstract]
Summary of Exploration Commitments	(a) Exploration commitments Year Ended June 30, 2022 2021 Commitments for payments under exploration permits in existence at the reporting date but not recognized as liabilities payable $ 23,000 $ 13,000
Summary of Significant Capital Expenditure Contracted	Significant capital expenditure contracted for at the end of the reporting period but not recognized as liabilities is as follows: Year Ended June 30, 2022 2021 Property, plant and equipment $ 14,893,026 $ 10,182,218 The capital commitments relate to purchases of property, plant and equipment in connection with the expansion of our business and development of our technologies in the NAM and BTS business segments and are expected to be recognized within the next twelve months.

Financial Risk Management (Tabl

Financial Risk Management (Tables)	12 Months Ended
	Jun. 30, 2022
Disclosure Of Financial Instruments [Abstract]
Summary of Financial Instruments	The totals for each category of financial instruments, measured in accordance with IAS 39: Financial Instruments: Recognition and Measurement, as detailed in the accounting policies to these consolidated financial statements, are as follows: June 30 2022 2021 Notes Financial assets Cash and cash equivalents 10 $ 207,083,935 $ 136,663,976 Trade and other receivables 11 3,558,016 2,042,963 Financial assets at fair value through profit or loss 16 24,179,998 — Total financial assets 234,821,949 138,706,939 Financial liabilities Trade payables 19 3,847,509 1,823,898 Lease liabilities 21 7,755,532 7,531,188 Borrowings 22 53,626,542 6,263,625 Total financial liabilities $ 65,229,583 $ 15,618,711
Schedule of Exposure to Foreign Currency Risk at the end of Reporting Period	The group’s exposure to foreign currency risk at the end of the reporting period, expressed in Australian dollars, was as follows: 2022 2021 2022 2021 Cash at bank $ - $ - $ 128,936,395 $ 69,950,408 Trade receivables — — 2,587,528 1,305,421 Trade payables — — 804,376 460,536 Borrowings $ 13,376 $ 1,919 $ - $ -
Summary of Contractual Maturities of Non-derivative Financial Liabilities	As of June 30, 2022, the contractual maturities of the group’s non-derivative financial liabilities were as follows: Contractual Less than 6 - 12 Between Between Over 5 Total Carrying At June 30, 2022 Trade payables $ 9,479,659 $ — $ — $ — $ — $ 9,479,659 $ 9,479,659 Lease liabilities 403,904 403,904 832,181 2,496,544 5,779,037 9,915,570 7,755,532 Borrowings 1,588,618 1,661,129 3,472,057 10,648,817 50,294,010 67,664,631 53,626,542 Total non-derivatives $ 11,472,181 $ 2,065,033 $ 4,304,238 $ 13,145,361 $ 56,073,047 $ 87,059,860 $ 70,861,733

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)	1 Months Ended			12 Months Ended
	Sep. 30, 2021 AUD ($)	May 31, 2021 AUD ($)	Mar. 31, 2021 AUD ($)	Jun. 30, 2022 AUD ($) Tonnes	Jun. 30, 2021 AUD ($)	Jun. 30, 2020 AUD ($)	Jun. 30, 2019 AUD ($)
Disclosure Of Initial Application Of Standards Or Interpretations [Line Items]
Net loss				$ 71,441,024	$ 18,076,077
Net operating cash outflows				40,353,292	8,172,064	$ 5,593,517
Cash balance				207,083,935	136,663,976	$ 38,807,662	$ 6,054,664
Net current assets				$ 223,906,897	$ 138,671,009
Number of tonnes production capacity per year | Tonnes				40,000
Brand Name
Disclosure Of Initial Application Of Standards Or Interpretations [Line Items]
Intangible assets useful life				10 years
Technology
Disclosure Of Initial Application Of Standards Or Interpretations [Line Items]
Intangible assets useful life				5 years
Software
Disclosure Of Initial Application Of Standards Or Interpretations [Line Items]
Intangible assets useful life				3 years
Phillips 66 Company
Disclosure Of Initial Application Of Standards Or Interpretations [Line Items]
Proceeds from issue of ordinary shares	$ 208,000,000	$ 131,000,000	$ 131,000,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Property, Plant and Equipment Over Their Expected Useful Lives (Details)	12 Months Ended
	Jun. 30, 2022
Buildings
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment expected useful lives	25 years
Plant and Equipment | Bottom of Range
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment expected useful lives	2 years
Plant and Equipment | Top of Range
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment expected useful lives	20 years

Parent Entity Financial Infor_3

Parent Entity Financial Information - Summary of Information Extracted from Books and Records of Parent (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021	Jul. 01, 2020	Jun. 30, 2020	Jun. 30, 2019
Current assets
Cash and cash equivalents	$ 207,083,935	$ 136,663,976		$ 38,807,662	$ 6,054,664
Trade and other receivables	3,558,016	2,042,963
Prepayments	7,356,917	2,538,207
Total current assets	235,354,430	144,025,519
Non-current assets
Exploration and evaluation assets	3,218,228	3,108,073		2,988,921
Imvestments at fair value through profit and loss	24,179,998
Other assets	242,634	156,584
Total non-current assets	204,206,972	58,831,754
Total assets	439,561,402	202,857,273
Current liabilities
Payables	3,847,509	1,823,898
Total current liabilities	11,447,533	5,354,510
Non-current liabilities
Total liabilities	75,218,083	18,461,471
Net assets	364,343,319	184,395,802
Equity [Abstract]
Contributed equity	458,677,068	233,196,507	$ 99,851,510
Reserves	59,040,536	33,132,556
Accumulated losses	(153,374,285)	(81,933,261)
Total equity	364,343,319	184,395,802		$ 66,532,293	$ 15,772,778
Parent
Current assets
Cash and cash equivalents	181,411,905	135,403,115
Trade and other receivables	31,966	132,838
Prepayments	5,291,126	2,462,643
Total current assets	186,734,997	137,998,596
Non-current assets
Amounts due from related parties	152,865,669	27,897,817
Exploration and evaluation assets	3,440,105	3,329,950
Imvestments at fair value through profit and loss	24,179,998
Investments		17,748,704
Other assets	10,950	8,450
Total non-current assets	180,496,722	48,984,921
Total assets	367,231,719	186,983,517
Current liabilities
Payables	2,888,400	2,587,715
Total current liabilities	2,888,400	2,587,715
Non-current liabilities
Total liabilities	2,888,400	2,587,715
Net assets	364,343,319	184,395,802
Equity [Abstract]
Contributed equity	458,677,068	233,196,507
Reserves	53,900,595	33,733,407
Accumulated losses	(148,234,344)	(82,534,112)
Total equity	$ 364,343,319	$ 184,395,802

Parent Entity Financial Infor_4

Parent Entity Financial Information - Summary of Information Extracted from Books and Records of Parent 1 (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Parent
Statement of profit or loss and other comprehensive income [abstract]
Total accumulated other comprehensive income	$ 65,700,232	$ 20,177,174

Parent Entity Financial Infor_5

Parent Entity Financial Information - Additional Information (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Statement Of Financial Position [Abstract]
Contingent liabilities	$ 0	$ 0
Contractual commitments	$ 0	$ 0

Revenue - Summary of Revenue Fr

Revenue - Summary of Revenue From Transfer of Goods And Services (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	$ 8,417,763	$ 5,227,347	$ 4,253,435
At a point in time
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	3,517,271	1,405,086	2,113,416
Over time
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	4,900,492	3,822,261	2,140,019
Hardware sales
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	3,517,271	1,405,086	2,113,416
Consulting sales
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	4,900,492	3,822,261	2,140,019
Battery Technology
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	8,417,763	5,227,347	4,253,435
Battery Technology | At a point in time
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	3,517,271	1,405,086	2,113,416
Battery Technology | Over time
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	4,900,492	3,822,261	2,140,019
Battery Technology | Hardware sales
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	3,517,271	1,405,086	2,113,416
Battery Technology | Consulting sales
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue from contracts with customers	$ 4,900,492	$ 3,822,261	$ 2,140,019

Revenue - Summary of Assets and

Revenue - Summary of Assets and Liabilities Related to Contracts with Customers Recognised (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Total other current liabilities	$ 3,938	$ 310,102
Hardware sales
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Total other current liabilities	$ 3,938	$ 310,102

Revenue - Summary of Revenue Re

Revenue - Summary of Revenue Recognised in Current Reporting Period Relates to Brought-Forward Contract Liabilities (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Hardware sales
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Revenue recognised that was included in the contract liability balance at the beginning of the period	$ 310,102	$ 98,783	$ 580,845

Revenue - Additional Informatio

Revenue - Additional Information (Detail) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]
Contract assets	$ 0	$ 0
Remaining performance obligations	$ 0
Remaining performance obligations maximum original expected term	1 year

Other Income, Net - Summary of

Other Income, Net - Summary of Other Income, Net (Detail) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Analysis Of Income And Expense [Abstract]
Interest received from unrelated parties	$ 11,471	$ 35,066	$ 723
COVID-19 Government stimulus		115,501	59,000
Grant funding	1,355,924	818,410	785,154
Fair value gain on borrowings	302,922
Other	531,850	15,675
Other Income	$ 2,202,167	$ 984,652	$ 844,877

Loss for the year - Loss Before

Loss for the year - Loss Before Income Tax (Details) - AUD ($)		12 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Share based payments expense^
Performance rights granted		$ 15,299,627	$ 2,952,676	$ 78,362
Share rights granted		3,615,341		6,291,510
Options granted		1,275,570	2,995,856	1,189,081
Total expense from share-based payment transactions		20,190,538	5,948,532	7,558,953
Borrowing costs
Interest accrued on loan notes				3,062,598
Loss on redemption of loan notes				1,765,353
Unwinding of fair value gain		55,728	40,547	48,377
Interest accrued on borrowings		2,031,135	188,847	454,633
Total borrowing costs		$ 2,086,863	229,394	$ 5,330,961
Impairment losses
Fixed assets written off	[1]		2,764,940
Total impairment losses			$ 2,764,940
[1] Impairments recognized during the prior period relate to the redundant furnace technology which has been replaced with new proprietary furnace technology under the Group’s strategic alliance with US-based Harper International Corporation. This amount represents the net book value of fixed assets written off.

Loss for the year - Schedule of

Loss for the year - Schedule of Administrative and Other Expenses (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Administrative and Other Expenses [Abstract]
Insurance	$ 5,300,985	$ 383,941	$ 234,544
Legal fees	1,967,564	263,532	558,745
Occupancy expenses	2,385,890	23,038	79,948
Consulting fees	2,280,680	683,856	259,992
Other expenses	4,800,904	2,591,462	1,606,169
Total Administrative and other expenses	$ 16,736,023	$ 3,945,829	$ 2,739,398

Income Tax Expense - Schedule o

Income Tax Expense - Schedule of Components of Income Tax Expense Benefit and Deferred Tax Assets and Liabilities (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
(a) Numerical reconciliation of income tax expense to prima facie tax payable
Loss before income tax expense	$ (71,441,024)	$ (18,076,077)	$ (26,505,567)
Tax at the Australian tax rate of 25% (2021: 26%)	(17,860,256)	(4,699,780)	(7,289,031)
Share based payments	4,233,641	1,546,618	1,835,215
Income inclusion - Scientific Research and Experimental Development ("SRED")	66,397	0
Unrealized foreign exchange gain	51,246	0
Borrowing costs	17,596	10,845	377,735
Other non-deductible amounts	976,484	56,291
Other non-assessable amounts	4,161	(39,005)	(24,234)
Difference in overseas tax rate	(739,293)	(139,141)	(90,888)
Adjustments for current tax of prior periods	0	0	(93,052)
Adjustment to deferred tax assets and liabilities for tax losses and temporary differences not recognized	13,250,024	3,264,172	3,911,457
Income tax expense / (benefit)	0	0	(383,655)
(b) Tax losses
Unused tax losses for which no deferred tax asset has been recognized	113,552,217	39,772,597	15,128,752
Potential tax benefit	28,388,054	9,943,149	$ 4,122,864
Deferred tax: Share issue costs	0	0
(d) Deferred tax assets
Tax losses	28,388,054	9,943,149
Exploration and evaluation assets	726,221	930,009
Business capital costs	2,309,219	1,543,399
Intangible assets & property, plant and equipment	2,737,888	0
Right of use asset	78,121	31,061
Unrealized exchange loss on borrowings	284,770	261,449
Accrued expenses	624,234	317,498
Other	440,239	402,368
Total deferred tax assets	35,588,746	13,428,933
Set-off of deferred tax liabilities pursuant to set-off provisions	(1,992,320)	(1,357,943)
Deferred tax assets not recognized	(33,596,426)	(12,070,990)
Net deferred tax assets	0	0
(e) Deferred tax liabilities
Intangible assets	0	164,713
Property, plant and equipment	1,524,592	1,193,230
Unrealized exchange loss on borrowings	467,728	0
Total deferred tax liabilities	1,992,320	1,357,943
Set-off of deferred tax liabilities pursuant to set-off provisions	(1,992,320)	(1,357,943)
Net deferred tax liabilities	$ 0	$ 0

Income Tax Expense - Schedule_2

Income Tax Expense - Schedule of Components of Income Tax Expense Benefit and Deferred Tax Assets and Liabilities (Parenthetical) (Details)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Major components of tax expense (income) [abstract]
Australian tax rate	25%	26%

Key Management Personnel Comp_3

Key Management Personnel Compensation - Summary of Remuneration Paid to KMP of Company and Group (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Key Management Personnel Compensation [Abstract]
Short-term employee benefits	$ 4,392,815	$ 1,934,648	$ 1,868,521
Post-employment benefits	199,497	29,297	46,218
Termination benefits		75,000
Share-based compensation	16,857,548	4,575,735	6,878,627
Total KMP compensation	$ 21,449,860	$ 6,614,680	$ 8,793,366

Auditor's Remuneration - Summar

Auditor's Remuneration - Summary of Detailed Information About Auditor's Remuneration (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Auditors Remuneration [Abstract]
Audit fees	$ 367,000	$ 190,329	$ 175,855
Audit-related fees	381,484	646,300
Total	$ 748,484	$ 836,629	$ 175,855

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Earnings Per Share (Details) - $ / shares	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
(a) Basic loss per share
Total basic loss per share attributable to the ordinary equity holders of the Company	$ (0.15)	$ (0.05)	$ (0.15)
(b) Diluted loss per share
Total diluted loss per share attributable to the ordinary equity holders of the Company	$ (0.15)	$ (0.05)	$ (0.15)

Earnings Per Share - Schedule_2

Earnings Per Share - Schedule of Reconciliations of Loss Used in Calculating Loss Per Share (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Basic loss per share
loss attributable to the ordinary equity holders of the Company used in calculating basic loss per share	$ (71,441,024)	$ (18,076,077)	$ (20,028,526)
Diluted loss per share
loss attributable to the ordinary equity holders of the Company used in calculating diluted loss per share	$ (71,441,024)	$ (18,076,077)	$ (20,028,526)

Earnings Per Share - Schedule_3

Earnings Per Share - Schedule of Weighted Average Number of Shares Used as the Denominator (Details) - shares	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Earnings Per Share [Abstract]
Weighted average number of ordinary shares used as the denominator in calculating basic and diluted loss per share	464,437,628	366,289,024	135,918,095

Capital Raising - Additional In

Capital Raising - Additional Information (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020	Mar. 03, 2021	Jul. 01, 2020
Capital Raising [Line Items]
Contributed equity	$ 458,677,068	$ 233,196,507			$ 99,851,510
Number of shares issued and fully paid	485,951,369	404,601,384			348,206,772
Proceeds on issue of shares	$ 208,290,142	$ 136,818,667	$ 45,845,239
Convertible loan notes face value			$ 990,741
Institutional Placement
Capital Raising [Line Items]
Number of shares issued and fully paid				39,700,000
Share price per share				$ 2.90

Capital Raising - Schedule of R

Capital Raising - Schedule of Repayment of Convertible Notes (Details)	12 Months Ended
	Jun. 30, 2020 AUD ($)
Capital Raising [Line Items]
Convertible loan notes face value	$ 990,741

Capital Raising - Schedule of S

Capital Raising - Schedule of Strategic Placement (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021	Jul. 01, 2020
Capital Raising [Line Items]
Ordinary shares Fully paid	$ 458,677,068	$ 233,196,507	$ 99,851,510

Impairment Testing of Goodwill

Impairment Testing of Goodwill - Summary of Carrying Amount of Goodwill Allocated to Cash Generating Unit (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Disclosure Of Information For Each Material Impairment Loss Recognised Or Reversed For Individual Asset Or Cashgenerating Unit [Line Items]
Total carrying amount of goodwill	$ 17,373,413	$ 15,950,624	$ 17,411,685	$ 17,037,297

Impairment Testing of Goodwil_2

Impairment Testing of Goodwill - Additional Information (Details)	12 Months Ended
	Jun. 30, 2021 AUD ($)
Disclosure Of Information For Each Material Impairment Loss Recognised Or Reversed For Individual Asset Or Cashgenerating Unit [Line Items]
Total impairment losses	$ 2,764,940

Cash and Cash Equivalents - Sum

Cash and Cash Equivalents - Summary of Cash at Bank (Details)	Jun. 30, 2022 AUD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 AUD ($)	Jun. 30, 2019 AUD ($)
Cash And Cash Equivalents [Abstract]
Cash at bank	$ 207,083,935	$ 128,936,395	$ 136,663,976	$ 69,950,408
Cash and cash equivalents	$ 207,083,935		$ 136,663,976		$ 38,807,662	$ 6,054,664

Cash and Cash Equivalents - S_2

Cash and Cash Equivalents - Summary of Reconciliation To Cash Flow Statement (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Cash And Cash Equivalents [Abstract]
Cash and cash equivalents	$ 207,083,935	$ 136,663,976	$ 38,807,662	$ 6,054,664
Bank overdrafts	0	0
Balance per statement of cash flows	$ 207,083,935	$ 136,663,976

Trade and Other Receivables - S

Trade and Other Receivables - Summary of Trade and Other Receivables (Details)	Jun. 30, 2022 AUD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2021 USD ($)
Trade And Other Current Receivables [Abstract]
Trade debtors	$ 3,019,580	$ 2,587,528	$ 1,533,963	$ 1,305,421
Other receivables	538,436		509,000
Total current trade and other receivables	$ 3,558,016		$ 2,042,963

Prepayments - Summary of Prepay

Prepayments - Summary of Prepayments (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Current Prepayments And Current Accrued Income Including Current Contract Assets [Abstract]
Deferred share issuance costs		$ 2,175,347
Prepayments of inventory components	$ 1,619,629
Prepaid general and administrative expenses	5,737,288	362,860
Total	$ 7,356,917	$ 2,538,207

Prepayments - Additional Inform

Prepayments - Additional Information (Details) $ in Millions	Jun. 30, 2022 AUD ($)
Current Prepayments And Current Accrued Income Including Current Contract Assets [Abstract]
Prepaid director and officer insurance premiums	$ 5.2

Escrow Reserves - Summary of Es

Escrow Reserves - Summary of Escrow Reserves (Details)	Jun. 30, 2022 AUD ($)
Escrow Reserves [abstract]
Escrow reserves	$ 14,639,419

Inventory - Summary of Inventor

Inventory - Summary of Inventory (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Classes Of Inventories [Abstract]
Raw materials	$ 832,538	$ 1,162,142
Components and assemblies	1,838,228	1,618,231
Finished goods – at cost	45,377
Total Inventory	$ 2,716,143	$ 2,780,373

Inventory - Additional Informat

Inventory - Additional Information (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Classes Of Inventories [Abstract]
Inventories recognized as an expense	$ 3,005,977	$ 969,774

Property, Plant and Equipment -

Property, Plant and Equipment - Summary of Property, Plant and Equipment (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment	$ 31,578,445	$ 9,620,797
Additions	116,234,046	26,244,700
Disposals	(39,495)	(39,285)
Assets written off		(2,764,940)
Depreciation charge	(4,967,886)	(1,175,040)
Exchange differences	8,379,086	(307,787)
Property, plant and equipment	151,184,196	31,578,445
Net book amount	151,184,196	9,620,797
Cost
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	158,665,059	10,969,471
Accumulated depreciation
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	(7,480,863)	(1,348,674)
Land
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment	1,053,875	372,995
Additions	2,177,802	666,920
Exchange differences	179,664	13,960
Property, plant and equipment	3,411,341	1,053,875
Net book amount	3,411,341	372,995
Land | Cost
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	3,411,341	372,995
Buildings
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment	6,057,545	1,666,801
Additions	59,330,097	4,358,515
Depreciation charge	(2,294,080)	(67,897)
Exchange differences	3,644,794	100,126
Property, plant and equipment	66,738,356	6,057,545
Net book amount	66,738,356	1,666,801
Buildings | Cost
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	69,383,589	1,821,526
Buildings | Accumulated depreciation
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	(2,645,233)	(154,725)
Leasehold improvements
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment	527,411	164,558
Additions	689,185	482,637
Assets written off	145,109
Depreciation charge	(360,141)	(110,681)
Exchange differences	69,337	(9,103)
Property, plant and equipment	1,070,901	527,411
Net book amount	1,070,901	164,558
Leasehold improvements | Cost
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	1,600,051	195,082
Leasehold improvements | Accumulated depreciation
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	(529,150)	(30,524)
Plant and equipment
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment	6,186,323	7,416,443
Additions	11,770,912	2,982,443
Disposals	(39,495)	(39,285)
Assets written off	12,628,351	(2,764,940)
Depreciation charge	(2,313,665)	(996,462)
Exchange differences	1,241,781	(411,876)
Property, plant and equipment	29,474,207	6,186,323
Net book amount	29,474,207	7,416,443
Plant and equipment | Cost
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	33,780,687	8,579,868
Plant and equipment | Accumulated depreciation
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	(4,306,480)	(1,163,425)
Construction work in progress
Disclosure Of Property Plant And Equipment [Line Items]
Property, plant and equipment	17,753,291
Additions	42,266,050	17,754,185
Assets written off	(12,773,460)
Exchange differences	3,243,510	(894)
Property, plant and equipment	50,489,391	$ 17,753,291
Net book amount	50,489,391
Construction work in progress | Cost
Disclosure Of Property Plant And Equipment [Line Items]
Net book amount	$ 50,489,391

Financial Assets at Fair Valu_3

Financial Assets at Fair Value Through Profit or Loss - Summary of Financial Assets Mandatorily Measured at FVPL (Details)	Jun. 30, 2022 AUD ($)
Unlisted Equity Securities
Disclosure of fair value measurement of assets [line items]
Financial assets measured at FVPL	$ 24,179,998

Financial Assets at Fair Valu_4

Financial Assets at Fair Value Through Profit or Loss - Additional Information (Details) $ / shares in Units, $ in Millions		12 Months Ended
	Jan. 31, 2022 USD ($) shares $ / shares	Jun. 30, 2022 AUD ($)	Jan. 31, 2022 AUD ($)
Disclosure of fair value measurement of assets [line items]
Transfers out of Level 1 into Level 2 of fair value hierarchy, entity's own equity instruments		$ 0
Transfers out of Level 2 into Level 1 of fair value hierarchy, entity's own equity instruments		0
Transfers into Level 3 of fair value hierarchy, entity's own equity instruments		0
Transfers out of Level 3 of fair value hierarchy, entity's own equity instruments		0
KORE Power | Securities Purchase Agreement
Disclosure of fair value measurement of assets [line items]
Common stock shares acquired | shares	3,333,333
Issue Price | $ / shares	$ 7.50
Percentage of common equity acquired	5%
Fair value of consideration transferred	$ 25		$ 35,131,550
Percentage of consideration settled in cash	50%
Percentage of consideration settled in shares	50%
Issuance of ordinary shares | shares	1,974,723
Loss recognized in consolidated statement of profit or loss and other comprehensive income related to equity investments held at FVPL		$ 10,951,552

Financial Assets at Fair Valu_5

Financial Assets at Fair Value Through Profit or Loss - Summary of Changes in Level 3 Instruments (Details)	12 Months Ended
	Jun. 30, 2022 AUD ($) shares	Jun. 30, 2022 USD ($) shares
Disclosure of fair value measurement of assets [line items]
Balance at the beginning of the year	$ 184,395,802
Purchases during the year:
Balance at the end of the year	$ 364,343,319
Level 3 | Unlisted Equity Securities
Purchases during the year:
Consideration settled in shares | shares	17,515,793	17,515,793
Consideration settled in cash		$ 17,615,757
Loss on change in fair value recognized in the consolidated statement of profit or loss and other comprehensive income		$ (10,951,552)
Balance at the end of the year	$ 24,179,998

Exploration and Evaluation As_3

Exploration and Evaluation Assets - Schedule of Exploration and Evaluation Assets (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Exploration And Evaluation Assets [Abstract]
Exploration and evaluation assets - at cost	$ 3,218,228	$ 3,108,073
Balance at the beginning of the year	3,108,073	2,988,921
Expenditure incurred during the year	110,155	119,152
Balance at the end of the year	$ 3,218,228	$ 3,108,073

Intangible Assets - Summary of

Intangible Assets - Summary of Intangible Assets (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Disclosure Of Intangible Assets [Line Items]
Goodwill	$ 17,373,413	$ 15,950,624	$ 17,411,685	$ 17,037,297
Total Intangible assets	17,938,868	16,581,709	18,367,245	18,233,245
Technology
Disclosure Of Intangible Assets [Line Items]
Intangible assets	421,296	$ 631,085	$ 955,560	$ 1,195,948
Software
Disclosure Of Intangible Assets [Line Items]
Intangible assets	$ 144,159

Intangible Assets - Summary o_2

Intangible Assets - Summary of Reconciliation of Intangible Assets (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure Of Intangible Assets [Line Items]
Goodwill, Beginning Balance	$ 15,950,624	$ 17,411,685	$ 17,037,297
Goodwill, Additions			374,388
Goodwill, Exchange differences	1,422,789	(1,461,061)
Goodwill, Ending Balance	17,373,413	15,950,624	17,411,685
Total, Beginning Balance	16,581,709	18,367,245	18,233,245
Total Additions	144,159		374,388
Total, Amortisation	(253,040)	(246,217)	(273,619)
Total, Exchange differences	1,466,040	(1,539,319)	33,231
Total, Ending Balance	17,938,868	16,581,709	18,367,245
Technology
Disclosure Of Intangible Assets [Line Items]
Intangible assets, Beginning Balance	631,085	955,560	1,195,948
Intangible assets, Amortisation	(253,040)	(246,217)	(273,619)
Intangible assets, Exchange differences	43,251	(78,258)	33,231
Ending Balance	421,296	$ 631,085	$ 955,560
Software
Disclosure Of Intangible Assets [Line Items]
Intangible assets, Additions	144,159
Ending Balance	$ 144,159

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Intangible Assets [Line Items]
Goodwill	$ 17,373,413	$ 15,950,624
Goodwill Impairment	$ 0
Software
Disclosure Of Intangible Assets [Line Items]
Intangible assets useful life	3 years
Technology
Disclosure Of Intangible Assets [Line Items]
Intangible assets useful life	5 years

Trade and Other Payables - Summ

Trade and Other Payables - Summary of Unsecured Liabilities (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Trade And Other Payables [Abstract]
Trade payables	$ 3,847,509	$ 1,823,898
Sundry payables and accrued expenses	5,632,150	2,532,658
Total	$ 9,479,659	$ 4,356,556

Contract Liabilities - Summary

Contract Liabilities - Summary of Grant Funding (Detail) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Contract Liabilities [Line Items]
Current - contract liabilities - hardware sales contracts	$ 3,938	$ 310,102
Non-current - Other liabilities	4,352,412
Contract liabilities	4,356,350	310,102
Hardware sales
Disclosure Of Contract Liabilities [Line Items]
Current - contract liabilities - hardware sales contracts	$ 3,938	$ 310,102

Contract Liabilities - Addition

Contract Liabilities - Additional Information (Details)	12 Months Ended
	Jun. 30, 2022 USD ($)
Contract Liabilities [Abstract]
Grant received	$ 3,000,000
Conditions on government assistance	The grant funds are conditional upon the Group creating, filling and maintaining 290 jobs in the State of Tennessee. The grant becomes fully earned once 90% of the performance target is achieved, and is repayable in full if a minimum of 50% of the jobs are not filled. The grant is proportionately repayable between 50% and 90%. Accordingly, as at June 30, 2022 the full amount of the grant has been deferred and classified as contract liabilities and will be recognized in income on a proportionate basis once the minimum 50% target is reached.

Leases - Summary of Leases Reco

Leases - Summary of Leases Recognized in Balance Sheet (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Disclosure of quantitative information about right-of-use assets [line items]
Right-of-use assets	$ 7,443,048	$ 7,406,943
Lease Liabilities [Abstract]
Current Lease Liabilities	489,846	410,792
Noncurrent Lease Liabilities	7,265,686	7,120,396
Lease liabilities	7,755,532	7,531,188
Buildings
Disclosure of quantitative information about right-of-use assets [line items]
Right-of-use assets	$ 7,443,048	$ 7,406,943

Leases - Summary of Lease Amoun

Leases - Summary of Lease Amounts Recognized in Profit or Loss and Other Comprehensive Income (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation of right-of-use assets	$ 593,980
Interest expense	312,786	$ 123,763	$ 112,303
Buildings
Disclosure of quantitative information about right-of-use assets [line items]
Depreciation of right-of-use assets	$ 593,980	$ 197,680	$ 210,381

Leases - Additional Information

Leases - Additional Information (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Presentation Of Leases For Lessee [Abstract]
Additions to right-of-use assets	$ 0	$ 5,084,858
Movements of depreciation expense and foreign currency gain	36,105
Depreciation of right-of-use assets	593,980
Lease, foreign currency gain	630,085
Short-term lease	0	0
Total cash outflow for leases	$ 425,506	$ 190,426

Borrowings - Summary of Borrowi

Borrowings - Summary of Borrowings (Details)	Jun. 30, 2022 AUD ($)	Jun. 30, 2022 CAD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2021 CAD ($)
Disclosure of detailed information about borrowings [abstract]
Secured bank loans, Current	$ 1,300,037		$ 110,752
Secured bank loans, Non-Current	50,563,095		5,297,180
Secured bank loans, Total	51,863,132		5,407,932
Total secured borrowings, Current	1,300,037		110,752
Total secured borrowings, Non-Current	50,563,095		5,297,180
Total secured borrowings	51,863,132		5,407,932
Unsecured other loans, Current	174,053		166,308
Unsecured other loans, Non-Current	1,589,357		689,385
Unsecured other loans, Total	1,763,410		855,693
Total unsecured borrowings, Current	174,053		166,308
Total unsecured borrowings, Non-Current	1,589,357		689,385
Total unsecured borrowings	1,763,410		855,693
Total borrowings, Current	1,474,090		277,060
Total borrowings, Non-Current	52,152,452		5,986,565
Total borrowings	$ 53,626,542	$ 13,376	$ 6,263,625	$ 1,919

Borrowings - Additional Informa

Borrowings - Additional Information (Details)

1 Months Ended

12 Months Ended

Jan. 24, 2022 CAD ($) Instalments

Jul. 28, 2021 USD ($)

May 28, 2021 CAD ($)

Feb. 05, 2021 CAD ($) Instalments

Jan. 31, 2024 CAD ($)

Dec. 31, 2023 CAD ($)

Jan. 31, 2023 CAD ($)

Dec. 31, 2022 CAD ($)

Mar. 31, 2021 CAD ($)

Oct. 31, 2018 CAD ($)

Dec. 31, 2017 CAD ($)

Jun. 30, 2022 AUD ($)

Jun. 30, 2022 CAD ($)

Jun. 30, 2022 USD ($)

Jun. 30, 2021 AUD ($)

Jun. 30, 2021 CAD ($)

Jun. 30, 2021 USD ($)

Jun. 30, 2020 AUD ($)

Jun. 30, 2020 CAD ($)

Jun. 30, 2020 USD ($)

Jun. 30, 2019 CAD ($)

Jun. 30, 2018 CAD ($)

Jun. 30, 2022 CAD ($)

Jun. 30, 2022 USD ($)

Jun. 30, 2021 CAD ($)

Disclosure of detailed information about borrowings [line items]

Remaining undrawn amount of loan facility

$ 1,861,830

$ 2,095,015

Liabilities

$ 75,218,083

$ 18,461,471

Borrowings

53,626,542

6,263,625

$ 13,376

$ 1,919

Net assets

364,343,319

184,395,802

Commercial land and buildings purchased

$ 115,462,952

26,164,470

$ 5,339,448

Day one gain on loan

$ 302,922

Commercial Land and Buildings | Chattanooga, USA

Disclosure of detailed information about borrowings [line items]

Total amount available under facility

$ 30,100,000

Liabilities

29,467,266

Interest rate

4.09%

Carrying amount of asset pledged as collateral

$ 40,913,359

Interest expense incurred

$ 223,229

$ 92,189

$ 80,445

Loan facility, frequency of periodic payment

monthly

monthly

monthly

Loan facility periodic payment commencement month and year

2021-09

Loan facility periodic payment end month and year

2031-08

Minimum liquidity

$ 3,100,000

Debt service coverage ratio

1.2

1.2

1.2

Commercial land and buildings purchased

$ 42,600,000

Commercial Land and Buildings | Chattanooga, USA | Bottom of Range

Disclosure of detailed information about borrowings [line items]

Net assets

$ 30,100,000

Equipment

Disclosure of detailed information about borrowings [line items]

Total amount available under facility

$ 2,300,000

Amount drawn down from facility

$ 500,000

Liabilities

500,000

Interest rate

1.50%

Borrowings interest rate basis

The facility is bearing interest at the bank’s base rate minus 1.5% payable monthly

Borrowings number of monthly instalments | Instalments

119

Borrowings maturity month and year

November 2033

Interest expense incurred

$ 7,617

$ 0

$ 0

Loan remains to be disbursed

1,800,000

Equipment | Forecast

Disclosure of detailed information about borrowings [line items]

Borrowings monthly principal instalment

$ 19,160

$ 19,960

Battery Technology Solutions Business | Commercial Land and Buildings | Nova Scotia, Canada

Disclosure of detailed information about borrowings [line items]

Initial loan

$ 1,330,000

Total amount available under facility

$ 2,680,000

Liabilities

2,597,512

Interest rate

1%

Borrowings interest rate basis

The facility is bearing interest at the bank’s base rate minus 1% payable monthly

Borrowings number of monthly instalments | Instalments

265

Borrowings monthly principal instalment

$ 9,760

$ 1,352

Borrowings maturity month and year

September 2044

Carrying amount of asset pledged as collateral

$ 4,890,976

3,104,819

Interest expense incurred

94,210

48,168

64,470

Contribution agreement

250,000

Cathode Business | Commercial Land and Buildings | Nova Scotia, Canada

Disclosure of detailed information about borrowings [line items]

Initial loan

$ 4,375,000

Total amount available under facility

$ 4,985,000

Liabilities

4,923,170

Interest rate

1%

Borrowings interest rate basis

The facility is bearing interest at the bank’s base rate minus 1% payable monthly

Borrowings number of monthly instalments | Instalments

299

Borrowings

4,923,170

Borrowings maturity month and year

November 2047

Carrying amount of asset pledged as collateral

$ 5,665,963

$ 4,006,926

Interest expense incurred

156,522

$ 9,975

$ 0

Loan remains to be disbursed

61,830

Commercial land and buildings purchased

$ 3,550,000

Cathode Business | Commercial Land and Buildings | Nova Scotia, Canada | Forecast

Disclosure of detailed information about borrowings [line items]

Borrowings monthly principal instalment

$ 16,610

$ 18,610

Cathode Business | Equipment

Disclosure of detailed information about borrowings [line items]

Amount drawn down from facility

900,000

Contribution agreement

$ 1,000,000

ACOA, December 2017 loan

Disclosure of detailed information about borrowings [line items]

Amount drawn down from facility

500,000

Contribution agreement

$ 500,000

Day one gain on loan

$ 100,152

ACOA, October 2018 loan

Disclosure of detailed information about borrowings [line items]

Amount drawn down from facility

$ 500,000

Contribution agreement

$ 500,000

Day one gain on loan

$ 114,106

Contributed Equity - Additional

Contributed Equity - Additional Information (Details) - shares	Jun. 30, 2022	Jun. 30, 2021	Jul. 01, 2020
Disclosure Of Classes Of Share Capital [Abstract]
Number of shares issued and fully paid	485,951,369	404,601,384	348,206,772

Contributed Equity - Schedule o

Contributed Equity - Schedule of Share Capital (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021	Jul. 01, 2020
Disclosure Of Classes Of Share Capital [Abstract]
Ordinary shares Fully paid, Shares	485,951,369	404,601,384	348,206,772
Ordinary shares Fully paid	$ 458,677,068	$ 233,196,507	$ 99,851,510

Contributed Equity - Ordinary S

Contributed Equity - Ordinary Share Capital (Details)																		12 Months Ended
	May 31, 2022 shares	Mar. 08, 2022 AUD ($) $ / shares shares	Feb. 01, 2022 AUD ($) $ / shares shares	Dec. 14, 2021 shares	Sep. 30, 2021 AUD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 03, 2021 AUD ($) $ / shares shares	May 24, 2021 AUD ($) $ / shares shares	May 11, 2021 AUD ($) $ / shares shares	Mar. 16, 2021 AUD ($) $ / shares shares	Mar. 16, 2021 AUD ($) $ / shares shares	Mar. 03, 2021 AUD ($) $ / shares shares	Sep. 28, 2020 shares	Sep. 24, 2020 AUD ($) $ / shares shares	Sep. 23, 2020 AUD ($) shares	Jul. 10, 2020 AUD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Jun. 30, 2022 AUD ($) shares	Jun. 30, 2021 AUD ($) shares	Jul. 01, 2020 AUD ($) shares
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares, Balance																		485,951,369	404,601,384	348,206,772
Ordinary shares Fully paid | $																		$ 458,677,068	$ 233,196,507	$ 99,851,510
Share issue costs						$ (4,973,671)											$ (1,458,798)	$ (190,374)	$ (4,973,671)
Exercise of Options
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares		33,333					150,000	2,500,000		1,500,000	1,500,000					250,000
Issue Price | $ / shares		$ 0.50					$ 0.90	$ 0.66			$ 0.74					$ 0.80
Ordinary shares Fully paid | $		$ 16,667					$ 135,000	$ 1,650,000		$ 1,110,000	$ 1,110,000					$ 200,000
Exercise of Options | Robert Natter
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares														500,000
Issue Price | $ / shares														$ 0.90
Ordinary shares Fully paid | $														$ 450,000
Exercise of Options | Andrew Liveris
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares														2,500,000
Issue Price | $ / shares														$ 0.66
Ordinary shares Fully paid | $														$ 1,650,000
Exercise of Options
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares										30,000	30,000
Issue Price | $ / shares											$ 0.90
Ordinary shares Fully paid | $										$ 27,000	$ 27,000
Exercise of Options | Andrew Liveris
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares														2,500,000
Issue Price | $ / shares														$ 0.66
Placement to Institutional Investors
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares												39,700,000
Issue Price | $ / shares												$ 2.90
Ordinary shares Fully paid | $												$ 115,130,000
Placement Shares
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares					77,962,578
Issue Price | $ / shares					$ 2.67
Ordinary shares Fully paid | $					$ 208,138,475
Exercise of Performance Rights
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares	87,500			1,291,851						3,400,000	3,400,000		158,865
KORE Power Consideration Shares
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares			1,974,723
Issue Price | $ / shares			$ 8.87
Ordinary shares Fully paid | $			$ 17,515,793
Exercise of Options
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares										33,333	33,333
Issue Price | (per share)										$ 0.50	$ 0.50
Ordinary shares Fully paid | $										$ 16,667	$ 16,667
Placement to Directors
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares									5,672,414
Issue Price | $ / shares									$ 2.90
Ordinary shares Fully paid | $									$ 16,450,001
Settlement of Limited Recourse Loan
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares															5,000,000
Ordinary shares Fully paid | $															$ 1,500,000

Contributed Equity - Ordinary_2

Contributed Equity - Ordinary Share Capital (Parenthetical) (Details)																12 Months Ended
	May 31, 2022 shares	Mar. 08, 2022 AUD ($) $ / shares shares	Feb. 01, 2022 AUD ($) $ / shares shares	Dec. 14, 2021 shares	Sep. 30, 2021 AUD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 03, 2021 AUD ($) $ / shares shares	May 24, 2021 AUD ($) $ / shares shares	Mar. 16, 2021 AUD ($) $ / shares shares	Mar. 16, 2021 AUD ($) $ / shares shares	Sep. 28, 2020 shares	Sep. 24, 2020 AUD ($) $ / shares shares	Sep. 23, 2020 AUD ($) shares	Jul. 10, 2020 AUD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Jun. 30, 2022 AUD ($) shares	Jun. 30, 2021 AUD ($) shares	Jun. 30, 2020 AUD ($)	Jan. 31, 2022 USD ($) shares	Sep. 30, 2021 USD ($) shares	May 11, 2021 AUD ($) $ / shares shares	Mar. 03, 2021 $ / shares shares	Jul. 01, 2020 AUD ($) shares
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued and fully paid																485,951,369	404,601,384						348,206,772
Share issue expenses						$ 7,908,866										$ 190,374	$ 7,908,866	$ 1,308,596
Share issue costs						$ 4,973,671									$ 1,458,798	190,374	4,973,671
Raised capital | $																$ 458,677,068	$ 233,196,507						$ 99,851,510
Ordinary Shares
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued																					5,672,414
Raised capital | $																					$ 16.45
Ordinary Shares | Trevor St Baker's
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued																					4,137,931
Par value per share | $ / shares																					$ 2.90
Ordinary Shares | Andrew Liveris
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued																					1,034,483
Par value per share | $ / shares																					$ 2.90
Ordinary Shares | Robert Natter
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued																					431,034
Par value per share | $ / shares																					$ 2.90
Ordinary Shares | Robert Cooper
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued																					68,966
Par value per share | $ / shares																					$ 2.90
Institutional Placement
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued and fully paid																						39,700,000
Par value per share | $ / shares																						$ 2.90
Placement Shares
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares					$ 2.67
Number of Shares					77,962,578
Raised capital | $					$ 208,138,475
Placement Shares | Phillips 66 Company
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares					$ 2.67
Number of shares issued					77,962,578															77,962,578
Raised capital | $																				$ 150,000,000
Exercise of Options
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares		$ 0.50					$ 0.90	$ 0.66		$ 0.74				$ 0.80
Number of Shares		33,333					150,000	2,500,000	1,500,000	1,500,000				250,000
Raised capital | $		$ 16,667					$ 135,000	$ 1,650,000	$ 1,110,000	$ 1,110,000				$ 200,000
Exercise of Options | Andrew Liveris
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares												$ 0.66
Number of Shares												2,500,000
Raised capital | $												$ 1,650,000
Exercise of Options | Robert Natter
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares												$ 0.90
Number of Shares												500,000
Raised capital | $												$ 450,000
Exercise of Options
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares										$ 0.90
Number of Shares									30,000	30,000
Raised capital | $									$ 27,000	$ 27,000
Exercise of Options | Andrew Liveris
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares												$ 0.66
Number of Shares												2,500,000
Exercise of Options
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | (per share)									$ 0.50	$ 0.50
Number of Shares									33,333	33,333
Raised capital | $									$ 16,667	$ 16,667
KORE Power Consideration Shares
Disclosure Of Classes Of Share Capital [Line Items]
Issue Price | $ / shares			$ 8.87
Number of Shares			1,974,723
Number of common stock shares acquired																			3,333,333
Percentage of common equity																			5%
Percentage of cash settled in business combination																			50%
Percentage of shares settled in business combination																			50%
Consideration amount | $																			$ 25,000,000
Raised capital | $			$ 17,515,793
KORE Power Consideration Shares | Ordinary Shares
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued																			1,974,723
Settlement of Limited Recourse Loan
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares													5,000,000
Vested performance rights													736,968
Limited resource loan | $													$ 1,500,000
Conversion ratio of ordinary shares													1
Market value | $													$ 1,252,846
Number of outstanding net employee entitlements amounting | $													247,154
Raised capital | $													$ 1,500,000
Exercise of Performance Rights
Disclosure Of Classes Of Share Capital [Line Items]
Number of Shares	87,500			1,291,851					3,400,000	3,400,000	158,865
Number of shares issued	87,500			599,851					3,400,000	3,400,000	158,865
Number of vested performance rights	87,500			1,291,851					3,400,000	3,400,000	158,865
Exercise of Performance Rights | Robert Natter
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued				200,000
Exercise of Performance Rights | Anthony Bellas
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued				200,000
Exercise of Performance Rights | Nick Liveris
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued				107,851
Exercise of Performance Rights | Chris Burns
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued				92,000
Exercise of Performance Rights | Philip St Baker
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued				600,000
Exercise of Performance Rights | Employees
Disclosure Of Classes Of Share Capital [Line Items]
Number of shares issued				92,000

Reserves - Summary of Reserves

Reserves - Summary of Reserves (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure of reserves within equity [line items]
Share-based payment reserve	$ 44,254,362	$ 27,513,594	$ 22,817,908
Foreign currency translation reserve	8,566,362	(600,850)	1,500,247
Convertible loan note reserve	6,219,812	6,219,812
Reserves	59,040,536	33,132,556
Balance at the beginning of the year	184,395,802	66,532,293	15,772,778
Settlement of limited recourse loan		247,154	1,189,081
Equity settled share-based payments	16,740,768	5,948,532	7,558,952
Balance at the end of the year	364,343,319	184,395,802	66,532,293
Share-based Payment Reserve
Disclosure of reserves within equity [line items]
Balance at the beginning of the year	27,513,594	22,817,908	15,258,956
Settlement of limited recourse loan		(1,252,846)
Performance rights net-settled in current period (refer note 28)	(3,426,420)
Equity settled share-based payments	20,190,538	5,948,532	6,369,871
Exchange differences	(23,350)
Balance at the end of the year	44,254,362	27,513,594	22,817,908
Foreign Currency Translation Reserve
Disclosure of reserves within equity [line items]
Balance at the beginning of the year	(600,850)	1,500,247	950,004
Exchange differences on translation of foreign operations	9,167,212	(2,101,097)	550,243
Balance at the end of the year	8,566,362	(600,850)	1,500,247
Convertible Loan Note Reserve
Disclosure of reserves within equity [line items]
Balance at the beginning of the year	6,219,812	6,219,812
Balance at the end of the year	$ 6,219,812	$ 6,219,812	$ 6,219,812

Reserves - Additional Informati

Reserves - Additional Information (Details)	12 Months Ended
	Jun. 30, 2022 AUD ($)
August 2019 Loan Notes
Disclosure of reserves within equity [line items]
Present value of liability component of notes issued	$ 3,009,259
Convertible note reserve recognized	$ 990,741
Financial instrument effective interest rate	24.25%
March 2019 Loan Notes
Disclosure of reserves within equity [line items]
Present value of liability component of notes issued	$ 5,170,660
Convertible note reserve recognized	$ 1,702,340
Financial instrument effective interest rate	24.50%
August 2018 Loan Notes
Disclosure of reserves within equity [line items]
Present value of liability component of notes issued	$ 4,361,289
Convertible note reserve recognized	$ 1,100,611
Financial instrument effective interest rate	25.60%

Operating Segments - Schedule o

Operating Segments - Schedule of Segment Performance (Details) - AUD ($)		12 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure Of Operating Segments [Line Items]
Segment revenue	[1]	$ 8,417,763	$ 5,227,347	$ 4,253,435
Other income		2,190,696	949,586	844,154
Interest income		11,471	35,066	723
Total income		10,619,930	6,211,999	5,098,312
Segment net profit / (loss) before tax		(71,441,024)	(18,076,077)	(20,028,526)
Operating Segments | Battery Materials
Disclosure Of Operating Segments [Line Items]
Other income		531,850	69,204
Total income		531,850	69,204
Segment net profit / (loss) before tax		(28,538,900)	(11,968,654)
Operating Segments | Battery Technology
Disclosure Of Operating Segments [Line Items]
Segment revenue	[1]	8,417,763	5,227,347	4,253,435
Other income		1,658,846	798,882	785,154
Interest income		6,042
Total income		10,082,651	6,026,229	5,038,589
Segment net profit / (loss) before tax		(8,730,995)	(63,661)	(853,084)
Operating Segments | Graphite Exploration and Mining
Disclosure Of Operating Segments [Line Items]
Segment net profit / (loss) before tax			(46,424)	(7,426,978)
Unallocated
Disclosure Of Operating Segments [Line Items]
Other income			81,500	59,000
Interest income		5,429	35,066	723
Total income		5,429	116,566	59,723
Segment net profit / (loss) before tax		$ (34,171,129)	$ (5,997,338)	$ (11,748,464)
[1] 1 See Note 3, Revenue , for segment revenue by product line for the years ended June 30, 2022, 2021 and 2020.

Operating Segments - Schedule_2

Operating Segments - Schedule of Segment Assets (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Operating Segments [Line Items]
Segment assets	$ 439,561,402	$ 202,857,273
Operating Segments | Battery Materials
Disclosure Of Operating Segments [Line Items]
Segment assets	197,613,494	47,899,929
Operating Segments | Battery Technology
Disclosure Of Operating Segments [Line Items]
Segment assets	27,616,815	13,990,451
Operating Segments | Graphite Exploration and Mining
Disclosure Of Operating Segments [Line Items]
Segment assets	3,229,178	3,116,523
Unallocated
Disclosure Of Operating Segments [Line Items]
Segment assets	$ 211,101,915	$ 137,850,370

Operating Segments - Schedule_3

Operating Segments - Schedule of Segment Liabilities (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Operating Segments [Line Items]
Liabilities	$ 75,218,083	$ 18,461,471
Operating Segments | Battery Materials
Disclosure Of Operating Segments [Line Items]
Liabilities	59,326,240	9,277,070
Operating Segments | Battery Technology
Disclosure Of Operating Segments [Line Items]
Liabilities	13,003,443	7,440,067
Unallocated
Disclosure Of Operating Segments [Line Items]
Liabilities	$ 2,888,400	$ 1,744,334

Operating segments - Additional

Operating segments - Additional Information (Details)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
North America
Disclosure Of Operating Segments [Line Items]
Percentage of entity's revenue	79%	82%	77%
Asia
Disclosure Of Operating Segments [Line Items]
Percentage of entity's revenue	17%	8%	13%
Europe
Disclosure Of Operating Segments [Line Items]
Percentage of entity's revenue	4%	10%	10%

Cash Flow Information - Summary

Cash Flow Information - Summary of Reconciliation of Profit / Loss After Income Tax (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Cash Flow Information [Abstract]
Loss for the period	$ (71,441,024)	$ (18,076,077)	$ (20,028,526)
Adjustments for
Share based compensation	20,190,538	5,948,532	7,558,953
Borrowing costs	64,297	760	5,098,906
Fixed assets written off		2,764,940	210,773
Loss on sale of fixed assets		6,777
Loss on equity investment securities at fair value through profit or loss	10,951,552
Foreign exchange (gain) / loss	(7,194,955)	106,787	387,371
Non-cash termination settlement		294,247
Depreciation & amortization expense	5,814,905	1,697,754	1,380,303
Government incentives	(302,922)	(49,278)
Change in operating assets and liabilities:
(Increase)/decrease in other operating assets	(6,028,224)	(1,927,128)	(976,969)
Increase in trade creditors and other operating liabilities	7,592,541	1,060,622	775,672
Net cash outflow from operating activities	$ (40,353,292)	$ (8,172,064)	$ (5,593,517)

Cash Flow Information - Summa_2

Cash Flow Information - Summary of Analysis of Net Debt and Movements in Net Debt (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2019
Disclosure of reconciliation of liabilities arising from financing activities [line items]
Cash and cash equivalents	$ 207,083,935	$ 136,663,976	$ 38,807,662	$ 6,054,664
Lease liability - repayable within one year	(489,846)	(410,792)
Borrowings - repayable within one year (including overdraft)	(1,474,090)	(277,060)
Lease liability - repayable after one year	(7,265,686)	(7,120,396)
Borrowings - repayable after one year	(52,152,452)	(5,986,565)
Net cash (debt)	145,701,861	122,869,163
Cash and cash equivalents	207,083,935	136,663,976	$ 38,807,662	$ 6,054,664
Gross debt - fixed interest rates	(9,518,941)	(8,386,881)
Gross debt - variable interest rates	(51,863,133)	(5,407,932)
Net cash (debt)	145,701,861	122,869,163
Cash flows from financing activities
Beginning Balance	122,869,163	33,675,547
Cashflows	(17,007,804)	94,156,418
Other non-cash movements	5,824,894	(4,962,802)
Ending Balance	145,701,861	122,869,163
Cash
Cash flows from financing activities
Beginning Balance	136,663,976	38,807,662
Cashflows	61,654,881	97,856,314
Other non-cash movements	8,765,078
Ending Balance	207,083,935	136,663,976
Borrowings due within 1year
Cash flows from financing activities
Beginning Balance	(687,852)	(416,041)
Cashflows	669,246	329,873
Other non-cash movements	(1,945,330)	(601,684)
Ending Balance	(1,963,936)	(687,852)
Borrowings due after 1 year
Cash flows from financing activities
Beginning Balance	(13,106,961)	(4,716,074)
Cashflows	(45,316,323)	(4,029,769)
Other non-cash movements	(994,854)	(4,361,118)
Ending Balance	$ (59,418,138)	$ (13,106,961)

Interests in Subsidiaries - Sum

Interests in Subsidiaries - Summary of Information About Principal Subsidiaries (Details)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
MD South Tenements Pty Ltd
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Name of entity	MD South Tenements Pty Ltd
Place of business / country of incorporation	Australia
Functional Currency	AUD
Ownership interest held of the group	100%	100%
Principal activities	Graphite exploration
Novonix Battery Technology Services Inc
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Name of entity	Novonix Battery Technology Solutions, Inc.
Place of business / country of incorporation	Canada
Functional Currency	CAN
Ownership interest held of the group	100%	100%
Principal activities	Battery technology services.
Novonix Corp
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Name of entity	Novonix Corp
Place of business / country of incorporation	USA
Functional Currency	USD
Ownership interest held of the group	100%	100%
Principal activities	Investment
Novonix Anode Materials LLC
Disclosure Of Significant Investments In Subsidiaries [Line Items]
Name of entity	Novonix Anode Materials, LLC
Place of business / country of incorporation	USA
Functional Currency	USD
Ownership interest held of the group	100%	100%
Principal activities	Battery materials development

Share-Based Payments - Addition

Share-Based Payments - Additional Information (Details)						12 Months Ended
	Mar. 14, 2021 AUD ($) shares	Dec. 14, 2020 AUD ($) shares	Jan. 16, 2020 AUD ($) shares Tranches	Dec. 07, 2019 AUD ($) shares Tranches	Jul. 08, 2019 AUD ($) shares Tranches	Jun. 30, 2022 AUD ($) shares	Jun. 30, 2021 shares $ / shares	Jun. 30, 2020 shares $ / shares	Jun. 30, 2022 USD ($)	Jun. 30, 2022 $ / shares
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Granted						4,676,946	3,500,000
Performance rights forfeited						200,000	1,000,000
Weighted average remaining contractual life of outstanding share options						4 years 9 months 18 days	5 years 9 months 18 days
Exercise price | $ / shares							$ 0.51			$ 0.51
Number of share options awarded						0
Top of Range
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Exercise price | $ / shares							1.40	$ 1.40		1.40
Bottom of Range
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Exercise price | $ / shares							$ 0.50	$ 0.50		$ 0.50
Employee
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of share options awarded	100,000	100,000	1,000,000	1,000,000	2,500,000
Fair value of options | $	$ 247,297	$ 83,444	$ 377,390	$ 456,580	$ 804,375
Number of tranche options vest | Tranches			10	10	10
Performance Rights and Options
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Dividend or voting rights						The performance rights and options carry no dividend or voting rights.
Number of performance right and option convertible to ordinary share						1
Performance Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Granted						5,344,777
Number of performance right convertible to ordinary shares						1
Performance rights forfeited						200,000
Share Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Dividend or voting rights						The share rights carry no dividend or voting rights.
Number of share right convertible to ordinary share						1
Granted						309,049	0	0
Performance rights forfeited						6,510
Share Rights | Non-Executive Directors
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share rights issuing fixed value | $									$ 110,000
Number of share rights convertible to ordinary shares						1
Share-based compensation expense recognized | $						$ 3,615,341

Share-Based Payments - Composit

Share-Based Payments - Composition of Share Based Payments Expense (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Share rights granted in current year	$ 3,615,341
Performance rights granted in current year	15,034,334	$ 2,952,676	$ 78,362
Performance rights granted in prior years	265,293
Options granted in current year			113,199
Options granted in prior years	1,275,570	2,995,856	7,367,392
Total expense from share-based payment transactions	20,190,538	5,948,532	7,558,953
Payments of withholding tax - Performance rights	(3,426,420)
Exchange differences	(23,350)
Movement in share-based payments reserve	$ 16,740,768	$ 5,948,532	$ 7,558,953

Share-Based Payments - Summary

Share-Based Payments - Summary of Movements of All Share Rights Issued (Details) - shares	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Beginning balance	1,600,000	3,395,833	3,395,833
Granted	4,676,946	3,500,000
Forfeited	(200,000)	(1,000,000)
Ending balance	5,057,277	1,600,000	3,395,833
Exercisable		600,000	2,395,833
Share Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Granted	309,049	0	0
Forfeited	(6,510)
Ending balance	302,539
Exercisable	302,539

Share-Based Payments - Summar_2

Share-Based Payments - Summary of Share Rights (Details)		12 Months Ended
		Jun. 30, 2022 AUD ($) shares $ / shares	Jun. 30, 2021 shares	Jun. 30, 2020 shares
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number		4,676,946	3,500,000
Share Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number		309,049	0	0
Share Rights | Non-Executive Directors
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Expense recognized | $		$ 3,615,341
Share Rights | Anthony Bellas
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date		Nov. 30, 2021
Number		66,000
Vesting date		Jun. 30, 2022
Fair value | $ / shares		$ 11.95
Expiry		Jun. 30, 2023
Expense recognized | $		$ 788,700
Share Rights | Andrew Liveris
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date		Nov. 30, 2021
Number		66,000
Vesting date		Jun. 30, 2022
Fair value | $ / shares		$ 11.95
Expiry		Jun. 30, 2023
Expense recognized | $		$ 788,700
Share Rights | Robert Cooper
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date		Nov. 30, 2021
Number		66,000
Vesting date		Jun. 30, 2022
Fair value | $ / shares		$ 11.95
Expiry		Jun. 30, 2023
Expense recognized | $		$ 788,700
Share Rights | Zhanna Golodryga
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date		Nov. 30, 2021
Number		17,549
Vesting date		Jun. 30, 2022
Fair value | $ / shares		$ 11.95
Expiry		Jun. 30, 2023
Expense recognized | $		$ 209,711
Share Rights | Trevor St Baker
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date		Nov. 30, 2021
Number		66,000
Vesting date		Jun. 30, 2022
Fair value | $ / shares		$ 11.95
Expiry		Jun. 30, 2023
Expense recognized | $	[1]	$ 710,905
Share Rights | Greg Baynton
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date		Nov. 30, 2021
Number		27,500
Vesting date		Jun. 30, 2022
Fair value | $ / shares		$ 11.95
Expiry		Jun. 30, 2023
Expense recognized | $	[2]	$ 328,625
[1] Trevor St Baker resigned as a Director on May 26, 2022, causing 6,510 of share rights previously issued to him to be forfeited. Greg Baynton retired as a Director on November 30, 2021 but retained his performance rights. The expense associated with his Share Rights was accelerated and the full value of the share rights was recognized at his retirement date

Share-Based Payments - Summar_3

Share-Based Payments - Summary of Share Rights (Parenthetical) (Details) - shares		12 Months Ended
	May 26, 2022	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Forfeited		200,000	1,000,000
Share Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Forfeited		6,510
Trevor St Baker | Share Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Forfeited	6,510

Share-Based Payments - Summar_4

Share-Based Payments - Summary of Movements of All Performance Rights Issued (Details) - shares		12 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Beginning balance		1,600,000	3,395,833	3,395,833
Granted		4,676,946	3,500,000
Awarded	[1]	667,831
Forfeited		(200,000)	(1,000,000)
Exercised		(1,687,500)	(3,558,865)
Settled			(736,968)
Ending balance		5,057,277	1,600,000	3,395,833
Exercisable			600,000	2,395,833
[1] Performance rights awarded to Key Management Personnel that are subject to shareholder approval which will be sought at the 2022 Annual General Meeting of Shareholders scheduled for October 26, 2022.

Share-Based Payments - Summar_5

Share-Based Payments - Summary of Performance Rights (Details)				12 Months Ended
		Jan. 28, 2022 shares	Nov. 30, 2021 shares	Jun. 30, 2022 AUD ($) shares $ / shares	Jun. 30, 2021 AUD ($) shares	Jun. 30, 2020 AUD ($)
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number				4,676,946	3,500,000
Expense recognized | $				$ 20,190,538	$ 5,948,532	$ 7,558,953
Performance Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number				5,344,777
Expense recognized | $				$ 15,034,334
Performance Rights | Key Management Personnel
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number			800,000
Performance Rights | Key Management Personnel | Rashda Buttar
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number		255,238
Performance Rights | Key Management Personnel | Rashda Buttar | Grant Date, One
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Oct. 06, 2021
Number				150,000
Vesting date, tranche one				Apr. 22, 2022
Vesting date, tranche two				Apr. 22, 2023
Vesting date, tranche three				Apr. 22, 2024
Vesting date, tranche four				Apr. 22, 2025
Fair value | $ / shares				$ 4.92
Expiry date, term				Cessation of employment
Expense recognized | $				$ 363,094
Performance Rights | Key Management Personnel | Rashda Buttar | Grant Date, Two
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Jan. 28, 2022
Number				255,238
Vesting date				Jun. 30, 2024
Fair value | $ / shares				$ 7.21
Expiry date, term				Cessation of employment
Expense recognized | $				$ 318,508
Performance Rights | Key Management Personnel | Anthony Bellas
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Nov. 30, 2021
Number				200,000
Vesting date				Nov. 30, 2021
Fair value | $ / shares				$ 11.95
Expiry date				Jun. 30, 2022
Expense recognized | $				$ 2,390,000
Performance Rights | Key Management Personnel | Robert Natter
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Nov. 30, 2021
Number				200,000
Vesting date				Nov. 30, 2021
Fair value | $ / shares				$ 11.95
Expiry date				Jun. 30, 2022
Expense recognized | $				$ 2,390,000
Performance Rights | Key Management Personnel | Nick Liveris
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Vesting date				Nov. 30, 2021
Performance Rights | Key Management Personnel | Nick Liveris | Grant Date, One
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Nov. 30, 2021
Number				200,000
Vesting date				Nov. 30, 2021
Fair value | $ / shares				$ 11.95
Expiry date				Jun. 30, 2022
Expense recognized | $				$ 2,390,000
Performance Rights | Key Management Personnel | Nick Liveris | Grant Date, Two
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date		Jan. 28, 2022		Jan. 28, 2022
Number		667,831		667,831
Vesting date				Jun. 30, 2024
Fair value | $ / shares	[1]			$ 2.28
Expiry date, term				Cessation of employment
Expense recognized | $				$ 263,536
Performance Rights | Key Management Personnel | Chris Burns
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Vesting date				Nov. 30, 2021
Performance Rights | Key Management Personnel | Chris Burns | Grant Date, One
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Nov. 30, 2021
Number				200,000
Vesting date				Nov. 30, 2021
Fair value | $ / shares				$ 11.95
Expiry date				Jun. 30, 2022
Expense recognized | $				$ 2,390,000
Performance Rights | Key Management Personnel | Chris Burns | Grant Date, Two
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Jan. 28, 2022
Number				1,412,000
Vesting date				Jun. 30, 2024
Fair value | $ / shares				$ 7.21
Expiry date, term				Cessation of employment
Expense recognized | $				$ 1,762,013
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Vesting date				Dec. 11, 2021
Vesting date, term				4 equal annual tranches commencing on the anniversary of employment
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Jul. 01, 2021
Number				1,000,000
Vesting date, tranche one				Jun. 30, 2022
Vesting date, tranche two				Jun. 30, 2023
Vesting date, tranche three				Jun. 30, 2024
Vesting date, tranche four				Jun. 30, 2025
Fair value | $ / shares				$ 2.32
Expiry date, term				Cessation of employment
Expense recognized | $				$ 1,208,731
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Oct. 06, 2021
Number				220,000
Fair value | $ / shares				$ 4.92
Expiry date, term				Cessation of employment
Expense recognized | $				$ 327,301
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Dec. 02, 2021
Number				100,000
Fair value | $ / shares				$ 12.15
Expiry date, term				Cessation of employment
Expense recognized | $				$ 540,801
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Dec. 20, 2021
Number				15,589
Fair value | $ / shares				$ 8.88
Expiry date, term				Cessation of employment
Expense recognized | $				$ 37,916
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Oct. 06, 2021
Number				500,000
Fair value | $ / shares				$ 4.92
Expiry date, term				Cessation of employment
Expense recognized | $				$ 614,522
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Feb. 14, 2022
Number				20,000
Fair value | $ / shares				$ 5.81
Expiry date, term				Cessation of employment
Expense recognized | $				$ 20,226
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Feb. 24, 2022
Number				6,009
Fair value | $ / shares				$ 4.82
Expiry date, term				Cessation of employment
Expense recognized | $				$ 5,095
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Apr. 12, 2022
Number				42,317
Fair value | $ / shares				$ 5.90
Expiry date, term				Cessation of employment
Expense recognized | $				$ 5,408
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Apr. 20, 2022
Number				11,359
Fair value | $ / shares				$ 6.01
Expiry date, term				Cessation of employment
Expense recognized | $				$ 876
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				May 02, 2022
Number				17,430
Fair value | $ / shares				$ 5.01
Expiry date, term				Cessation of employment
Expense recognized | $				$ 1,245
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				May 23, 2022
Number				53,200
Fair value | $ / shares				$ 3.93
Expiry date, term				Cessation of employment
Expense recognized | $				$ 3,046
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				May 28, 2022
Number				10,853
Fair value | $ / shares				$ 3.73
Expiry date, term				Cessation of employment
Expense recognized | $				$ 577
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Jun. 06, 2022
Number				11,400
Fair value | $ / shares				$ 3.51
Expiry date, term				Cessation of employment
Expense recognized | $				$ 114
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Jun. 15, 2022
Number				40,698
Fair value | $ / shares				$ 2.47
Expiry date, term				Cessation of employment
Expense recognized | $				$ 1,290
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Grant date				Jun. 22, 2022
Number				10,853
Fair value | $ / shares				$ 2.27
Expiry date, term				Cessation of employment
Expense recognized | $				$ 35
[1] On January 28, 2022 667,831 performance rights were awarded to Nick Liveris. These performance rights are subject to shareholder approval which will be sought at the 2022 Annual General Meeting of shareholders and have not been formerly granted at June 30, 2022. The fair value per performance right represents an estimate at June 30, 2022 of the grant date fair value of the performance rights.

Share-Based Payments - Summar_6

Share-Based Payments - Summary of Performance Rights (Parenthetical) (Details) - shares			12 Months Ended
	Jan. 28, 2022	Nov. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Performance rights awarded			4,676,946	3,500,000
Performance Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Performance rights awarded			5,344,777
Performance Rights | Key Management Personnel
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Performance rights awarded		800,000
Performance Rights | Key Management Personnel | Nick Liveris | Grant Date, Two
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Performance rights awarded	667,831		667,831
Grant date	Jan. 28, 2022		Jan. 28, 2022

Share-Based Payments - Summar_7

Share-Based Payments - Summary of Group Net Settled in Share-Based Payments (Details)	12 Months Ended
	Jun. 30, 2022 AUD ($) shares	Jun. 30, 2021 shares
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Performance rights vested & exercised	1,687,500	3,558,865
Withholding obligation | $	$ 3,426,420
Performance Rights
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Withholding obligation | $	$ 3,426,420
Performance Rights | Key Management Personnel | Chris Burns
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Vesting date	Nov. 30, 2021
Performance rights vested & exercised	200,000
Net settled shares	92,000
Withholding obligation | $	$ 1,290,600
Performance Rights | Key Management Personnel | Nick Liveris
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Vesting date	Nov. 30, 2021
Performance rights vested & exercised	200,000
Net settled shares	107,851
Withholding obligation | $	$ 1,101,180
Performance Rights | Non-KMP employees
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Vesting date	Dec. 11, 2021
Performance rights vested & exercised	200,000
Net settled shares	92,000
Withholding obligation | $	$ 1,034,640

Share-Based Payments - Summar_8

Share-Based Payments - Summary of Movements of Options Issued (Details)	12 Months Ended
	Jun. 30, 2022 shares $ / shares
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Options outstanding, Beginning balance	32,103,334
Granted	0
Forfeited	(2,740,000)
Exercised	(33,333)
Options outstanding, Ending balance	29,330,001
Options exercisable	13,796,667
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 0.51
Weighted Average Exercise Price, Forfeited | $ / shares	0.53
Weighted Average Exercise Price, Exercised | $ / shares	0.50
Weighted Average Exercise Price, Ending Balance | $ / shares	0.51
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.52

Share-Based Payments - Valuatio

Share-Based Payments - Valuations of Options Granted (Details)	Mar. 14, 2021 shares $ / shares	Dec. 14, 2020 shares $ / shares	Jan. 16, 2020 shares $ / shares	Dec. 07, 2019 shares $ / shares	Jul. 08, 2019 shares $ / shares	Jun. 30, 2022 shares	Jun. 30, 2021 shares
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares						29,330,001	32,103,334
Employee | Tranche 1
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares	33,333	33,333	100,000	100,000	250,000
Exercise price	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50
Award date	Mar. 14, 2021	Dec. 14, 2020	Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date	Mar. 14, 2021	Dec. 14, 2030	Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date	Feb. 24, 2022	Feb. 24, 2021	May 31, 2022	May 31, 2022	May 31, 2022
Volatility	96.28%	94.20%	82.80%	84.89%	85.08%
Dividend yield	0%	0%	0%	0%	0%
Risk-free interest rate	1.72%	0.98%	1.18%	1.14%	1.32%
Fair value at grant date	$ 2.4101	$ 0.7878	$ 0.3541	$ 0.4274	$ 0.3026
Employee | Tranche 2
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares	33,333	33,333	100,000	100,000	250,000
Exercise price	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50
Award date	Mar. 14, 2021	Dec. 14, 2020	Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date	Mar. 14, 2031	Dec. 14, 2030	Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date	Feb. 24, 2023	Feb. 24, 2022	Mar. 31, 2023	Mar. 31, 2023	Mar. 31, 2023
Volatility	96.28%	94.20%	82.80%	84.89%	85.08%
Dividend yield	0%	0%	0%	0%	0%
Risk-free interest rate	1.72%	0.98%	1.18%	1.14%	1.32%
Fair value at grant date	$ 2.4811	$ 0.8394	$ 0.3648	$ 0.4415	$ 0.3115
Employee | Tranche 3
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares	33,334	33,334	100,000	100,000	250,000
Exercise price	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50
Award date	Mar. 14, 2021	Dec. 14, 2020	Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date	Mar. 14, 2031	Dec. 14, 2030	Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date	Feb. 24, 2024	Feb. 24, 2023	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2023
Volatility	96.28%	94.20%	82.80%	84.89%	85.08%
Dividend yield	0%	0%	0%	0%	0%
Risk-free interest rate	1.72%	0.98%	1.18%	1.14%	1.32%
Fair value at grant date	$ 2.5277	$ 0.8758	$ 0.3726	$ 0.4513	$ 0.3179
Employee | Tranche 4
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares			100,000	100,000	250,000
Exercise price			$ 0.50	$ 0.50	$ 0.50
Award date			Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date			Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date			Nov. 30, 2023	Nov. 30, 2023	Nov. 30, 2023
Volatility			82.80%	84.89%	85.08%
Dividend yield			0%	0%	0%
Risk-free interest rate			1.18%	1.14%	1.32%
Fair value at grant date			$ 0.3753	$ 0.4543	$ 0.3201
Employee | Tranche 5
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares			100,000	100,000	250,000
Exercise price			$ 0.50	$ 0.50	$ 0.50
Award date			Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date			Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date			Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2023
Volatility			82.80%	84.89%	85.08%
Dividend yield			0%	0%	0%
Risk-free interest rate			1.18%	1.14%	1.32%
Fair value at grant date			$ 0.3809	$ 0.4611	$ 0.3248
Employee | Tranche 6
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares			100,000	100,000	250,000
Exercise price			$ 0.50	$ 0.50	$ 0.50
Award date			Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date			Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date			Feb. 28, 2024	Feb. 28, 2024	Feb. 28, 2024
Volatility			82.80%	84.89%	85.08%
Dividend yield			0%	0%	0%
Risk-free interest rate			1.18%	1.14%	1.32%
Fair value at grant date			$ 0.3819	$ 0.4623	$ 0.3255
Employee | Tranche 7
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares			100,000	100,000	250,000
Exercise price			$ 0.50	$ 0.50	$ 0.50
Award date			Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date			Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date			Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2024
Volatility			82.80%	84.89%	85.08%
Dividend yield			0%	0%	0%
Risk-free interest rate			1.18%	1.14%	1.32%
Fair value at grant date			$ 0.3832	$ 0.4636	$ 0.3264
Employee | Tranche 8
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares			100,000	100,000	250,000
Exercise price			$ 0.50	$ 0.50	$ 0.50
Award date			Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date			Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date			Apr. 30, 2024	Apr. 30, 2024	Apr. 30, 2024
Volatility			82.80%	84.89%	85.08%
Dividend yield			0%	0%	0%
Risk-free interest rate			1.18%	1.14%	1.32%
Fair value at grant date			$ 0.3839	$ 0.4644	$ 0.3270
Employee | Tranche 9
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares			100,000	100,000	250,000
Exercise price			$ 0.50	$ 0.50	$ 0.50
Award date			Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date			Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date			May 31, 2024	May 31, 2024	May 31, 2024
Volatility			82.80%	84.89%	85.08%
Dividend yield			0%	0%	0%
Risk-free interest rate			1.18%	1.14%	1.32%
Fair value at grant date			$ 0.3883	$ 0.4696	$ 0.3307
Employee | Tranche 10
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]
Number of options | shares			100,000	100,000	250,000
Exercise price			$ 0.50	$ 0.50	$ 0.50
Award date			Jan. 16, 2020	Dec. 07, 2019	Jul. 08, 2019
Expiry date			Jan. 16, 2030	Dec. 07, 2029	Jul. 08, 2029
Vesting date			Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2024
Volatility			82.80%	84.89%	85.08%
Dividend yield			0%	0%	0%
Risk-free interest rate			1.18%	1.14%	1.32%
Fair value at grant date			$ 0.3889	$ 0.4703	$ 0.3310

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details)						12 Months Ended
	Jan. 28, 2022 shares	Nov. 30, 2021 shares $ / shares	Mar. 16, 2021 shares	Dec. 14, 2020 shares $ / shares	Sep. 23, 2020 AUD ($)	Jun. 30, 2022 AUD ($) shares	Jun. 30, 2021 AUD ($) shares	Jun. 30, 2020 AUD ($) $ / shares shares	Jun. 30, 2020 USD ($)	Mar. 31, 2020 AUD ($)
Disclosure of transactions between related parties [line items]
Granted						4,676,946	3,500,000
Expense recognized | $						$ 20,190,538	$ 5,948,532	$ 7,558,953
Exercised/Vested						1,687,500	3,558,865
Unsecured loan | $						$ 1,763,410	$ 855,693
Proceeds on issue of shares | $						$ 208,290,142	136,818,667	45,845,239
Description of transactions with related party						There were no other related party transactions during the current or prior financial years.
Performance Rights
Disclosure of transactions between related parties [line items]
Granted						5,344,777
Number Of Performance Right Convertible To Ordinary Shares						1
Settlement of Limited Recourse Loan
Disclosure of transactions between related parties [line items]
Limited resource loan | $					$ 1,500,000
Greg Baynton
Disclosure of transactions between related parties [line items]
Exercised/Vested			300,000
Chris Burns, CEO
Disclosure of transactions between related parties [line items]
Exercised/Vested			1,800,000
Nick Liveris, CFO
Disclosure of transactions between related parties [line items]
Exercised/Vested			900,000
Director | Short-Term Loan
Disclosure of transactions between related parties [line items]
Unsecured loan | $								$ 3,148,960
Interest rate								8%
Philip St Baker
Disclosure of transactions between related parties [line items]
Paid rent								$ 77,579	$ 52,000
Number of shares issued								67,085,100
Par Value Per Share | $ / shares								$ 0.29
Proceeds on issue of shares | $								$ 19,454,679
Philip St Baker | Loan Notes
Disclosure of transactions between related parties [line items]
Unsecured loan | $								$ 10,000,000
Face value | $ / shares								$ 0.40
Number of shares issued								38,577,232
Philip St Baker | Short-Term Loan
Disclosure of transactions between related parties [line items]
Unsecured loan | $								$ 4,000,000		$ 3,400,000
Interest rate								10%		12.50%
Number of shares issued								12,177,845
Key Management Personnel | Performance Rights
Disclosure of transactions between related parties [line items]
Granted		800,000
Key Management Personnel | Robert Natter, Chairman
Disclosure of transactions between related parties [line items]
Value of performance right with reference to market value of underlying securities | $ / shares		$ 11.95
Key Management Personnel | Robert Natter, Chairman | Performance Rights
Disclosure of transactions between related parties [line items]
Granted		200,000
Number Of Performance Right Convertible To Ordinary Shares		1
Key Management Personnel | Tony Bellas
Disclosure of transactions between related parties [line items]
Value of performance right with reference to market value of underlying securities | $ / shares		$ 11.95
Key Management Personnel | Tony Bellas | Performance Rights
Disclosure of transactions between related parties [line items]
Granted		200,000
Number Of Performance Right Convertible To Ordinary Shares		1
Issued		66,000
Key Management Personnel | Andrew Liveris | Performance Rights
Disclosure of transactions between related parties [line items]
Issued		66,000
Key Management Personnel | Robert Cooper | Performance Rights
Disclosure of transactions between related parties [line items]
Issued		66,000
Key Management Personnel | Trevor St Baker's | Performance Rights
Disclosure of transactions between related parties [line items]
Issued		66,000
Key Management Personnel | Greg Baynton | Performance Rights
Disclosure of transactions between related parties [line items]
Issued		27,500
Key Management Personnel | Zhanna Golodryga | Performance Rights
Disclosure of transactions between related parties [line items]
Issued		17,549
Key Management Personnel | Chris Burns, CEO
Disclosure of transactions between related parties [line items]
Value of performance right with reference to market value of underlying securities | $ / shares		$ 11.95
Key Management Personnel | Chris Burns, CEO | Performance Rights
Disclosure of transactions between related parties [line items]
Granted	1,412,000	200,000		1,500,000
Number Of Performance Right Convertible To Ordinary Shares	1
Performance rights vest subject to continued employment percentage	50%
Vesting percentage subject to achievement of performance conditions	50%
Key Management Personnel | Nick Liveris, CFO
Disclosure of transactions between related parties [line items]
Value of performance right with reference to market value of underlying securities | $ / shares		$ 11.95
Key Management Personnel | Nick Liveris, CFO | Performance Rights
Disclosure of transactions between related parties [line items]
Granted	667,831	200,000		750,000
Number Of Performance Right Convertible To Ordinary Shares	1
Performance rights vest subject to continued employment percentage	50%
Vesting percentage subject to achievement of performance conditions	50%
Key Management Personnel | Chris Burns, CEO and Nick Liveris, CFO | Performance Rights
Disclosure of transactions between related parties [line items]
Granted				2,250,000
Number Of Performance Right Convertible To Ordinary Shares				1
Vesting date				Jan. 04, 2021
Expiry date	Jun. 30, 2024
Value of performance right with reference to market value of underlying securities | $ / shares				$ 1.06
Expense recognized | $						$ 9,560,000	$ 2,044,286
Key Management Personnel | Rashda Buttar | Performance Rights
Disclosure of transactions between related parties [line items]
Granted	255,238
Number Of Performance Right Convertible To Ordinary Shares	1
Performance rights vest subject to continued employment percentage	50%
Vesting percentage subject to achievement of performance conditions	50%

Related Party Transactions - Su

Related Party Transactions - Summary of Strategic Placement (Details)	12 Months Ended
	Jun. 30, 2020 AUD ($) shares
Disclosure of transactions between related parties [line items]
Interest accrued	$ 3,062,598
Philip St Baker
Disclosure of transactions between related parties [line items]
Face value of loan notes and balance of short-term loan	13,400,000
Interest accrued	1,318,972
Placement proceeds	4,735,707
Total	$ 19,454,679
Shares issued (Number) | shares	67,085,100
Philip St Baker | Loan Notes
Disclosure of transactions between related parties [line items]
Face value of loan notes and balance of short-term loan	$ 10,000,000
Interest accrued	1,187,397
Total	$ 11,187,397
Shares issued (Number) | shares	38,577,232
Philip St Baker | Short-Term Loan
Disclosure of transactions between related parties [line items]
Face value of loan notes and balance of short-term loan	$ 3,400,000
Interest accrued	131,575
Total	$ 3,531,575
Shares issued (Number) | shares	12,177,845
Philip St Baker | Placement Proceeds
Disclosure of transactions between related parties [line items]
Placement proceeds	$ 4,735,707
Total	$ 4,735,707
Shares issued (Number) | shares	16,330,023

Commitments and Contingencies -

Commitments and Contingencies - Summary of Exploration Commitments (Details) - AUD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Commitments and Contingencies [Abstract]
Commitments for payments under exploration permits in existence at the reporting date but not recognised as liabilities payable	$ 23,000	$ 13,000

Commitments and Contingencies_2

Commitments and Contingencies - Summary of Significant Capital Expenditure Contracted (Details) - AUD ($)	Jun. 30, 2022	Jun. 30, 2021
Commitments and Contingencies [Abstract]
Property, plant and equipment	$ 14,893,026	$ 10,182,218

Financial Risk Management - Sum

Financial Risk Management - Summary of Financial Instruments (Details)	Jun. 30, 2022 AUD ($)	Jun. 30, 2022 CAD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2021 CAD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2020 AUD ($)	Jun. 30, 2019 AUD ($)
Financial assets
Cash and cash equivalents	$ 207,083,935			$ 136,663,976			$ 38,807,662	$ 6,054,664
Trade and other receivables	3,558,016			2,042,963
Financial assets at fair value through profit or loss	24,179,998
Total financial assets	234,821,949			138,706,939
Financial liabilities
Trade payables	3,847,509		$ 804,376	1,823,898		$ 460,536
Lease liabilities	7,755,532			7,531,188
Borrowings	53,626,542	$ 13,376		6,263,625	$ 1,919
Total financial liabilities	$ 65,229,583			$ 15,618,711

Financial Risk Management - Sch

Financial Risk Management - Schedule of Exposure to Foreign Currency Risk at the end of Reporting Period (Details)	Jun. 30, 2022 AUD ($)	Jun. 30, 2022 CAD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2021 CAD ($)	Jun. 30, 2021 USD ($)
Disclosure Of Financial Instruments [Abstract]
Cash at bank	$ 207,083,935		$ 128,936,395	$ 136,663,976		$ 69,950,408
Trade receivables	3,019,580		2,587,528	1,533,963		1,305,421
Trade payables	3,847,509		$ 804,376	1,823,898		$ 460,536
Borrowings	53,626,542	$ 13,376		6,263,625	$ 1,919
Lease liabilities	$ 7,755,532			$ 7,531,188

Financial Risk Management - Add

Financial Risk Management - Additional Information (Details)	12 Months Ended
	Jun. 30, 2022 AUD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2022 CAD ($)
Disclosure Of Financial Instruments [Abstract]
Post tax profit loss if interest rate changed by 100 basis points	$ 1,552,208	$ 1,237,193
Undrawn borrowing facilities			$ 2,095,015	$ 1,861,830

Financial Risk Management - S_2

Financial Risk Management - Summary of Contractual Maturities of Non-derivative Financial Liabilities (Details)	Jun. 30, 2022 AUD ($)	Jun. 30, 2022 CAD ($)	Jun. 30, 2021 AUD ($)	Jun. 30, 2021 CAD ($)
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Line Items]
Trade payables	$ 9,479,659
Lease liabilities	9,915,570
Borrowings	67,664,631
Total non derivatives	87,059,860
Trade payables Carrying amount	9,479,659		$ 4,356,556
Lease liabilities Carrying amount	7,755,532		7,531,188
Borrowings	53,626,542	$ 13,376	$ 6,263,625	$ 1,919
Total non derivatives Carrying amount	70,861,733
Not Later Than Six Months
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Line Items]
Trade payables	9,479,659
Lease liabilities	403,904
Borrowings	1,588,618
Total non derivatives	11,472,181
Later than six months and not later than one year [member]
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Line Items]
Lease liabilities	403,904
Borrowings	1,661,129
Total non derivatives	2,065,033
Later than one year and not later than two years [member]
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Line Items]
Lease liabilities	832,181
Borrowings	3,472,057
Total non derivatives	4,304,238
Later than two years and not later than five years [member]
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Line Items]
Lease liabilities	2,496,544
Borrowings	10,648,817
Total non derivatives	13,145,361
Later than five years [member]
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Line Items]
Lease liabilities	5,779,037
Borrowings	50,294,010
Total non derivatives	$ 56,073,047